var data={"specialtyName":"Authors and Editors in Oncology","contributorTypes":

[{"name":"Editors-in-Chief","contributors":[{"name":"George P Canellos,
MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous
Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Lowell Schnipper, MD","credentials":["Editor-in-Chief —
Oncology\n","Theodore W and Evelyn G Berenson Professor of Medicine\n","Harvard
Medical School"],"disclosure":"Consultant/Advisory Boards: Eviti [Quality/value of
care (N/A)]."}]},{"name":"Deputy Editors","contributors":[{"name":"Michael E Ross,
MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor —
Oncology"],"disclosure":""},{"name":"Diane MF Savarese, MD","credentials":["Senior
Deputy Editor — UpToDate\n","Deputy Editor — Oncology and Palliative
Care\n","Clinical Instructor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Sadhna R Vora, MD","credentials":["Deputy Editor
— Oncology\n","Instructor in Medicine\n","Harvard Medical
School"],"disclosure":""}]},{"name":"Section Editors","contributors":
[{"name":"David M Aboulafia, MD","credentials":["Section Editor — AIDS-Related
Malignancies\n","Section Head\n","Division of Hematology and Oncology\n","Virginia
Mason Medical Center\n","Clinical Professor"],"disclosure":""},{"name":"Michael B
Atkins, MD","credentials":["Section Editor — Malignant Melanoma and Other Cutaneous
Neoplasms; Cancer of the Kidney\n","Deputy Director\n","Georgetown Lombardi
Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support:
BMS [Melanoma and RCC (Nivolumab and ipilimumab)]; Roche [Melanoma (Vemurafenib and
cobimetinib); RCC (Atezolizumab and bevacizumab)]; Novartis [Melanoma (Dabrafenib
and trametinib); RCC (Pazopanib and everolimus)]. Consultant/Advisory Boards: BMS;
Merck; Novartis; Pfizer; Roche; Exelixis; Eisai [Melanoma; RCC; immunotherapy
(Everoliumus, pazopanib; dabrafenib/trametinib; axitinib, sunitinib, avelumab;
vemurafenib/cobimetinib, atezolizumab; ipilimumab/nivolumab; pembrolizumab,
interferon; cabozantinib; lenvatinib)]."},{"name":"David M Brizel,
MD","credentials":["Section Editor — Radiation Therapy\n","Leonard R Prosnitz
Professor of Radiation Oncology\n","Professor of Otolaryngology Head & Neck
Surgery\n","Duke University Cancer Institute"],"disclosure":""},{"name":"Bruce E
Brockstein, MD","credentials":["Section Editor — Cancer of the Head and
Neck\n","Clinical Professor of Medicine\n","University of Chicago Pritzker School
of Medicine"],"disclosure":"Consultant/Advisory Boards: Astra Zeneca [Immunotherapy
- head and neck and melanoma (Durvalumab, tremelimumab)]; Bristol Meyers [Melanoma,
head and neck cancer (Ipilimumab, nivolumab)]; Novartis [GIST, sarcoma, melanoma
(Imatinib, Dabrafenib, trametinib)]."},{"name":"Harold Burstein, MD,
PhD","credentials":["Section Editor — Breast Cancer\n","Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"George P Canellos,
MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous
Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Thomas F DeLaney, MD","credentials":["Section Editor — Bone and Soft
Tissue Tumors\n","Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"Don S Dizon, MD, FACP","credentials":["Section
Editor – Gynecologic Oncology\n","Head of Women's Cancers, Lifespan Cancer
Institute\n","Director of Medical Oncology, Rhode Island Hospital\n","Associate
Professor of Medicine, Warren Alpert Medical School of Brown
University"],"disclosure":"Consultant/Advisory Boards: Pfizer; Fuji Pharmaceuticals
[Chemotherapy (Biosimilars)]."},{"name":"Reed E Drews, MD","credentials":["Section
Editor — Complications of Cancer\n","Associate Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Patricia A Ganz, MD","credentials":
["Section Editor — Cancer Survivorship\n","Professor\n","UCLA Schools of Medicine
and Public Health\n","Jonsson Comprehensive Cancer Center"],"disclosure":""},
{"name":"Barbara Goff, MD","credentials":["Section Editor — Gynecologic
Oncology\n","Department Chair, Gynecologic Oncology\n","Surgeon-in-
Chief\n","University of Washington Medical Center"],"disclosure":"Employment
(Spouse): Lilly [General oncology (Gemcitabine, pemetrexed)] - No relevant conflict
on topics."},{"name":"Richard M Goldberg, MD","credentials":["Section Editor —
Gastrointestinal Cancer\n","Director of the West Virginia University Cancer
Institute and the Mary Babb Randolph Cancer Center\n","Professor of Medicine
\n","Laurence S. & Jean J. DeLynn Chair of
Oncology"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Colon cancer
(Pembrolizumab)]. Consultant/Advisory Boards: EMD Serono [Drug development
(Multiple experimental agents)]; Taiho [Drug development (TAS 102)]; Merck [GI
cancers (Pembrolizumab)]; Merck Serano [GI cancers (Multiple experimental
agents)]."},{"name":"Daniel F Hayes, MD","credentials":["Section Editor — Breast
Cancer\n","Professor of Medicine\n","University of Michigan School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen R&D, LLC
[Breast cancer (Abiraterone)]; Menarini Silicon Biosystems, LLC [Breast cancer
(CellSearch)]; Puma Biotechnology [Breast cancer (Neratinib)]; Pfizer [Breast
cancer (Palbociclib)]; AstraZeneca [Breast cancer (Circulating tumor cells)]; Eli
Lilly and Company [Breast cancer]. Speaker's Bureau: Lilly Oncology (Breast
cancer). Patent Holder: Immunicon Corporation [Inventor (05725638.0-1223-
US2005008602)]; University of Michigan [Inventor (US 8,790,878 B2)]; University of
Michigan [Inventor (US 8,951,484 B2)]. Equity Ownership/Stock Options: Oncimmune
LLC [Stock]; Inbiomotion [Stock]. Other Financial Interest: Menarini Silicon
Biosystems [Breast cancer (CellSearch)]; University of Michigan [Inventor (US
8,790,878 B2)]."},{"name":"Paul J Hesketh, MD","credentials":["Section Editor —
Supportive Care\n","Chair, Lahey Health Cancer Institute\n","Director, Thoracic
Oncology, Lahey Hospital and Medical Center\n","Professor of Medicine, Tufts
University School of Medicine"],"disclosure":""},{"name":"James R Jett,
MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine
Emeritus\n","National Jewish Health"],"disclosure":"Employment: Oncimmune
[Biomarkers for early cancer detection (Early CDT-Lung blood test)]. Equity
Ownership/Stock Options: Oncimmune [Biomarkers for early cancer detection (Early
CDT-Lung blood test)]."},{"name":"Philip W Kantoff, MD","credentials":["Section
Editor — Testicular Cancer\n","Chairman of Medicine\n","Memorial Sloan Kettering
Cancer Center"],"disclosure":""},{"name":"W Robert Lee, MD, MS, MEd","credentials":
["Section Editor — Prostate Cancer\n","Professor of Radiation Oncology\n","Duke
University Medical Center"],"disclosure":""},{"name":"Seth P Lerner,
MD","credentials":["Section Editor — Bladder Cancer\n","Beth and Dave Swalm Chair
in Urologic Oncology\n","Professor of Urology\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Endo; FKD; Viventia
[Bladder cancer (Valrubicin, Ad/IFN, Viccinium)]. Consultant/Advisory Boards:
Biocancell; UroGen; Vaxxion; Incyte; Nucleix [Bladder cancer (BC-819, Mitogel,
Vesigel)]."},{"name":"Rogerio C Lilenbaum, MD, FACP","credentials":["Section Editor
— Lung Cancer\n","Yale Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Celgene [Non-small cell lung cancer (Nab-paclitaxel)]. Consultant/Advisory
Boards: Genentech [Lung cancer (Bevacizumab/erlotinib)]; Boehringer Ingelheim [Non-
small cell lung cancer (Afatinib)]; Celgene [Non-small cell lung cancer (Nab-
paclitaxel)]; AstraZeneca [Non-small cell lung cancer (Osimertinib)]."},
{"name":"Robert Maki, MD, PhD","credentials":["Section Editor — Bone and Soft
Tissue Tumors\n","Professor of Medicine \n","Monter Cancer Center\n","Hofstra-
Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
Bayer [Medical oncology (Regorafenib)]; Gem Pharmaceuticals [Medical oncology (GPX-
150)]; Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical
oncology (Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Sarcoma
Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib,
pembrolizumab)], Tracon (TRC105). Speaker’s Bureau: ABIM [Medical oncology];
Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology
(Regorafenib, pembrolizumab)]. Consultant/Advisory Boards: ABIM [Medical
oncology]; AADi [Medical oncology (Nab-rapamycin)]; Arcus (medical oncology); Bayer
[Medical oncology (Regorafenib); Gem Pharmaceuticals [Medical oncology (GPX-150)];
Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology
(Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Lilly/Imclone [Medical
oncology (Olaratumab)]; Sarcoma Alliance for Research through Collaboration (SARC)
[Medical oncology (Regorafenib, pembrolizumab)]."},{"name":"David E Midthun,
MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine, Mayo
Clinic College of Medicine"],"disclosure":""},{"name":"John W Mucenski,
PharmD","credentials":["Section Editor — Chemotherapy
Regimens\n","Director\n","Pharmacy Operations\n","UPMC Cancer
Centers"],"disclosure":""},{"name":"Arno J Mundt, MD","credentials":["Section
Editor — Radiation Therapy\n","Chairman of Radiation Oncology\n","University of
California, San Diego"],"disclosure":""},{"name":"Larissa Nekhlyudov, MD,
MPH","credentials":["Section Editor — Cancer Survivorship\n","Associate
Professor\n","Department of Medicine\n","Brigham & Women’s Hospital\n","Harvard
Medical School"],"disclosure":""},{"name":"William K Oh, MD","credentials":
["Section Editor — Testicular Cancer\n","Professor of Medicine\n","Mount
Sinai School of Medicine\n","Chief, Division of Hematology Oncology\n","Tisch
Cancer Institute"],"disclosure":""},{"name":"Alberto S Pappo, MD","credentials":
["Section Editor — Pediatric Oncology\n","Head of Solid Malignancies
Program\n","St. Jude Children's Research Hospital"],"disclosure":""},{"name":"Lori
J Pierce, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of
Radiation Oncology\n","University of Michigan School of
Medicine"],"disclosure":""},{"name":"Jerome B Posner, MD","credentials":["Editor-
in-Chief — Neurology\n","Section Editor — Neurooncology\n","Evelyn Frew American
Cancer Society Clinical Research Professor\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"Marshall R Posner, MD","credentials":["Section
Editor — Cancer of the Head and Neck\n","Professor of Gene and Cell
Medicine\n","The Tisch Cancer Institute\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Consultant/Advisory Boards: Merck [DMC (Pembro)]; Cel Sci
[DMC (IL-2 injections)]."},{"name":"Derek Raghavan, MD, PhD, FACP,
FASCO","credentials":["Section Editor — Bladder Cancer\n","President, Levine Cancer
Institute\n","Carolinas HealthCare System\n","Charlotte, NC"],"disclosure":"Other
Financial Interest: Caris Life Sciences [Molecular prognostication (Panomic
sequencing - unpaid)]."},{"name":"Jerome P Richie, MD, FACS","credentials":
["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery;
Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Steven E Schild, MD","credentials":["Section
Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Kenneth K Tanabe,
MD","credentials":["Section Editor — Gastrointestinal Malignancies\n","Professor of
Surgery\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Nimbus Therapeutics [Hepatocellular carcinoma (ND654, Acetyl Co-A
Carboxylase allosteric inhibitor)]. Consultant/Advisory Boards: Best Doctors [GI
cancers; melanoma (Medical care)]; CRICO [Medical malpractice (Case review)].
Patent Holder: EGF SNP to determine risk for HCC [Cirrhosis, hepatocellular
carcinoma]; Use of EGFR inhibitors to prevent HCC [Cirrhosis, hepatocellular
carcinoma]. Equity Ownership/Stock Options: Helix12 [Breast cancer (Company owns IP
on selective estrogen receptor modulators for breast cancer)]."},{"name":"Eric
Vallières, MD, FRCSC","credentials":["Section Editor — Lung Cancer\n","Surgical
Director of the Lung Cancer Program\n","Swedish Cancer
Institute"],"disclosure":""},{"name":"Nicholas Vogelzang, MD","credentials":
["Section Editor — Prostate Cancer\n","Professor of Medicine\n","University of
Nevada School of Medicine\n","US Oncology Research"],"disclosure":"Speaker's
Bureau: Pfizer [Kidney cancer (Sunitinib, axitinib)]; Bayer [Prostate cancer
(Radium 223)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus); Sanofi
[Prostate cancer (Cabazitaxel)], BMS [Kidney cancer (BMS-nivolumab)];
Genentech/Roche [Bladder cancer (Atezolizumab); Astra Zeneca {Bladder cancer
(durvalumab)]. Consultant/Advisory Boards: Amgen [Prostate cancer (Denosumab)];
Bayer [Prostate cancer (Radium 223)]; Pfizer [Kidney cancer (Sunitinib, axitinib)];
Novartis [Kidney cancer, PNET (Pazopanib, everolimus)]; Sanofi [Prostate cancer
(cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche (Bladder
cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer (durvalumab)] Exelexis
[Kidney cancer (Cabozantinib)]; Clinical Care Options, Cerulean [Kidney cancer
(Liposomal irinotecan)]; Dava Oncology/PER; Dendreon; Medivation/Astellas [Prostate
(Enzalutamide)], Janssen [Prostate cancer (Abiraterone,apalutamide)]; Heron [Nausea
control (Liposomal granisetron)]; Eisai [Kidney cancer (Levantinib)]; Agensys
[Kidney cancer (New targeted agent)]; Boehringer Ingelheim [Mesothelioma
(Nerantinib)]. Employment: US Oncology [GU research (none)]. Equity
Ownership/Stock Options: Caris [Genetic testing for cancer (none)]."},
{"name":"David E Wazer, MD","credentials":["Section Editor — Radiation
Therapy\n","Professor of Radiation Oncology\n","Tufts University School of
Medicine\n","Brown University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Advanced Radiation Therapy,
LLC [Breast cancer treatment (Brachytherapy device)]."},{"name":"Howard J West,
MD","credentials":["Section Editor — Lung Cancer\n","Medical Director\n","Thoracic
Oncology Program\n","Swedish Cancer Institute (Seattle)"],"disclosure":"Speaker’s
Bureau: BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)];
Genentech/Roche [Non-small cell lung cancer (Atezolizumab)]. Consultant/Advisory
Boards: AstraZeneca [Non-small cell lung cancer (Gefitinib)]; Boehringer-Ingelheim
[Non-small cell lung cancer (Afatinib)]; BristolMyersSquibb [Non-small cell lung
cancer (Nivolumab)]; Celgene [Non-small cell lung cancer (nab-paclitaxel)];
Genentech/Roche [Non-small cell lung cancer (Alectinib, Atezolizumab, Erlotinib)];
Merck [Non-small cell lung cancer (Pembrolizumab)]; Novartis [Non-small cell lung
cancer (Ceritinib)]; Pfizer [Non-small cell lung cancer (Crizotinib)]; Takeda [Non-
small cell lung cancer (nab-Paclitaxel, dabrafenib, trametinib, durvlumab)]."},
{"name":"Christopher G Willett, MD","credentials":["Section Editor — Radiation
Therapy\n","Professor\n","Duke University Medical
School"],"disclosure":"Consultant/Advisory Boards: Entrinsic Health [Esophageal,
stomach, pancreatic, and colorectal cancer and GIST (Amino acid medical foods, a
liquid solution that may improve mucosal reactions to chemotherapy and radiation
therapy)]."}]},{"name":"Editorial Assistants","contributors":[{"name":"Laura
Blockhus, BA","credentials":["Editorial Assistant — UpToDate"],"disclosure":""},
{"name":"Cara Rapoport, BA","credentials":["Senior Editorial Assistant —
UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Sumaira Z
Aasi, MD","credentials":["Professor\n","Department of Dermatology\n","Stanford
University School of Medicine"],"disclosure":""},{"name":"Eddie K Abdalla,
MD","credentials":["Professor of Surgery\n","The Lebanese American
University"],"disclosure":""},{"name":"Ghassan K Abou-Alfa, MD","credentials":
["Associate Attending\n","Memorial Sloan Kettering Cancer Center\n","Associate
Professor\n","Weill Cornell Medi"],"disclosure":"Grant/Research/Clinical Trial
Support: CASI Pharmaceuticals [Fibrolamellar cancer (ENMD-2076)].
Consultant/Advisory Boards: CASI Pharmaceuticals [Fibrolamellar cancer (ENMD-
2076)]; Blueprint [Fibrolamellar cancer]; Aslan [Fibrolamellar cancer]; Puma
Biotechnbology [Fibrolamellar cancer (Neratinib)]."},{"name":"David H Abramson, MD,
FACS","credentials":["Professor of Ophthalmology\n","Weill-Cornell Medical
School\n","Chief\n","Ophthalmic Oncology Service\n","Memorial Sloan-Kettering
Cancer Center"],"disclosure":""},{"name":"Nadeem R Abu-Rustum, MD","credentials":
["Professor of Obstetrics & Gynecology\n","Weill Cornell Medical
College\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"M
Jacob Adams, MD, MPH","credentials":["Associate Professor (retired)\n","University
of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"Tomer
Adar, MD","credentials":["Research Fellow, Gastroenterology
Division\n","Massachusetts General Hospital\n","Senior Gastroenterologist,
Digestive Diseases Institute \n","Senior Physician in Internal Medicine, Shaare-
Zedek Medical Center\n","Hebrew University, Jerusalem,
Israel"],"disclosure":"Research Support: Synageva [Hepatic steatosis (Sebelipase
alfa)]. Consultant/Article Writing: Janssen Pharmaceuticals [IBD (Infliximab)]. Web
Editor: United European Gastroenterology [Gastroenterology and Hepatology].
Lectures: Shire International [Gaucher disease (Velaglucerase alfa)]."},
{"name":"Anjali S Advani, MD","credentials":["Director, Inpatient Leukemia
Unit\n","Associate Professor, Cleveland Clinic Lerner College of
Medicine\n","Staff, Department of Hematology/Oncology\n","Taussig Cancer Institute,
The Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen
(ALL [blinotumomab]); Pfizer (ALL [inotuzumab]). Consultant/Advisory Boards: Pfizer
(ALL [inotuzumab])."},{"name":"Maryam Rafael Aghalar, DO","credentials":["Attending
Physician\n","Nassau University Medical Center"],"disclosure":""},{"name":"Ebtesam
Ahmed, PharmD, MS","credentials":["Clinical Professor,\n","St. John's University
College of Pharmacy\n","Clinical Pharmacy Specialist Innovative Institute for
Palliative Care"],"disclosure":""},{"name":"Dennis J Ahnen, MD","credentials":
["Director, Genetics Clinic\n","Gastroenterology of the
Rockies"],"disclosure":"Speaker's Bureau: Ambry Genetics [Genetic testing (Genetic
testing laboratory)]. Consultant/Advisory Boards: Cancer Prevention Pharmaceuticals
[Chemoprevention (DFMO for chemoprevention)]."},{"name":"Vivek N Ahya,
MD","credentials":["Assistant Professor of Medicine\n","University of Pennsylvania
School of Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":
["Clinical Associate Professor of Medicine\n","University of California, San
Francisco"],"disclosure":""},{"name":"H Richard Alexander, Jr, MD","credentials":
["Chief Surgical Officer,\n","Rutgers Cancer Institute of New Jersey\n","Professor,
Department of Surgery,\n","Rutgers Robert Wood Johnson Medical
School"],"disclosure":""},{"name":"Tarek Alhamad, MD, MS, FACP,
FASN","credentials":["Assistant Professor of Medicine\n","Washington University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
Mallinckrodt [Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's
Bureau: Veloxis [Immunosuppression medications (Tacrolimus XR)].
Consultant/Advisory Board: Veloxis [Immunosuppression medications (Tacrolimus
XR)]."},{"name":"Larry
Allen, MD, MHS","credentials":["Associate Professor of Medicine\n","Medical
Director, Advanced Heart Failure and Transplantation\n","University of Colorado
School of Medicine"],"disclosure":"Grant/Research Support: PCORI [Patient decision
aid for LVAD]; NIH [Post-hospitalization transitions]; AHA [Patient engagement too
for medication use]. Consultant/Advisory Boards: ACI [Clinical events adjudication
committee (BNP assay)]; Boston Scientific [Steering committee MANAGE-HF]; Duke
Clinical Research Institute [Steering committee CONNECT-HF]; Cytokinetics
[Publication committee]; Jannsen [Steering committee ORBIT registry (Rivaroxiban)];
Novartis [Clinical events adjudication committee (Serelaxin)]."},{"name":"John
Allendorf, MD, FACS","credentials":["Associate Professor of Surgery\n","SUNY Stony
Brook\n","Vice Chairman of Surgery\n","Winthrop University
Hospital"],"disclosure":""},{"name":"Maha Ali Al-Mohaya, BDS, MS, DMSc,
ABOM","credentials":["Diplomate of American Board of Oral Medicine\n","Head of Oral
Medicine\n","Department of Dentistry\n","Riyadh Military Hospital\n","Riyadh
College of Dentistry and Pharmacy\n","Saudi Arabia"],"disclosure":""},
{"name":"Richard F Ambinder, MD, PhD","credentials":["James B Murphy Professor of
Oncology\n","Johns Hopkins School of Medicine"],"disclosure":"Consultant/Advisory
Boards: Bristol-Myers Squibb [Cancer drugs (Checkpoint inhibitors)]; Viracta
[Cancer drugs (Therapeutic trial for unlicensed drug)]; Cellgenesis [Cancer drugs
(Imides, proteasome inhibitors)]; National Comprehensive Cancer Network [Hodgkin
lymphoma, HIV malignancy)]."},{"name":"Robert J Amdur, MD","credentials":
["Professor\n","Department of Radiation Oncology\n","University of Florida College
of Medicine"],"disclosure":""},{"name":"Carey K Anders, MD","credentials":
["Assistant Professor \n","University of North Carolina - Chapel
Hill\n","Lineberger Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Novartis [Breast cancer (Everolimus)]; Sanofi [Breast cancer (Iniparib)];
to-BBB [Breast cancer (Iniparib, 2B3101)]; GERON [Breast cancer (GRN1005)];
Angiochem [Breast cancer (ANG1005)]; Merrimack Pharmaceuticals [Breast cancer
(MM398, MM302)]; PUMA [Breast cancer (Neratinib)]; Lilly [Breast cancer
(Abemacilib)]; Merck [Breast cancer (Pembrolizumab)]; Oncothyreon [Breast cancer
(ONT380)]; TESARO [Breast cancer (Preclinical, Niraparib/Pembro)]; Cascadian
Therapeutics; Nektar Therapeutics [Breast cancer]. Consultant/Advisory Boards:
Novartis [Breast cancer and/or brain metastases (Everolimus)]; Sanofi [Breast
cancer and/or brain metastases (Iniparib)]; to-BBB [Breast cancer and/or brain
metastases (2B3101)]; GERON [Breast cancer and/or brain metastases (GRN1005)];
Angiochem [Breast cancer and/or brain metastases (ANG1005)]; Merrimack
Pharmaceuticals [Breast cancer and/or brain metastases (MM398, MM302)]; Lilly
[Breast cancer and/or brain metastases (Abemacilib)]; Genentech [Breast cancer
and/or brain metastases (Etirinotecan pegol)]; Nektar Therapeutics [Breast cancer
and/or brain metastases (KD019)]; Kadmon Corporation, LLC [Breast cancer and/or
brain metastases (KD019)]."},{"name":"Christopher D Anderson, MD,
FACS","credentials":["James D. Hardy Professor and Chair, Department of
Surgery\n","Chief, Transplant and Hepatobiliary Surgery\n","University of
Mississippi Medical Center"],"disclosure":""},{"name":"Stephan Anderson,
MD","credentials":["Professor of Radiology\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Stephen M Ansell, MD, PhD","credentials":
["Professor of Medicine, Division of Hematology\n","Mayo
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb,
Merck [immune checkpoint inhibitors (nivolumab, pembrolizumab)]."},
{"name":"Emmanuel S Antonarakis, MD","credentials":["Associate Professor of
Oncology and Urology\n","Sidney Kimmel Comphrehensive Oncology Center\n","Johns
Hopkins University"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":
["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia
University College of Physicians and
Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus
Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal
Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-
0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta
[Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis
(Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx
[Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau:
Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)].
Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers
Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi;
Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives
(Drugs under development for immunosuppression)]."},{"name":"Selim M Arcasoy,
MD","credentials":["Associate Professor of Clinical Medicine\n","Columbia
University School of Medicine\n","Medical Director, Lung Transplantation
Program"],"disclosure":"Grant/Research/Clinical Trial Support: CMS Pharma Co., Ltd,
Therakos, Inc. [Bronchiolitis obliterans syndrome (Extracorporeal
photopheresis)]."},{"name":"Charlotte Ariyan, MD, PhD","credentials":["Associate
Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},
{"name":"April W Armstrong, MD, MPH","credentials":["Associate Dean for Clinical
Research\n","Department of Dermatology\n","University of Southern
California"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; AbbVie;
Janssen; Eli Lilly and Company [Psoriasis (Etanercept, adalimumab, ustekinumab,
ixekizumab)]. Speaker's Bureau: AbbVie; Eli Lilly and Company; Janssen [Psoriasis
(Adalimumab, ixekizumab, guselkumab)]. Consultant/Advisory Boards: AbbVie; Janssen;
Pfizer; Celgene; Novartis; Eli Lilly and Company; Sanofi; Regeneron [Psoriasis
(Adalimumab, ustekinumab, tofacitinib, apremilast, tildrakizumab, ixekizumab,
dupilumab)]."},{"name":"Deborah K Armstrong, MD","credentials":["Professor of
Oncology\n","Professor of Gynecology & Obstetrics\n","Johns Hopkins Kimmel Cancer
Center"],"disclosure":"Research Support: Genentech [endometrial carcinoma];
Medimmune [advanced solid tumors]; Clovis [ovarian cancer]; AstraZeneca [ovarian
cancer]; Tesaro [endometrial cancer]; Syndax [ovarian cancer]; Pfizer [ovarian
cancer]. Consultant/Advisory Boards: Cue Biopharma [cervical cancer]."},
{"name":"Andrew Arnold, MD","credentials":["Murray-Heilig Professor of Molecular
Medicine\n","University of Connecticut"],"disclosure":""},{"name":"Monish Aron, MD,
MCh, FRCS","credentials":["Professor of Clinical Urology\n","Co-Director, Robotic
Surgery & Advanced Laparoscopy\n","USC Institute of Urology, Keck School of
Medicine\n","University of Southern California"],"disclosure":"Consultant/Advisory
Boards: Baxter [Hemostasis (drug not relevant)]; Boston Scientific [AUS, IPP after
RRP (drug not relevant)]."},{"name":"Maryam Asgari, MD, MPH","credentials":
["Associate Professor\n","Massachusetts General Hospital at Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Psoriasis
(Anti-tumor necrosis factor-alpha inhibitor, immunosuppressants)]; Valeant [Atopic
dermatitis (Pimecrolimus, topical corticosteroid, topical calcineurin
inhibitor)]."},{"name":"Stanley W Ashley, MD","credentials":["Section Editor —
Pancreatic and Hepatobiliary Surgery\n","Chief Medical Officer and Senior Vice
President for Clinical Affairs\n","Brigham and Women’s Hospital\n","Frank Sawyer
Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Jon C
Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic
malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch
inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis
[Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options:
Cellestia; Anastasis."},{"name":"Ajlan Atasoy, MD","credentials":["Assistant
Professor\n","GI Oncology\n","Department of Medicine\n","Roswell Park Cancer
Institute"],"disclosure":"Consultant/Advisory Boards: Boston Biomedical [Oncology
(Napabucasin)]."},{"name":"Michael B Atkins, MD","credentials":["Section Editor —
Malignant Melanoma and Other Cutaneous Neoplasms; Cancer of the Kidney\n","Deputy
Director\n","Georgetown Lombardi Comprehensive Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [Melanoma and RCC
(Nivolumab and ipilimumab)]; Roche [Melanoma (Vemurafenib and cobimetinib); RCC
(Atezolizumab and bevacizumab)]; Novartis [Melanoma (Dabrafenib and trametinib);
RCC (Pazopanib and everolimus)]. Consultant/Advisory Boards: BMS; Merck; Novartis;
Pfizer; Roche; Exelixis; Eisai [Melanoma; RCC; immunotherapy (Everoliumus,
pazopanib; dabrafenib/trametinib; axitinib, sunitinib, avelumab;
vemurafenib/cobimetinib, atezolizumab; ipilimumab/nivolumab; pembrolizumab,
interferon; cabozantinib; lenvatinib)]."},{"name":"Edward K Avila,
DO","credentials":["Associate Clinical Member, Department of Neurology\n","Memorial
Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Lisen Axell, MS,
CGC","credentials":["Genetic Counselor\n","University of Colorado Comprehensive
Cancer Center"],"disclosure":""},{"name":"Floor J Backes, MD","credentials":
["Assistant Professor\n","Division of Gynecologic Oncology \n","Department of
Obstetrics and Gynecology \n","The Ohio State University College of
Medicine"],"disclosure":""},{"name":"Rebecca N Baergen, MD","credentials":
["Professor of Clinical Pathology and Laboratory Medicine\n","Weill Medical College
of Cornell University"],"disclosure":""},{"name":"Armita
Bahrami, MD","credentials":["St. Jude Children’s Research Hospital\n","University
of Tennessee Health Science Center"],"disclosure":""},{"name":"F Amos Bailey,
MD","credentials":["Professor of Medicine \n","University of Colorado at
Denver"],"disclosure":""},{"name":"Elizabeth H Baldini, MD, MPH","credentials":
["Associate Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"Robert A Balk, MD","credentials":["Professor of
Medicine\n","Rush-University Medical Center"],"disclosure":""},{"name":"Douglas W
Ball, MD","credentials":["Associate Professor of Medicine and Oncology\n","Johns
Hopkins University School of Medicine"],"disclosure":""},{"name":"Jose Banchs, MD,
FACC, FASE","credentials":["Director of Echocardiography\n","Associate Professor of
Medicine\n","Cardiology Department\n","University of Texas \n","MD Anderson Cancer
Center"],"disclosure":""},{"name":"Anindo K Banerjee, PhD, FRCP","credentials":
["Consultant Respiratory Physician\n","Southampton General Hospital, Southampton,
UK"],"disclosure":""},{"name":"Victoria Banuchi, MD, MPH","credentials":["Assistant
Professor of Otolaryngology\n","Weill Cornell Medical College"],"disclosure":""},
{"name":"Benjamin Barankin, MD, FRCPC","credentials":["Dermatologist, Medical
Director \n","Toronto Dermatology Centre, Toronto, Canada"],"disclosure":""},
{"name":"Aditya Bardia, MD, MPH","credentials":["Attending
Physician\n","Massachusetts General Hospital Cancer Center\n","Assistant Professor
of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Novartis [Breast cancer (Letrozole)]; Pfizer [Breast cancer (Exemestane)]."},
{"name":"Carlton C Barnett, Jr, MD","credentials":["Professor of
Surgery\n","University of Colorado at Denver"],"disclosure":""},{"name":"Tracy
Batchelor, MD, MPH","credentials":["Giovanni Armenise Professor of
Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research Support: Pfizer
[Glioblastoma]. Consultant/Advisory Boards: Merck [Glioblastoma (temozolomide)];
Proximagen/Upsher [Glioblastoma]; Roche [Glioblastoma (rituximab)]; Oxigene
[Glioblastoma]; Cavion [Glioblastoma]; Accerta [Lymphoma]; Amgen [Glioblastoma];
Genomicare [Brain tumors (diagnostic testing)]. Other Financial Interest: Oakstone
Publishing; Champions Biotechnology; Imedex [Neuro-Oncology CME/Education
(Educational Material)]."},{"name":"Clair J Beard, MD","credentials":["Associate
Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},
{"name":"Tanios Bekaii-Saab, MD","credentials":["Program Co-Director, GI Cancers,
Mayo Clinic Cancer Center\n","Senior Associate Consultant , Mayo Clinic, Phoenix
AZ\n","Professor, Mayo College of Medicine and Science"],"disclosure":""},
{"name":"Joaquim Bellmunt, MD, PhD","credentials":["Associate Professor of
Medicine, Harvard Medical School\n","GU Oncology Research Coordinator
PSMAR\n","Director, IMIM-Hospital del Mar Medical Research
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Merck;
Sanofi [Urothelial cancer (Pembrolizumab)]; Novartis, Sanofi [Research support
(Urothelial cancer); Merck, Genentech, Bioclin [Clinical trial support (Urothelial
cancer). Consultant/Advisory Boards: Genentech, Merck, Pfizer, Sanofi, Astra-
Zeneca, Bioclin (Urothelial cancer)."},{"name":"Jennifer R Bellon,
MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"Johanna Bendell, MD","credentials":
["Director\n","GI Oncology Research\n","Sarah Cannon Research
Institute"],"disclosure":""},{"name":"Jonathan S Berek, MD, MMS","credentials":
["Laurie Kraus Lacob Professor\n","Stanford University School of
Medicine\n","Fellow, Stanford Distinguished Careers Institute\n","Director,
Stanford Women's Cancer Center\n","Senior Scientific Advisor, Stanford Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro, Inc.
[Gynecologic cancers (Niraparib)]."},{"name":"James R Berenson, MD","credentials":
["Medical and Scientific Director\n","Institute for Myeloma and Bone Cancer
Research"],"disclosure":""},{"name":"Jonas Bergh, MD, PhD, FRCP (London
UK)","credentials":["Professor of Oncology (Mimi Althainz´donation)\n","Karolinska
Institutet and University Hospital\n","Cancer Center Karolinska\n","Stockholm,
Sweden"],"disclosure":"Grant/Research/Clinical Trial Support: Karolinska
Institutet/Karolinska University Hospital; Amgen; AstraZeneca; Bayer; Merck;
Pfizer; Roche; Sanofi-Aventis [Breast cancer (Molecular markers)]."},
{"name":"Amanda Bergner, MS, CGC","credentials":["Associate Professor of Genetics
and Development\n","Columbia University"],"disclosure":""},{"name":"Emily
Bergsland, MD","credentials":["Professor of Medicine \n","University of California
San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Lexicon
[Carcinoid (telotristat)]; Merck [Carcinoid/panNET (Pembrolizumab)]; Novartis
[Carcinoid/pNET]. Consultant/Advisory Board: Lexicon [Carcinoid (telotristat)];
Ipsen [ Neuroendocrine tumors (lanreotide)]; Exelixis [Carcinoid/panNET
(cabozantinib)]."},{"name":"Ross S Berkowitz, MD","credentials":["William H. Baker
Professor of Gynecology\n","Harvard Medical School\n","Director of Gynecologic
Oncology and Gynecology \n","Brigham and Women's Hospital and Dana Farber
Cancer Institute\n","Co-Director\n","New England Trophoblastic Disease
Center"],"disclosure":""},{"name":"Mark F Berry, MD","credentials":["Associate
Professor\n","Department of Cardiothoracic Surgery\n","Stanford
University"],"disclosure":"Consultant/Advisory Boards: Verb Surgical [surgical
robot]."},{"name":"Simon Best, MD","credentials":["Assistant Professor \n","Johns
Hopkins Department of Otolaryngology – Head and Neck Surgery"],"disclosure":""},
{"name":"Mihir K Bhayani, MD, FACS","credentials":["Clinical Assistant
Professor\n","Department of Surgery, University of Chicago Pritzker School of
Medicine\n","Division of Otolaryngology, NorthShore University
HealthSystem"],"disclosure":""},{"name":"Jonathan Bijron, MD","credentials":
["University Medical Center Utrecht, The Netherlands"],"disclosure":""},
{"name":"Mark Bilsky, MD","credentials":["Attending Neurologic Surgeon\n","Memorial
Sloan-Kettering Cancer Center\n","Professor Neurologic Surgery\n","Weill Medical
College of Cornell University"],"disclosure":""},{"name":"Kenneth F Binmoeller, MD,
FASGE, FACG","credentials":["Director, Interventional Endoscopy\n","California
Pacific Medical Center, San Francisco"],"disclosure":""},{"name":"Marc Birkhahn,
MD","credentials":["Urologie am Ring\n","Cologne"],"disclosure":""},
{"name":"Michael J Birrer, MD, PhD","credentials":["Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Roche Pharmaceuticals [Ovarian cancer]."},{"name":"Peter Black, MD, FACS,
FRCSC","credentials":["Khosrowshahi Chair in Bladder Cancer
Research\n","Professor\n","Department of Urologic Sciences\n","University of
British Columbia\n","Vancouver Prostate
Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; NewB;
Innovation; iProgen [Bladder cancer (Atezolizumab, investigational agents)].
Consultant/Advisory Boards: AbbVie [Prostate cancer (Leuprolide)]; Astellas
[Prostate/bladder cancer (Enzalutamide)]; Bayer [Prostate cancer (Alpharadin)];
Biocancell [Bladder cancer (BC819)]; Ferring [Nocturia (DDAVP)]; Janssen [Prostate
cancer (Abiraterone)]; Lilly [Bladder cancer (Drug pipeline)]; Merck [Post-op ileus
(Alvimopan)]; Sanofi [Prostate cancer (Leuprolide)]; Sitka [Bladder cancer (STK-
01)]; Spectrum [Bladder cancer (Apaziquone)]; Allergan [Prostate cancer
(Triptorelin pamoate)]; Biosyent [Bladder cancer (Hexaminolevulinate
hydrochloride)]. Patent Holder: GenomeDx [Bladder cancer (Gene signature
biomarker)]."},{"name":"Ronald Bleday, MD","credentials":["Associate Professor of
Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Ira J Bleiweiss,
MD","credentials":["Professor of Pathology\n","Perelman School of
Medicine\n","University of Pennsylvania\n","Subspecialty Director, Breast
Pathology\n","Section of Surgical Pathology\n","Hospital of the University of
Pennsylvania Founders 6"],"disclosure":""},{"name":"Sharon L Bober,
PhD","credentials":["Assistant Professor of Psychiatry\n","Harvard Medical
School"],"disclosure":""},{"name":"Bernard H Bochner, MD","credentials":["Attending
Surgeon , Urology Service\n","Vice Chairman, Department of Surgery\n","Memorial
Sloan-Kettering Cancer Center\n","Professor of Urology\n","Weill Medical College of
Cornell University"],"disclosure":""},{"name":"Almut Böer-Auer, MD","credentials":
["Director of Academics, Dermatologikum Hamburg\n","Lecturer, Westfälischen
Wilhelms-Universität Münster"],"disclosure":""},{"name":"Jeffrey A Bogart,
MD","credentials":["Professor & Chair\n","Department of Radiation
Oncology\n","Upstate Medical University"],"disclosure":""},{"name":"Peter A L
Bonis, MD","credentials":["Chief Medical Officer of Clinical Effectiveness
(UpToDate, Clinical Drug Information, and Emmi Solutions)\n","Deputy Editor —
Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts University
School of Medicine"],"disclosure":""},{"name":"Barry A Borlaug, MD","credentials":
["Section Editor — Heart Failure\n","Professor of Medicine\n","Mayo Clinic College
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca;
Corvia; MAST Therapeutics; Medtronic; Mesoblast; GlaxoSmithKline; Novartis [Heart
failure]. Consultant/Advisory Boards: Actelion; Amgen; Merck; AstraZeneca;
MyoKardia [Heart failure]."},{"name":"Judith VMG Bovée, MD, PhD","credentials":
["Pathologist\n","Professor of Pathology\n","Leiden University Medical
Center"],"disclosure":""},{"name":"Carol R Bradford, MD, FACS","credentials":
["Professor and Chair\n","Department of Otolaryngology-Head and Neck
Surgery\n","University of Michigan"],"disclosure":""},{"name":"Kristin
A Bradley, MD","credentials":["Associate Professor\n","University of Wisconsin
School of Medicine and Public Health"],"disclosure":""},{"name":"Carlos E Bravo
Iniguez, MD","credentials":["Fellow, Center for Surgery and Public
Health\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Miriam
Bredella, MD","credentials":["Associate Professor of Radiology\n","Harvard Medical
School\n","Massachusetts General Hospital"],"disclosure":""},{"name":"William
Breitbart, MD","credentials":["Professor of Clinical Psychiatry\n","Weill Medical
College of Cornell University\n","Chairman\n","Department of Psychiatry and
Behavioral Sciences\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},
{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief —
Nephrology\n","Section Editor — Renal Transplantation\n","Professor of
Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant
Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion;
CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody
mediated rejection, delayed graft function, immunosuppression, induction
(Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte
globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical
hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes,
immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab,
mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory
Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody
mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab,
tacrolimus, antithymocyte globulin)]."},{"name":"Tim Brenner, PharmD,
BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer
Centers"],"disclosure":""},{"name":"Molly Brewer, DVM, MD, MS","credentials":
["Professor\n","Chief\n","Division of Gynecologic Oncology\n","Department of
Obstetrics and Gynecology\n","Carole and Ray Neag Comprehensive Cancer
Center\n","University of Connecticut Health Center"],"disclosure":""},
{"name":"James D Brierley, MB, BS, FRCP, FRCR, FRCPC","credentials":
["Professor\n","Department of Radiation Oncology\n","University of Toronto,
Canada"],"disclosure":""},{"name":"Robert E Bristow, MD, MBA","credentials":
["University of California, Irvine - Medical Center"],"disclosure":""},
{"name":"Bruce E Brockstein, MD","credentials":["Section Editor — Cancer of the
Head and Neck\n","Clinical Professor of Medicine\n","University of Chicago Pritzker
School of Medicine"],"disclosure":"Consultant/Advisory Boards: Astra Zeneca
[Immunotherapy - head and neck and melanoma (Durvalumab, tremelimumab)]; Bristol
Meyers [Melanoma, head and neck cancer (Ipilimumab, nivolumab)]; Novartis [GIST,
sarcoma, melanoma (Imatinib, Dabrafenib, trametinib)]."},{"name":"Kathleen Broglio,
DNP, ANP-BC, ACHPN, CPE, FPCN","credentials":["Nurse Practitioner - Palliative
Care\n","Dartmouth Hitchcock Medical Center"],"disclosure":""},{"name":"Jennifer R
Brown, MD, PhD","credentials":["Associate Professor\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead; Verastem
[CLL]. Consultant/Advisory Boards: Pharmacyclics; Infinity; Janssen; Celgene;
Roche/Genentech; Gilead [CLL (Ibrutinib, IPI-145, lenalidomide, obinutuzumab,
idelalisib)]; AbbVie [CLL (Venetoclax)]; Astra-Zeneca [CLL (Acalabrutinib)]."},
{"name":"Paul Brown, MD","credentials":["Professor Radiation Oncology\n","Mayo
Clinic, Rochester, MN"],"disclosure":"Other Financial Interest: Novella [DMC Member
(None)]."},{"name":"Eduardo Bruera, MD","credentials":["Section Editor — Non Pain
Symptoms: Assessment and Management\n","Professor of Oncology\n","University of
Texas, MD Anderson Cancer Center at Houston"],"disclosure":"Grant/Research/Clinical
Trial Support: Helsinn [Nausea, cachexia (Netupitant, Anamorelin)]."},
{"name":"Glenn J Bubley, MD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel Buchbinder,
DMD, MD","credentials":["Professor and Chief Maxillofacial Surgery, Dept. of
Otolaryngology Head and Neck Surgery\n","Icahn School of Medicine at Mount Sinai,
New York, NY"],"disclosure":""},{"name":"Harold Burstein, MD, PhD","credentials":
["Section Editor — Breast Cancer\n","Associate Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Bryan M Burt, MD","credentials":
["Assistant Professor of Surgery\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Jan Buter, MD, PhD","credentials":["department Medical Oncology, \n","VU
University Medical Center, \n","Amsterdam, The Netherlands"],"disclosure":""},
{"name":"Antonio C Buzaid, MD","credentials":["General Medical Director,
\n","Centro Oncologico Antonio Ermirio de Moraes, \n","BP de Sao Paulo,
Brazil\n","Steering Committee Member,\n","Centro Oncológico do Hospital Israelita
Albert Einstein, \n","Sao Paulo, Brazil"],"disclosure":""},{"name":"Lauren A Byers,
MD","credentials":["Assistant Professor\n","University of Texas MD Anderson Cancer
Center"],"disclosure":""},{"name":"Matthew R Callstrom, MD, PhD","credentials":
["Professor of Radiology\n","Mayo Clinic"],"disclosure":"Grant/Research Support:
Galil Medical (lung ablation trial [Cryoablation system]); EDDA Technology, Inc.
[image registration system]. Consultant/Advisory Boards: Covidien; Medtronic [RF
ablation (RF ablation)]; Johnson and Johnson [MW ablation (MW ablation)]
Thermedical [RF ablation (RF ablation)]."},{"name":"Michael Camilleri,
MD","credentials":["Professor of Medicine, Pharmacology, and Physiology\n","Mayo
Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
Rhythm Pharmaceuticals [Gastroparesis (RM-131)]; Takeda [Gastroparesis (TAK954)];
Novartis [Bile acid diarrhea (LJN452)]; AstraZeneca [Naloxegol effects on GI
transit in health]; NGM Biopharma [Functional constipation (NGM282)]; Allergan
[Bile acid malabsorption (Eluxadoline)]; ELIRA [Gastric emptying (T6 dermatome
device)]; Vibrant [Vibrating capsule and constipation]. Consultant/Advisory Boards:
Ironwood [Gastroparesis (Advisory Board on treatment and management approaches)];
Allergan [Diabetic gastroparesis]; AstraZeneca [Naloxegol and OIC]; ElobixAB [Bile
acid inhibitor for constipation]; Shire [Prucalopride for constipation]; Takeda
[Clinical trials]; Theravance [50-HT4 receptor agonists and PAMORA]; Bio-kier
[Obesity, diabetes]; OUTPOST medicine [OP687 for IBS]. Equity Ownership/Stock
Options: Dignify Therapeutics; Enterin."},{"name":"Steven C Campbell, MD,
PhD","credentials":["Glickman Urological and Kidney Institute\n","Cleveland
Clinic"],"disclosure":""},{"name":"Susana M Campos, MD","credentials":["Dana Farber
Cancer Institute"],"disclosure":"Consultant/Advisory Boards: Genentech [Ovary
(bevacizumab)]; AstraZeneca [Ovary]; Clovis [parp inhibitors]."},{"name":"George P
Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor —
Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Marcia Irene Canto, MD, MHS","credentials":
["Professor of Medicine and Oncology\n","Johns Hopkins
University"],"disclosure":""},{"name":"Michael A Carducci, MD","credentials":
["Aegon Professor of Prostate Cancer Research\n","Professor of Oncology and
Urology\n","Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences
[Prostate cancer (GS5829)]; Pfizer [Renal cancer (avelumab)]; EMD Serrano [Solid
tumors (metAP2 inhibitor)]. Consultant/Advisory Boards: Pfizer [Prostate cancer (AR
antagonists)]; Astellas Pharma [Prostate cancer (AR antagonists)]; Merck [Prostate
cancer (Immune checkpoint inhibitors)]; Roche Genentech [Prostate cancer (PI3K
inhibitors)]; Churchill [Prostate cancer (Lyase inhibitors)]."},{"name":"Lisa A
Carey, MD","credentials":["Professor of Medicine\n","University of North
Carolina\n","Lineberger Comprehensive Cancer Center"],"disclosure":""},
{"name":"Robert L Carithers, Jr, MD","credentials":["Professor of
Medicine\n","University of Washington"],"disclosure":""},{"name":"Karen J Carlson,
MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Shamus Carr, MD, FACS","credentials":["Assistant
Professor of Surgery\n","University of Maryland School of
Medicine"],"disclosure":""},{"name":"Peter Carroll, MD, MPH","credentials":
["Professor and Chair\n","Department of Urology\n","University of California, San
Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Genomic Health
[Prostate cancer (N/A)]"},{"name":"Bob S Carter, MD, PhD","credentials":["Professor
of Neurosurgery\n","Harvard Medical School"],"disclosure":""},{"name":"Sally E
Carty, MD, FACS","credentials":["Section Editor — Endocrine Surgery\n","Professor,
Chief, Division of Endocrine Surgery\n","University of Pittsburgh School of
Medicine"],"disclosure":"Other Financial Interest: Jaypee Brothers [Endocrine
surgery (Textbook)]."},{"name":"Richard D Carvajal, MD","credentials":["Associate
Professor of Medicine \n","Director, Experimental Therapeutics\n","Director,
Melanoma Service\n","Columbia University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Castle Biosciences [Melanoma
(DecisionDX)]; Iconic Therapeutics [Melanoma (ICON1)]; BMS [Melanoma (Ipilimumab,
nivolumab)]; Novartis [Melanoma (Imatinib, nilotinib)]; AstraZeneca [Melanoma
(Selumetinib)]; Immunocore [Melanoma (IMCgp100)]; Merck [Melanoma (Pembrolizumab)];
Aura Biosciences [Melanoma (AU-011)]."},{"name":"Mariana C Castells, MD,
PhD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Daniel Catovsky, MD, DSc (Med), FRCPath, FRCP,
FMedSci","credentials":["Emeritus Professor of Haematology\n","Institute of Cancer
Research, Sutton, Surrey, UK"],"disclosure":""},{"name":"Emi H Caywood,
MD","credentials":["Director, Blood and Bone Marrow Transplant\n","Nemours/Alfred I
duPont Hospital for Children"],"disclosure":""},{"name":"David Cella,
PhD","credentials":["Professor\n","Feinberg School at Northwestern
University"],"disclosure":""},{"name":"John Chabot, MD","credentials":["David V.
Habif Professor of Surgery\n","Columbia University Medical
Center"],"disclosure":""},{"name":"Jasmeet Chadha Singh, MD","credentials":
["Attending Physician\n","Memorial Sloan Kettering Cancer Center\n","Commack,
NY"],"disclosure":""},{"name":"A Bapsi Chakravarthy, MD, FASTRO","credentials":
["Professor\n","Vanderbilt University"],"disclosure":""},{"name":"Annie On On Chan,
MD","credentials":["Department of Medicine\n","University of Hong
Kong"],"disclosure":""},{"name":"Anthony TC Chan, MD","credentials":["Professor of
Clinical Oncology\n","Prince of Wales Hospital\n","The Chinese University of Hong
Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Nasopharyngeal
carcinoma (Axitinib); Boehringer Ingelheim [Head and neck squamous cell carcinoma
(Afatinib)]; Bristol-Myers Squibb [Head and neck squamous cell carcinoma
(Nivolumab)]; MSD [Nasopharyngeal carcinoma]."},{"name":"Edward D Chan,
MD","credentials":["Professor of Medicine\n","National Jewish
Health"],"disclosure":""},{"name":"Jennifer Ang Chan, MD, MPH","credentials":
["Dana-Farber Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial
Support: Lilly [Neuroendocrine tumors (Ramucirumab)]; Sanofi [neuroendocrine tumors
(aflibercept)]. Consultant/Advisory Boards: Novartis [Neuroendocrine tumors
(Octreotide, everolimus)]; Ipsen [Neuroendocrine tumors (Lanreotide)]; Lexicon
[Neuroendocrine tumors (Telotristat)]; Advanced Accelerator Applications
[Neuroendocrine tumors (Lu-177 dotatate)]. Equity Ownership/Stock Options: Merck
[Neuroendocrine tumors (Temozolomidede)]."},{"name":"Victor T Chang,
MD","credentials":["Professor of Medicine,\n","Rutgers New Jersey Medical
School,\n","VA New Jersey Health Care System"],"disclosure":""},{"name":"Paul H
Chapman, MD","credentials":["Distinguished Nicholas T Professor of
Neurosurgery\n","Harvard Medical School"],"disclosure":""},{"name":"Clark C Chen,
MD, PhD","credentials":["Lyle A. French Chair of Neurosurgery\n","Professor and
Department Head\n","University of Minnesota
Neurosurgery"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic
[Clinical applications of restriction spectrum imaging (None)]. Speaker's Bureau:
Monteris [Laser thermal ablation (Edge)]; Varian [Radiosurgery (Edge)].
Consultant/Advisory Boards: Tocagen [Oncolytic virus (Clearpoint)]; MRI
Intervention [MRI compatible stereotaxis (Clearpoint)]."},{"name":"Lee-may Chen,
MD","credentials":["Professor of Obstetrics, Gynecology, & Reproductive
Sciences\n","Division of Gynecologic Oncology\n","UCSF Helen Diller Family
Comprehensive Cancer Center"],"disclosure":""},{"name":"Wendy Y Chen, MD,
MPH","credentials":["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Heather H Cheng, MD, PhD","credentials":
["Assistant Professor, Division of Medical Oncology, University of Washington
\n","Assistant Member, Division of Clinical Research, Fred Hutchinson Cancer
Research Center"],"disclosure":""},{"name":"Athena M Cherry, PhD","credentials":
["Professor of Pathology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Winson Y Cheung, MD, MPH","credentials":
["Associate Professor\n","British Columbia Cancer Agency\n","University of British
Columbia\n","Division of Medical Oncology"],"disclosure":""},{"name":"Milan G
Chheda, MD","credentials":["Assistant Professor\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Dennis S Chi, MD","credentials":["Memorial
Sloan-Kettering Cancer Center"],"disclosure":"Consultant/Advisory Boards: Bovie
Medical Corporation [Ovarian cancer (Surgical devices)]; Verthermia [Ovarian cancer
(Heated chemotherapy device)]. Equity Ownership/Stock Options: Bovie Medical
Corporation [Ovarian cancer (Surgical devices)]; Verthermia [Ovarian cancer (Heated
chemotherapy device)]; CSurgeries [Ovarian cancer (Surgical devices)]."},
{"name":"Stephen Chia, MD, FRCPC","credentials":["Associate Professor of
Medicine\n","British Columbia Cancer Agency"],"disclosure":""},{"name":"Murali
Chintagumpala, MD","credentials":["Professor of Pediatric Hematology and
Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Steven J
Chmura, MD, PhD","credentials":["Assistant Professor\n","University of
Chicago"],"disclosure":""},{"name":"Noah C Choi, MD","credentials":["Professor of
Radiation Oncology\n","Harvard Medical School\n","Distinguished Scholar of Thoracic
Oncology\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Toni K
Choueiri, MD","credentials":["Director, The Lank Center for Genitourinary
Oncology\n","Dana-Farber Cancer Institute and Brigham and Women's Hospital
\n","Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca; BMS;
Exelixis; Genentech; GSK; Merck; Novartis; Peloton; Pfizer; Roche; Tracon; Eisai
[Genitourinary oncology (Sunitinib, pazopanib, axitinib, temsirolimus, everolimus,
nivolumab, bevacizumab, cabozantinib, TRC105, savolitinib, pembrolizumab, PT-
2385)]. Consultant/Advisory Boards: AstraZeneca; Bayer; BMS; Cerulean; Eisai;
Foundation Medicine Inc.; Exelixis; Genentech; Roche; GlaxoSmithKline; Merck;
Novartis; Peloton; Pfizer; Prometheus Labs; Corvus [Genitourinary oncology
(Sunitinib, pazopanib, axitinib, temsirolimus, everolimus, nivolumab, bevacizumab,
levantinib, sorafenib, interleukin-2, pembrolizumab, cabozantinib, savolitinib; PT-
2385)]."},{"name":"George P Chrousos, MD","credentials":["Professor and
Chairman\n","First Department of Pediatrics\n","Director, Division of
Endocrinology, Metabolism, and Diabetes\n","University of Athens Medical School,
Greece"],"disclosure":""},{"name":"Rashmi Chugh, MD","credentials":["Associate
Professor of Medical Oncology\n","University of Michigan Medical
School"],"disclosure":""},{"name":"Daniel C Chung, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jane E
Churpek, MD","credentials":["Assistant Professor, Section of
Hematology/Oncology\n","The University of Chicago"],"disclosure":""},{"name":"Jay P
Ciezki, MD","credentials":["Staff Physician \n","Cleveland Clinic Department of
Radiation Oncology"],"disclosure":""},{"name":"Paul M Cinciripini,
PhD","credentials":["UT MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Cancer
Prevention Research Institute in Texas (Varenicline, placebo)]."},{"name":"Thomas E
Clancy, MD","credentials":["Assistant Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Jeffrey W Clark, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Mark W
Clemens, MD, FACS","credentials":["Associate Professor, Plastic Surgery\n","MD
Anderson Cancer Center, University of Texas"],"disclosure":""},{"name":"Mark
Clemons, FRCP","credentials":["Professor, \n","Department of Medicine, University
of Ottawa"],"disclosure":""},{"name":"Megan B Clowse, MD, MPH","credentials":
["Assistant Professor of Medicine\n","Duke University Medical Center\n","Division
of Rheumatology and Immunology"],"disclosure":""},{"name":"Harvey Jay Cohen,
MD","credentials":["Director, Center for the Study of Aging\n","Walter Kempner
Professor of Medicine\n","Chair Emeritus, Department of Medicine\n","Duke
University"],"disclosure":""},{"name":"David E Cohn, MD","credentials":["Director,
Division of Gynecologic Oncology \n","Professor of Obstetrics & Gynecology
\n","Stuart M Sloan and Larry J Copeland Chair in Gynecologic Oncology\n","Ohio
State University College of Medicine \n","James Cancer Hospital and Solove Research
Institute"],"disclosure":"Consultant/Advisory Boards: Oncology Analytics [Medical
Advisory Board]. Other Financial Interest: Gynecologic Oncology [journal Deputy
Editor]."},{"name":"Robert L Coleman, MD","credentials":["Professor & Vice
Chair\n","Clinical Research\n","Ann Rife Cox Chair in Gynecology\n","Department of
Gynecologic Oncology\n","University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Merck, Oncomed,
Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie [ovarian, uterine, cervix
(pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib,
bevacizumab, emactuzumab, durvalumab, tremelumumab, nivolumab, selumetinib,
everolimus, ribociclib, AZD-1775)]. Consultant/Advisory Boards: Merck, Oncomed,
Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie, Bayer, immunogen [ovarian,
uterine (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib,
bevacizumab, emactuzumab, AZD-1775, IMGN-853)]."},{"name":"Laura C Collins,
MD","credentials":["Professor of Pathology\n","Harvard Medical School\n","Vice
Chair of Anatomic Pathology\n","Beth Israel Deaconess Medical Center,
Boston"],"disclosure":""},{"name":"Henri G Colt, MD","credentials":["Professor of
Medicine\n","University of California Irvine"],"disclosure":""},{"name":"Steven E
Come, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School\n","Director of Breast Medical Oncology Program\n","Beth Israel Deaconess
Medical Center"],"disclosure":""},{"name":"Carolyn C Compton, MD,
PhD","credentials":["Professor\n","Arizona State University"],"disclosure":""},
{"name":"Heidi M Connolly, MD, FASE","credentials":["Section Editor — Congenital
Heart Disease\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":""},
{"name":"Louis S Constine,
MD","credentials":["Professor of Radiation Oncology and Pediatrics\n","Vice
Chair\n","University of Rochester Medical Center"],"disclosure":""},
{"name":"Suzanne D Conzen, MD","credentials":["Professor of Medicine\n","The
University of Chicago"],"disclosure":""},{"name":"Timothy P Cooley,
MD","credentials":["Associate Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Todd M Cooper, DO","credentials":["Associate
Professor of Pediatrics \n","University of Washington\n","Director - Leukemia
Program\n","Seattle Children's Cancer and Blood Disorders
Center"],"disclosure":""},{"name":"David J Copenhaver, MD","credentials":["Director
of Cancer Pain Management and Supportive Care, Anesthesiology and Pain Medicine
Department \n","University of California at Davis"],"disclosure":""},
{"name":"Pelayo Correa, MD","credentials":["Anne Potter Wilson Professor of
Medicine\n","Division of Gastroenterology, Hepatology and Nutrition\n","Vanderbilt
University Medical Center"],"disclosure":""},{"name":"Richard J Cote, MD,
FRCPath","credentials":["Professor and Chair\n","Department of
Pathology\n","University of Miami Miller School of Medicine"],"disclosure":""},
{"name":"Scott J Cotler, MD","credentials":["Professor of Medicine\n","Director,
Division of Hepatology\n","Loyola University Medical Center"],"disclosure":""},
{"name":"Ross D Cranston, MD","credentials":["Visiting Professor\n","Fundació
Lluita contra la Sida\n","Hospital Universitari Germans Trias i
Pujol\n","Autonomous University of Barcelona\n","Barcelona,
Spain"],"disclosure":"Grant/Research/Clinical Trial Support: ABIVAX [HIV small
molecule therapeutics]. Consultant/Advisory Boards (Spouse): ABIVAX [HIV small
molecule therapeutics]; Aelix Therapeutics [HIV therapeutic vaccine]; Novicol
[topical HIV microbicide]."},{"name":"Sheila E Crowe, MD, FRCPC, FACP, FACG,
AGAF","credentials":["Professor of Medicine\n","University of California, San
Diego"],"disclosure":""},{"name":"Christopher P Crum, MD","credentials":
["Department of Pathology\n","Brigham and Women's Hospital"],"disclosure":""},
{"name":"Adam Cuker, MD, MS","credentials":["Assistant Professor of Medicine,
Assistant Professor of Pathology & Laboratory Medicine\n","Perelman School of
Medicine University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial
Support: Biogen-Idec, Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals.
Consultant/Advisory Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Clara
Curiel-Lewandrowski, MD","credentials":["Associate Professor of
Dermatology\n","Arizona Cancer Center, University of Arizona"],"disclosure":""},
{"name":"Steven A Curley, MD, FACS","credentials":["Professor of Surgery\n","Baylor
College of Medicine"],"disclosure":""},{"name":"James C Cusack, Jr,
MD","credentials":["Associate Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Corey Cutler, MD, MPH, FRCP(C)","credentials":
["Associate Professor of Medicine \n","Harvard Medical School\n","Medical
Director \n","Bone Marrow Transplant Survivors Clinic\n","Division of Hematologic
Malignancies\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Brian G
Czito, MD","credentials":["Associate Professor\n","Duke University Medical
Center"],"disclosure":"Speaker’s Bureau: Varian [GI malignancies (linear
accelerators used for radiation)]."},{"name":"Roi Dagan, MD","credentials":
["Assistant Professor, Radiation Oncology\n","University of Florida, College of
Medicine"],"disclosure":""},{"name":"Nicholas Dainiak, MD, FACP","credentials":
["Clinical Professor, Department of Therapeutic Radiology\n","Yale University
School of Medicine\n","Medical and Technical Director\n","Radiation Emergency and
Assistance Center (REAC/TS)"],"disclosure":""},{"name":"Josep Dalmau, MD,
PhD","credentials":["ICREA Professor of Neurology\n","Hospital Clinic/IDIBAPS,
University of Barcelona, Spain\n","Adjunct Professor of Neurology\n","University of
Pennsylvania"],"disclosure":"Grant/Research Support (with spouse): Euroimmun Inc,
[Identification of antibodies associated with disorders of the nervous system-
paraneoplastic and non-paraneoplastic (diagnostic tests to measure these antibodies
in serum and CSF)]. Patent Holder: Euroimmun, Inc, (I hold patents for the use of
NMDAR, GABAA, GABAB, DPPX, IgLON5 as antibody tests that have been licensed to
Euroimmun. and for which we receive royalties. My spouse holds a patent for the use
of NMDAR as an antibody test that has been licensed to Euroimmun and for which she
receives royalties); Athena Diagnostics (We hold a patent for the use of Ma2 as an
antibody test that has been licensed to Athena and for which we receive
royalties)."},{"name":"Anthony V D'Amico, MD, PhD","credentials":["Professor and
Chief of Genitourinary Radiation Oncology\n","Brigham and Women's Hospital\n","Dana
Farber Cancer Institute\n","Harvard Medical School"],"disclosure":""},
{"name":"Timothy A Damron, MD","credentials":["Vice-Chair and David G. Murray
Endowed Professor of Orthopedic Surgery\n","SUNY Upstate Medical
University"],"disclosure":"Grant/Research/Clinical Trial Support: Stryker [Vitoss
bone graft subsitute (Vitoss); Revision total joint clinical trial (Triathlon
revision total knees)]; Wright Medical [Prodense bone graft substitute
(Prodense)]."},{"name":"Siamak Daneshmand, MD","credentials":["Associate Professor
of Urology\n","Director, Center for Urologic Oncology\n","University of Southern
California"],"disclosure":""},{"name":"Marion Danis, MD","credentials":["Ethics
Consultant"],"disclosure":""},{"name":"Matthew S Davids, MD, MMSc","credentials":
["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Brian Davis, MD, PhD","credentials":["Professor of Radiation
Oncology\n","Mayo Clinic and Foundation"],"disclosure":"Speaker’s Bureau: Augmenix
Inc. [Prostate cancer (Hydrogel spacer)]. Equity Ownership/Stock Options: Pfizer
[Stock]. Equity Ownership/Stock Options (Spouse): Pfizer [Stock]."},{"name":"Nancy
A Dawson, MD","credentials":["Professor of Medicine\n","Lombardi Comprehensive
Cancer Center\n","Georgetown University"],"disclosure":"Grant/Research/Clinical
Trial Support: Bayer [Prostate cancer (Radium-223)]; Genetech/Roche [Bladder cancer
(Atezolizumab)]. Speaker’s Bureau: Bayer [Prostate cancer (Radium-223)]; Astellas
[Prostate cancer (Enzalutamide)]; Janssen [Prostate cancer (Abirateorne)]; Sanofi
[Prostate cancer (Cabazitaxel, deoetaxel)]; Amgen [Bone metastases (Denosumab)];
Pfizer [Kidney cancer (Sunitinib, axitinib, temsorilimus)]; Novartis [Kidney cancer
(Pazopanib, everolimus)]; Genetech/Roche [Bladder cancer (Atezolizumab)]; Eisai
[Kidney cancer (Lenvatanib)]; Exelexis [kidney cancer (Cabozantanib)].
Consultant/Advisory Boards: Janssen [Prostate cancer (Abiraterone)]; AstraZeneca
[Bladder cancer (Durvalumab)]; Novartis [Kidney cancer (Pazopanib, everolimus)];
Abvie [Prostate cancer (Leuprolide acetate)]; Sanofi [Prosate cancer (Docetaxel,
cabazitaxel)]."},{"name":"Marc E De Broe, MD, PhD","credentials":["Emeritus
Professor of Medicine\n","University of Antwerp, Belgium"],"disclosure":""},
{"name":"Jennifer F De Los Santos, MD","credentials":["Associate
Professor\n","Department of Radiation Oncology\n","University of Alabama at
Birmingham"],"disclosure":"Speaker's Bureau: Varian Medical Systems [Breast cancer
(Course in breast cancer treatment)]."},{"name":"Claire Dearden, MD, BSc, FRCP,
FRCPath","credentials":["Consultant Haematologist\n","The Royal Marsden Hospital
and Institute of Cancer Research, London"],"disclosure":"Consultant/Advisory
Boards: Roche [B-PLL (Rituximab)]; Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL
(Ibrutinib)]; Sanofi [T-PLL (Alemtuzumab)]."},{"name":"Malcolm M DeCamp,
MD","credentials":["Fowler McCormick Professor of Surgery\n","Northwestern
University Feinberg School of Medicine"],"disclosure":""},{"name":"John F Deeken,
MD","credentials":["Associate Professor\n","Virginia Commonwealth
University\n","Associate Director for Medical Oncology and Clinical
Research\n","Inova Comprehensive Cancer and Research Institute"],"disclosure":""},
{"name":"Mark E Deffebach, MD","credentials":["Associate Professor of
Medicine\n","Oregon Health and Science University\n","Portland Veterans Affairs
Medical Center"],"disclosure":""},{"name":"Marcela G del Carmen, MD","credentials":
["Professor\n","Department of Obstetrics, Gynecology and Reproductive
Biology\n","Harvard Medical School\n","Medical Director\n","Massachusetts General
Physicians Organization"],"disclosure":""},{"name":"Giuseppe Del Priore, MD,
MPH","credentials":["Professor\n","Morehouse School of Medicine"],"disclosure":""},
{"name":"Thomas F DeLaney, MD","credentials":["Section Editor — Bone and Soft
Tissue Tumors\n","Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"George D Demetri, MD","credentials":["Professor
of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research Support:
Bayer [GIST and soft tissue sarcoma therapy (Regorafenib)]; Novartis [GIST and soft
tissue sarcoma therapy (Imatinib and pazopanib)]; Pfizer [GIST and soft tissue
sarcoma therapy (Sunitinib)]; Janssen/PharmaMar [Soft tissue sarcoma therapy
(Trabectedin)]; Eisai [Soft tissue sarcoma therapy (Eribulin)]; Adaptimmune [Soft
tissue sarcoma therapy (Engineered T cells)]. Consultant/Advisory Boards: Bayer
[GIST and soft tissue sarcoma therapy (Regorafenib)]; Novartis [GIST and soft
tissue sarcoma therapy (Imatinib and pazopanib)]; Pfizer [GIST and soft tissue
sarcoma therapy (Sunitinib)]; Daiichi-Sankyo [GIST and soft tissue sarcoma therapy
(Various new agents)]; Blueprint Medicines [GIST and soft tissue sarcoma therapy
(BLU-285)]; Janssen/PharmaMar [GIST and soft tissue sarcoma therapy (Trabectedin)];
Eisai [GIST and soft tissue sarcoma therapy (Eribulin)]; EMD Serono [GIST and soft
tissue sarcoma therapy (TH-302)];
Ariad [GIST and soft tissue sarcoma therapy (Ponatinib)]; Eli Lilly [GIST and soft
tissue sarcoma therapy (Olaratumab)]; Caris Life Sciences [molecular diagnostics].
Patent Holder: Novartis [GIST (Use patent from Dana-Farber licensed to Novartis)].
Equity Ownership/Stock Options: Blueprint Medicines [GIST (BLU-285)]; Caris Life
Sciences [molecular diagnostics]. Other Financial Interest: Blueprint Medicines
[GIST (Independent member of board of directors; BLU-285)]."},{"name":"Elizabeth G
Demicco, MD, PhD","credentials":["Associate Professor of Pathology\n","Mount Sinai
Hospital\n","University of Toronto"],"disclosure":""},{"name":"Alexis Demopoulos,
MD","credentials":["Assistant Professor, Department of Neurology\n","Hofstra North
Shore - LIJ School of Medicine"],"disclosure":""},{"name":"Lynette Denny, MD,
PhD","credentials":["Professor Obstetrics and Gynaecology\n","University of Cape
Town\n","Groote Schuur Hospital and Institute of Infectious Diseases and Molecular
Medicine"],"disclosure":""},{"name":"Jayesh Desai, MD, FRACP","credentials":
["Medical Oncologist\n","Peter MacCallum Cancer Centre\n","Royal Melbourne
Hospital\n","Senior Research Fellow\n","Walter and Eliza Hall Institute\n","Chair
of Australasian Sarcoma Study Group"],"disclosure":""},{"name":"Daniel G Deschler,
MD, FACS","credentials":["Section Editor — Otorhinolaryngology\n","Professor of
Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Rony
Dev, DO","credentials":["Assistant Professor\n","University of Texas MD Anderson
Cancer Center"],"disclosure":""},{"name":"Lara K Dhingra, PhD","credentials":
["Assistant Professor of Neurology and Psychiatry and Behavioral
Sciences\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Steven
J DiBiase, MD","credentials":["Professor of Radiation Oncology\n","Tulane
University School of Medicine\n","Medical Director, Department of Radiation
Oncology\n","Tulane Cancer Center"],"disclosure":"Speaker’s Bureau: Bayer
Pharmaceuticals [Prostate cancer (Radium 223)]."},{"name":"Anna L Dickerman,
MD","credentials":["Assistant Professor of Psychiatry\n","Weill Medical College of
Cornell University"],"disclosure":""},{"name":"Maura Dickler, MD","credentials":
["Interim Chief, Breast Medicine Service\n","Section Head, Endocrine Therapy
Clinical Research Program"],"disclosure":"Grant/Research/Clinical Trial Support:
Novartis, Eli Lilly, Roche/Genentech [Breast cancer]. Consultant/Advisory Boards:
Astra Zeneca [Breast cancer (Fulvestrant)]; Novartis [Breast cancer (Alpelisib,
letrozole, ribociclib)]; Roche/Genentech [Breast cancer (Trastuzumab, pertuzumab,
bevacizumab)]; Eli Lilly [Breast cancer (Abemaciclib)]; Pfizer [Breast cancer
(Palbociclib)]; Syndax [Breast cancer (Etinostat)]; Puma Biotechnology [Breast
cancer (Neratinib)]."},{"name":"Jorg Dietrich, MD, PhD","credentials":["Assistant
Professor of Neurology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Monteris Medical Corporation
[Surgical laser device (Neuroblate)]."},{"name":"Paul A DiSilvestro,
MD","credentials":["Professor\n","Program in Women's Oncology\n","Women and Infants
Hospital\n","Alpert School of Medicine at Brown University"],"disclosure":""},
{"name":"Angela Dispenzieri, MD","credentials":["Serene M. and Frances C. Durling
Professor of Medicine and of Laboratory Medicine, and Pathology\n","Mayo
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Celgene,
Takeda, Alnylam, Janssen, Prothena (tafamidis, lenalidomide, pomalidomide,
ixazomib, bortezomib, NEOD001]."},{"name":"J Michael Dixon, MD","credentials":
["Professor of Surgery and Consultant Surgeon\n","Edinburgh
University"],"disclosure":""},{"name":"Don S Dizon, MD, FACP","credentials":
["Section Editor – Gynecologic Oncology\n","Head of Women's Cancers, Lifespan
Cancer Institute\n","Director of Medical Oncology, Rhode Island
Hospital\n","Associate Professor of Medicine, Warren Alpert Medical School of Brown
University"],"disclosure":"Consultant/Advisory Boards: Pfizer; Fuji Pharmaceuticals
[Chemotherapy (Biosimilars)]."},{"name":"Donald C Doll, MD","credentials":
["Professor Emeritus\n","Ellis Fischel Cancer Center\n","University of
Missouri"],"disclosure":""},{"name":"John E Donahue, MD","credentials":["Associate
Professor of Pathology and Laboratory Medicine and Neurology\n","Rhode Island
Hospital, Warren Alpert Medical School of Brown University"],"disclosure":""},
{"name":"Timothy F Donahue, MD","credentials":["Associate Attending Surgeon,
Urology Service\n","Department of Surgery\n","Memorial Sloan-Kettering Cancer
Center\n","Associate Professor of Urology\n","Weill Medical College of Cornell
University"],"disclosure":""},{"name":"Kevin Donohoe, MD","credentials":["Assistant
Professor of Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Tanya
B Dorff, MD","credentials":["Associate Professor of Clinical Medicine\n","USC Keck
School of Medicine\n","Norris Comprehensive Cancer Center"],"disclosure":""},
{"name":"Chyke Doubeni, MD, FRCS, MPH","credentials":["Chair and Presidential
Associate Professor,\n","Department of Family Medicine and Community
Health\n","Perelman School of Medicine, University of
Pennsylvania"],"disclosure":""},{"name":"Jan Drappatz, MD","credentials":
["Associate Director\n","Adult Neuro-Oncology Program\n","Associate
Professor\n","Departments of Neurology and Medicine\n","University of
Pittsburgh"],"disclosure":""},{"name":"Reed E Drews, MD","credentials":["Section
Editor — Complications of Cancer\n","Associate Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Marc K Drezner, MD","credentials":
["Section Editor — Bone Disease\n","Professor of Medicine\n","University of
Wisconsin Medical School"],"disclosure":""},{"name":"Marcia S Driscoll, MD,
PharmD","credentials":["Clinical Associate Professor of Dermatology\n","University
of Maryland School of Medicine"],"disclosure":""},{"name":"Steven G DuBois, MD,
MS","credentials":["Member of Faculty\n","Department of Pediatrics\n","Harvard
Medical School."],"disclosure":"Grant/Research/Clinical Trial Support: Loxo
Oncology; Lilly; Merck; Novartis; Roche [Oncology (Multiple products)].
Consultant/Advisory Boards: Loxo Oncology [Oncology (Loxo-101)]."},{"name":"Deborah
Dudgeon, MD, FRCPC","credentials":["W. Ford Connell Professor of Palliative Care
Medicine\n","Director of Palliative Care Medicine, Queens University\n","Head,
Palliative Medicine & Supportive Care Program, Kingston Regional Cancer Centre,
Kingston, ON"],"disclosure":""},{"name":"Anette Duensing, MD","credentials":
["Assistant Professor of Pathology\n","University of Pittsburgh School of
Medicine"],"disclosure":""},{"name":"Shrina Duggal, PharmD, BCOP","credentials":
["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker’s
Bureau: Incyte [Gastrointestinal cancer (Ruxolitinib)]; Boehringer Ingelheim
[Gastrointestinal cancer (Afatinib)]; Pfizer/Astellas [Gastrointestinal cancer
(Enzalutamide)]."},{"name":"Damian E Dupuy, MD","credentials":["Director of Tumor
Ablation\n","Rhode Island Hospital\n","Professor of Diagnostic Imaging\n","Brown
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic
[Oncology (Tumor ablation devices)]; Galil Medical [Oncology (Tumor ablation
devices)]. Consultant/Advisory Boards: Perseon Medical [Oncology (Tumor ablation
devices)]; Boston Scientific Corp [Tumor ablation (Medical consult)]. Equity
Ownership/Stock Options: Perseon Corporation [Oncology (Tumor ablation devices)].
Other Financial Interest: Springer-Verlag [Interventional oncology (Textbook)]."},
{"name":"Linda R Duska, MD","credentials":["Associate Professor\n","Fellowship
Director\n","Gynecologic Oncology\n","University of Virginia"],"disclosure":""},
{"name":"Raed A Dweik, MD, FACP, FCCP, FRCP(C), FCCM, FAHA","credentials":
["Professor of Medicine\n","Cleveland Clinic Lerner College of
Medicine"],"disclosure":""},{"name":"Peter T Dziegielewski, MD,
FRCS(C)","credentials":["Assistant Professor\n","Chief of Head & Neck Surgical
Oncology and Microvascular Reconstructive Surgery\n","University of
Florida"],"disclosure":""},{"name":"Craig Earle, MD, MSc, FRCPC","credentials":
["Director, Health Services Research Program\n","Cancer Care Center and the Ontario
Institute for Cancer Research"],"disclosure":""},{"name":"Keith D Eaton, MD,
PhD","credentials":["Associate Professor of Medicine\n","Division of Medical
Oncology\n","University of Washington"],"disclosure":""},{"name":"Jason A
Efstathiou, MD, DPhil","credentials":["Associate Professor of Radiation Oncology
\n","Harvard Medical School\n","Associate Radiation Oncologist\n","Massachusetts
General Hospital"],"disclosure":""},{"name":"Rachel A Egler, MD","credentials":
["Assistant Professor of Pediatrics\n","Case Western Reserve
University"],"disclosure":""},{"name":"April F Eichler, MD, MPH","credentials":
["Senior Deputy Editor — UpToDate\n","Deputy Editor — Neurology and Sleep
Medicine\n","Assistant Professor of Neurology\n","Harvard Medical
School"],"disclosure":""},{"name":"Mark H Einstein, MD, MS, FACS,
FACOG","credentials":["Professor and Chair\n","Department of Obstetrics,
Gynecology, and Women’s Health\n","Assistant Dean\n","Clinical Research Unit
Rutgers New Jersey Medical School"],"disclosure":""},{"name":"Avraham Eisbruch,
MD","credentials":["Professor and Associate Chair for Clinical
Research\n","Department of Radiation Oncology\n","University of
Michigan"],"disclosure":""},{"name":"Aymen Elfiky, MD, MPH, MSc","credentials":
["Dana-Farber Cancer Institute\n","Harvard Medical School"],"disclosure":""},
{"name":"Moataz N El-Ghamry, MD","credentials":["Director of Brachytherapy
Service\n","Department of Radiation Oncology\n","Baylor Scott & White Healthcare
System"],"disclosure":""},{"name":"Ghada El-Hajj Fuleihan, MD, MPH","credentials":
["Professor of Medicine\n","American
University of Beirut Medical Center, Lebanon"],"disclosure":""},{"name":"Joann G
Elmore, MD, MPH","credentials":["Editor-in-Chief — Primary Care (Adult)\n","Section
Editor — General Medicine\n","Professor of Medicine, David Geffen School of
Medicine at UCLA"],"disclosure":""},{"name":"Kevin Emerick, MD","credentials":
["Assistant Professor in the Department of Otology and Laryngology\n","Harvard
Medical School"],"disclosure":""},{"name":"Edzard Ernst, MD, PhD, FMEdSci, FSB,
FRCP, FRCP (Edin.)","credentials":["Emeritus Professor of Complementary
Medicine\n","Peninsula Medical School, University of Exeter"],"disclosure":""},
{"name":"Carmen P Escalante, MD","credentials":["Professor\n","The University of
Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Laura J Esserman, MD,
MBA","credentials":["Professor of Surgery and Radiology\n","University of
California, San Francisco\n","Director, UCSF Carol Franc Buck Breast Care
Center"],"disclosure":""},{"name":"Elihu H Estey, MD","credentials":
["Professor\n","University of Washington School of Medicine"],"disclosure":""},
{"name":"Zeev Estrov, MD","credentials":["Professor of Medicine\n","University of
Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Incyte. Consultant/Advisory Boards: Incyte."},{"name":"D Gareth Evans, MD,
FRCP","credentials":["Cancer Lead and Consultant in Clinical Genetics\n","Genetic
Medicine\n","Manchester Academic Health Sciences Centre\n","Central Manchester
University Hospitals NHS Foundation Trust"],"disclosure":""},{"name":"Sandy J Falk,
MD, FACOG","credentials":["Director, Editorial Relations — UpToDate\n","Deputy
Editor — Obstetrics, Gynecology and Women's Health \n","Instructor of Obstetrics,
Gynecology and Reproductive Biology, Part-time\n","Harvard Medical
School"],"disclosure":""},{"name":"Francis A Farraye, MD, MSc","credentials":
["Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Alan Fein, MD","credentials":["Director,
Center for Pulmonary and Critical Care Medicine\n","North Shore University
Hospital"],"disclosure":""},{"name":"Steven H Feinsilver, MD","credentials":
["Professor of Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":""},{"name":"Darren Feldman, MD","credentials":["Assistant
Attending Physician, \n","Department of Medicine, \n","Memorial Sloan Kettering
Cancer Center\n","Assistant Professor in Medicine, \n","Weill Cornell Medical
College"],"disclosure":""},{"name":"Sarah Feldman, MD, MPH","credentials":
["Associate Professor\n","Harvard Medical School"],"disclosure":""},{"name":"Mary
Feng, MD","credentials":["Associate Professor\n","University of California at San
Francisco"],"disclosure":""},{"name":"Carlos Fernandez-del Castillo,
MD","credentials":["Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Betty Ferrell, PhD, MA, FAAN,
FPCN","credentials":["Director and Professor, Division of Nursing Research and
Education\n","City of Hope Medical Center"],"disclosure":""},{"name":"Fernando C
Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases
\n","Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech
[Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy]
and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-
mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion
pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-
mediated diseases]. Employment: Mayo Clinic."},{"name":"Petra Feyer,
MD","credentials":["Professor, \n","Head of Department, Radiation
Oncology\n","Vivantes Clinics Berlin Neukoelln"],"disclosure":"Consultant/Advisory
Boards: MSD/MERCK; Amgen; Riemser; TEVA [Aantiemetics (aprepitant, fosaprepitant)];
Mundipharma; TESARO [Complementary medicine (selen, mistletoe)]."},{"name":"David C
Fisher, MD","credentials":["Assistant Professor of Medicine \n","Harvard Medical
School"],"disclosure":"Speaker's Bureau: Seattle Genetics [Hodgkin's disease
(Brentuximab)]; Celgene [Cutaneous T-cell lymphoma (Romidepsin)]."},{"name":"David
E Fisher, MD, PhD","credentials":["Chief, Department of Dermatology\n","Director,
Melanoma Program, MGH Cancer Center\n","Director, Cutaneous Biology Research
Center\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Kevin R
Flaherty, MD, MS","credentials":["Section Editor — Interstitial Lung
Disease\n","Associate Professor of Medicine\n","University of Michigan Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer Ingelheim
[IPF (Nintedanib)]; Roche/Genentech [IPF (Pirfenidone)]. Consultant/Advisory
Boards: Boehringer Ingelheim [IPF (Nintedanib)]; Genetech [IPF (Pirfenidone)];
Roche [IPF (Pirfenidone)]; Veracyte [IPF]; Fibrogen [IPF]; Celgene [ILD]; Sanofi-
Genzyme [IPF]."},{"name":"Steven Flamm, MD","credentials":["Chief, Liver
Transplantation Program\n","Professor of Medicine\n","Feinberg School of
Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical Trial
Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV).
Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"Gini Fleming,
MD","credentials":["Professor of Medicine\n","University of Chicago Medical
Center"],"disclosure":""},{"name":"Charles W Flexner, MD","credentials":["Professor
of Medicine, Pharmacology and Molecular Sciences, and International
Health\n","Johns Hopkins University School of Medicine and Bloomberg School of
Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead
Sciences [HIV (tenofovir, elvitegravir, bictegravir, emtricitabine, cobicistat)].
Consultant/Advisory Boards: Merck [HIV (Efavirenz, indinavir, raltegravir)]; ViiV
Healthcare [HIV (Abacavir, lamivudine, dolutegravir)]; Janssen [HIV (darunavir,
rilpivirine, etravirine)]; Mylan [HIV (Generic antiretroviral drugs)]; Cipla LLC
[HIV (Generic antiretroviral drugs)]."},{"name":"Franklin P Flowers,
MD","credentials":["Professor Emeritus\n","Division of Dermatology and Cutaneous
Surgery\n","University of Florida College of Medicine"],"disclosure":""},
{"name":"Justin Floyd, DO","credentials":["Cancer Care Specialists of
Illinois\n","Assistant Professor of Clinical Medicine\n","Washington University
School of Medicine, St. Louis"],"disclosure":""},{"name":"Robert Foote, MD, FACR,
FASTRO","credentials":["Professor and Chair, Department of Radiation
Oncology\n","Mayo Clinic College of Medicine"],"disclosure":"Patent Holder:
TruGuard/Bionix [Oral cavity and sinus cancer (Treatment device with RT)]. Other
Financial Interest: Elsevier [Radiation oncology (Editor for Clinical Radiation
Oncology journal)]."},{"name":"Theodoros Foukakis, MD, PhD","credentials":
["Department of Oncology\n","Karolinska Institutet and University
Hospital\n","Stockholm, Sweden"],"disclosure":"Grant/Research/Clinical Trial
Support: Pfizer [Breast cancer (palbociclib)]."},{"name":"Jeffrey M Fowler,
MD","credentials":["Vice Chairman and Professor\n","Department of Obstetrics and
Gynecology\n","Division of Gynecologic Oncology\n","John G. Boutselis Chair in
Gynecologic Oncology\n","The Ohio State University Medical
Center"],"disclosure":""},{"name":"Jasmine H Francis, MD","credentials":
["Attending\n","Ophthalmic Oncology Service\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":""},{"name":"Stephen Freedland, MD","credentials":["Editor-
in-Chief, Prostate Cancer and Prostatic Diseases\n","Professor of Surgery
(Urology)\n","Director, Center for Integrated Research on Cancer and Lifestyle
(CIRCL)\n","Associate Director, Samuel Oschin Comprehensive Cancer
Center\n","Cedars Sinai Medical Center"],"disclosure":"Grant/Research/Clinical
Trial Support: GenomeDx [Molecular prognostic for prostate cancer (genetic test for
prostate cancer)]; Myriad [Molecular prognostic for prostate cancer (genetic test
for prostate cancer)]; MDxHealth [Molecular prognostic for prostate cancer (genetic
test for prostate cancer)]. Consultant/Advisory Boards: Gave one talk for GenomeDx
[Molecular prognostic for prostate cancer (genetic test for prostate cancer)]."},
{"name":"Arnold S Freedman, MD","credentials":["Section Editor —
Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB]. Other
Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer 17833)]."},
{"name":"Neil Freedman, MD","credentials":["Head, Division of Pulmonary, Critical
Care, Allergy and Immunology\n","North Shore University Health
System"],"disclosure":""},{"name":"Jonathan W Friedberg, MD","credentials":
["Professor of Medicine\n","James P Wilmot Cancer Center, University of
Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials
(Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},
{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General
Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts
University School of Medicine"],"disclosure":"Consultant/Advisory Boards:
Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley
Hospital (through June 2017). Employment: Boston Health Care for the Homeless.
Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)];
McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology
(Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy
[Gastroenterology and hepatology (Honorarium as newsletter editor)]."},
{"name":"Erik K Fromme, MD","credentials":["Member of the faculty of Harvard
Medical School\n","Associate Physician at Brigham and Women's Hospital and Dana
Farber Cancer Institute"],"disclosure":""},{"name":"Harold Frucht,
MD","credentials":["Associate Professor of Clinical Medicine\n","College of
Physicians and Surgeons, Columbia University"],"disclosure":""},{"name":"Michael
Frumovitz, MD, MPH","credentials":["Professor of Gynecologic Oncology\n","MD
Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support:
Novadaq [Cervical cancer (Clinical trial support)]; Navidea [Cervical cancer
(Clinical trial support)]. Consultant/Advisory Boards: Novadaq [Surgical imaging
technology (PinPoint system for detection of sentinel nodes)]; Genentech
[Bevacizumab (Educational content for business)]."},{"name":"Keiichi Fujiwara, MD,
PhD","credentials":["Professor of Gynecologic Oncology\n","Saitama Medical
University"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Ovarian
cancer (Avelumab)]; AstraZeneca [Ovarian cancer (Olaparib)]; Esai [Ovarian cancer
(Farletuzumab)]; Zeria Pharmaceutical [Ovarian cancer (Z-100)]; MSD Pharmaceuticals
[Ovarian cancer (Penblorizumab)]; Ono Pharmaceutical [Ovarian cancer (Nivolumab)];
Taiho Pharmaceutical [Ovarian cancer (TAS-117)]; Clovis Oncology [Ovarian cancer
(Rucaparib)]. Speaker's Bureau: Chugai Pharmaceutical [Ovarian cancer]; Nippon
Kayaku [Ovarian cancer]; Yakult Pharmaceutical [Ovarian cancer]; Taiho
Pharmaceutical [Ovarian cancer, Cervical Cancer]; Janssen [Ovarian Cancer].
Consultant/Advisory Boards: Pfizer [Ovarian cancer (Avelumab)]; AstraZeneca
[Ovarian cancer (Olaparib)]; Esai [Ovarian cancer (Farletuzumab)]; Zeria
Pharmaceutical [Ovarian cancer (Z-100)]; MSD Pharmaceuticals [Ovarian cancer
(Penblorizumab)]; GlaxoSmithKline[Ovarian cancer (Pazopanib)]; Taiho Pharmaceutical
[Ovarian cancer (TAS-117)]; Eisai Co., Ltd. [Endometrial cancer (Lenvatinib)]."},
{"name":"Suzanne A.W. Fuqua, PhD","credentials":["Professor, Departments of
Medicine and Molecular Cell Biology\n","Lester and Sue Smith Breast
Center\n","Baylor College of Medicine"],"disclosure":""},{"name":"William H Gaasch,
MD","credentials":["Section Editor — Valvular Disease\n","Professor of
Medicine\n","University of Massachusetts Medical School\n","Tufts University School
of Medicine\n","Senior Consultant in Cardiology\n","Lahey
Clinic"],"disclosure":""},{"name":"Paul J Gaglio, MD","credentials":["Professor of
Medicine (in Surgery)\n","Director: Hepatology Outreach\n","Columbia University
College of Physicians and Surgeons Center for Liver Disease and Transplantation
\n","\n","NY Presbyterian Hospital-Columbia University Medical Center\n","622 West
168th Street PH 14 Room 202 F\n","NY, NY 10032"],"disclosure":"Consultant/Advisory
Boards: Abbvie, Gilead, Salix [Viral hepatitis (Sofosbuvir/Ledipasvir/
Velpatasvir/Voxilaprevir/Glecaprevir Pibrenastvix)]."},{"name":"Stéphanie Gaillard,
MD, PhD","credentials":["Director, Gynecologic Cancer Trials\n","Assistant
Professor, Oncology and Gynecology & Obstetrics\n","Johns Hopkins University School
of Medicine"],"disclosure":""},{"name":"Thomas Galloway, MD","credentials":
["Assistant Professor\n","Department of Radiation Oncology\n","Fox Chase Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Varian Medical Systems [Head and
neck cancer (Training course)]."},{"name":"Moira Garraus, MD","credentials":
["Paediatric Oncologist\n","Hospital San Joan de Deu"],"disclosure":""},
{"name":"Mark C Gebhardt, MD","credentials":["Frederic W. and Jane M. Ilfeld
Professor of Orthopedic Surgery\n","Harvard Medical
School"],"disclosure":"Employment: Clinical Orthopedics and Related Research
(journal) [Senior Associate Editor]."},{"name":"AJ Gelderblom, MD,
PhD","credentials":["Medical Oncologist\n","Department of Clinical
Oncology\n","Leiden University Medical Center"],"disclosure":""},{"name":"Alan C
Geller, RN, MPH","credentials":["Senior Lecturer\n","Social and Behavioral
Sciences\n","Harvard School of Public Health"],"disclosure":""},{"name":"Daniel
George, MD","credentials":["Professor of Medicine and Surgery\n","Duke University
Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta
[Urothelial CA (Acalabrutinib)]; Astellas/Medivation [Prostate CA (Enzalutamide)];
Astrazeneca (Bladder CA (Durvalumumab)]; Bayer [Prostate CA (Radium 223)]; BMS
[Renal cell carcinoma (Nivolumab)]; Celldex [Bladder CA (Varlilumab)]; Exelixis
[Prostate CA/Renal cell carcinoma (Cabozanitinib)]; Genentech [Renal cell carcinoma
(Bevacizumab)]; GSK [Renal cell carcinoma (Pazopanib)]; Janssen [Prostate CA
(Abiraterone)]; Millenium [Prostate CA (Orteronel)]; Novartis [Renal cell carcinoma
(Everolimus)], Pfizer [Prostate CA (Sunitinib, Temsirolimus), RCC (Axitinib)];
Viamet/Innocrin [Prostate CA (Seviteronel)]. Speaker's Bureau: Bayer [Prostate
Cancer (Radium 223)]; Dendreon [Renal cell carcinoma (Sipuleucel-T)]; Sanofi
[Prostate CA (cabazitaxel)]. Consultant/Advisory Boards: Astellas/Medivation
[Prostate CA (Enzalutamide)]; Bayer [Prostate CA (Radium-223)]; BMS [Renal cell
carcinoma (Nivolumab, ipilimumab)]; Dendreon [Renal cell carcinoma (Sipuleucel-T)];
Exelixis [Prostate CA, renal cell carcinoma (Cabozanibinib)]; Merck [Renal cell
cancer (Pembrolizumab)]; Pfizer [Prostate CA, renal cell carcinoma (Sunitinib,
axitinib, temsirolimus)]; Innocrin [Prostate CA (Seviteronel)]; Acceleron Pharma
[Renal cell carcinoma (Dalantercept)]; Clovis [Prostate (Rucaparib)]; Genentech
[Bladder CA (Atezolizumab)]; Janssen [Prostate CA (Nirapanib)]; Novartis [Renal
cell carcinoma (Everolimus)]; Sanofi [Prostate CA (Jevtana)]; Myovant Sciences, Inc
[Prostate CA (Steering committee)]."},{"name":"James N George, MD","credentials":
["Professor of Medicine\n","University of Oklahoma Health Sciences
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ablynx [TTP
(caplacizumab)]."},{"name":"Suzanne George, MD","credentials":["Associate Professor
of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Blueprint; Decipera; Pfizer; Bayer; Ariad; Novartis; [GIST (BLU285;
DCC sunitinib; regorafenib; ponatinib; imatinib)]."},{"name":"David M Gershenson,
MD","credentials":["J Taylor Wharton MD Distinguished Chair in Gynecologic
Oncology\n","Professor of Gynecologic Oncology\n","The University of Texas MD
Anderson Cancer Center"],"disclosure":""},{"name":"Jeffrey E Gershenwald, MD,
FACS","credentials":["Professor of Surgery and Cancer Biology\n","The University of
Texas MD Anderson Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck
[Melanoma therapy (Pembrolizumab, interferonxx)]."},{"name":"Peter C Gerszten, MD,
MPH, FACS","credentials":["Professor of Neurosurgery and Radiation
Oncology\n","University of Pittsburgh Medical Center"],"disclosure":""},
{"name":"Scott Gettinger, MD","credentials":["Associate Professor of
Medicine\n","Yale University School of Medicine\n","Yale Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Bristol Meyers Squibb [Lung
cancer (Nivolumab)]."},{"name":"Nicholas J Giacalone, MD","credentials":
["Resident\n","Radiation Oncology Program\n","Harvard Medical
School"],"disclosure":""},{"name":"Giuseppe Giaccone, MD, PhD","credentials":
["Professor of Medical Oncology and Pharmacology\n","Lombardi Comprehensive Cancer
Center, Georgetown University"],"disclosure":"Grant/Research Support: Eli-Lilly
[oncology (CHK1 INHIBITOR)]. Consultant/Advisory Boards: Astra-Zeneca
[IMMUNOONCOLOGY]; Syndax [HYPOTHEYLATING AGENTS]; G1 therapeutics [HDAC
INHIBITORS]."},{"name":"Michael K Gibson, MD, PhD, FACP","credentials":["Associate
Professor of Medicine\n","Research Director for Head and Neck
Oncology\n","Vanderbilt University"],"disclosure":"Grant/Research/Clinical Trial
Support: NCCN [Head and Neck Cancer (Afatinib)]; NCI [Head and Neck Cancer
(cooperative group tirals)]. Consultant/Advisory Boards: Amgen [Gastric cancer
(pembrolizumab)]."},{"name":"Jill Gilbert, MD","credentials":["Professor of
Medicine\n","Vanderbilt University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Astra Zeneca [head
and neck cancer (durvalumab and tremilumimab)]; BMS [head and neck cancer
(nivolumab)]; Pfizer [head and neck cancer (avelumab and cisplatin, pablociclib and
cetuximab)]; Merck [head and neck cancer (pembrolizumab)]; Speake’s Bureau: EPIC
/TRIM [HPV related head and neck cancer and metastatic thyroid cancer];
Consultant/Advisory Boards: IRX [head and neck cancer (DSMB for clinical trial of a
vaccine, IRX-2)]; Genzyme [thyroid cancer (treatment paradigms, not drug
specific)]"},{"name":"James M Gilchrist, MD","credentials":["Professor and Chair,
Department of Neurology\n","Southern Illinois University School of
Medicine"],"disclosure":""},{"name":"Inderbir S Gill, MD, MCh","credentials":
["Chairman and Professor\n","Department of Urology\n","Executive Director of the
USC Institute of Urology\n","Associate Dean (Clinical Innovation)\n","Keck School
of Medicine\n","University of Southern
California"],"disclosure":"Consultant/Advisory Boards: EDAP [HIFU]; Mimic
Technologies [Simulation]."},{"name":"Timothy D Gilligan, MD","credentials":
["Associate Professor of Medicine\n","Cleveland Clinic Lerner College of
Medicine\n","Vice-Chair for Education\n","Cleveland Clinic Taussig Cancer
Institute\n","Director of Coaching, Center for Excellence in Healthcare
Communication\n","Cleveland Clinic"],"disclosure":""},{"name":"Bonnie S Glisson,
MD, FACP","credentials":["Professor and Associate Chair \n","Department of
Thoracic/Head and Neck Medical Oncology\n","University of Texas MD Anderson Cancer
Center"],"disclosure":""},{"name":"Lucy A Godley, MD, PhD","credentials":
["Professor of Medicine\n","The University of
Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Onconova, Inc
[epigenetic profiling of rigosertib response (rigosertib)]."},{"name":"Barbara
Goff, MD","credentials":["Section Editor — Gynecologic Oncology\n","Department
Chair, Gynecologic Oncology\n","Surgeon-in-Chief\n","University of Washington
Medical Center"],"disclosure":"Employment
(Spouse): Lilly [General oncology (Gemcitabine, pemetrexed)] - No relevant
conflict on topics."},{"name":"S Nahum Goldberg, MD","credentials":["Director of
Abdominal Intervention and Tumor Ablation\n","Minimally-Invasive Tumor Therapies
Laboratory\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Angiodynamics [tumor
ablation (tumor ablation devices)]. Consultant/Advisory Boards: Angiodynamics;
Cosman Instruments [tumor ablation (tumor ablation devices)]."},{"name":"Gary
Goldenberg, MD","credentials":["Assistant Professor of Dermatology and
Pathology\n","Mount Sinai School of Medicine\n","Medical Director of the
Dermatology Faculty Practice"],"disclosure":""},{"name":"Donald Peter Goldstein,
MD","credentials":["Professor of Obstetrics, Gynecology, and Reproductive
Biology\n","Harvard Medical School\n","Founder and Co-Director \n","New England
Trophoblastic Disease Center"],"disclosure":""},{"name":"Vinai Gondi,
MD","credentials":["Clinical Assistant Professor\n","University of Wisconsin School
of Medicine and Public Health"],"disclosure":""},{"name":"Annekathryn Goodman, MD,
MPH","credentials":["Professor\n","Obstetrics, Gynecology, Reproductive
Biology\n","Harvard Medical School\n","Division of Gynecologic
Oncology\n","Massachusetts General Hospital\n","MGH Global Disaster
Response"],"disclosure":""},{"name":"Peter D Gorevic, MD","credentials":["Professor
of Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},
{"name":"Michael K Gould, MD, MS","credentials":["Senior Research Scientist
\n","Director for Health Services Research\n","Department of Research and
Evaluation\n","Kaiser Permanente Southern
California"],"disclosure":"Grant/Research/Clinical Trial Support: Medial EarlySign
[Lung cancer (Risk models)]."},{"name":"Mrinal M Gounder, MD","credentials":
["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical
College"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Sarcoma
(Sorafenib)]. Consultant/Advisory Boards: Epizyme; Karyopharm; Daiichi-Sankyo;
Amgen [Sarcoma (None)]."},{"name":"William J Gradishar, MD","credentials":
["Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern
University"],"disclosure":""},{"name":"William M Grady, MD","credentials":
["Professor of Medicine\n","University of Washington and the Fred Hutchinson Cancer
Research Center"],"disclosure":""},{"name":"David Graham, MD, FASCO","credentials":
["Medical Director\n","Western Region, Levine Cancer Institute\n","Carolinas
HealthCare System\n","Charlotte, NC"],"disclosure":"Consultant/Advisory Boards:
Biopeps, Inc [Prostate]."},{"name":"David Y Graham, MD","credentials":["Professor
of Medicine\n","Michael E. DeBakey VAMC and Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: RedHill Biopharma
[H pylori]. Consultant/Advisory Boards: BioGaia; Takeda [H pylori]."},{"name":"Jane
M Grant-Kels, MD","credentials":["Founding Chair, Emeritus, Department of
Dermatology\n","Vice Chair, Department of Dermatology\n","Professor of Dermatology,
Pathology, and Pediatrics\n","Founding Director, Cutaneous Oncology Center and
Melanoma Program\n","University of Connecticut Health Center"],"disclosure":""},
{"name":"Ana M Grau, MD, FACS","credentials":["Associate Professor\n","Vanderbilt
University"],"disclosure":""},{"name":"Heidi J Gray, MD","credentials":["Associate
Professor\n","Division of Gynecologic Oncology\n","Dept of OB/GYN\n","University of
Washington"],"disclosure":""},{"name":"F Anthony Greco, MD","credentials":["Medical
Director\n","Sarah Cannon Cancer Center"],"disclosure":"Speaker's Bureau:
BioTheranostics [CUP (Molecular assay)]. Consultant/Advisory Boards:
BioTheranostics [CUP (Molecular assay)]."},{"name":"Frank G Gress,
MD","credentials":["Professor of Medicine \n","Columbia University College of
Physicians and Surgeons"],"disclosure":""},{"name":"Jerome E Groopman,
MD","credentials":["Dina and Raphael Recanati Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Neil D Gross, MD, FACS","credentials":
["Professor\n","Head and Neck Surgery\n","MD Anderson Cancer
Center"],"disclosure":"Consultant/Advisory Boards: PDS Biotechnology [Head and neck
cancer (Investigation agents)]."},{"name":"Thomas G Gross, MD, PhD","credentials":
["Deputy Director for Science\n","Center for Global Health, NCI, NIH,
DHHS"],"disclosure":""},{"name":"Axel Grothey, MD","credentials":["Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Shilpa Grover, MD, MPH,
AGAF","credentials":["Deputy Editor — Gastroenterology/Hepatology\n","Assistant
Professor of Medicine, Part-time\n","Harvard Medical School"],"disclosure":"Other
Financial Interest: Honorarium (travel)- Novartis ($3,000)"},{"name":"Sandeep
Gurbuxani, MBBS, PhD","credentials":["Associate Professor, Section of
Hematopathology, Department of Pathology\n","University of
Chicago"],"disclosure":""},{"name":"Robert I Haddad, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: BMS; Merck; Astra
Zeneca; Celgene [Head and neck cancer clinical trials support to institution
(None)]. Consultant/Advisory Boards: BMS; Astra Zeneca; Merck; Pfizer; Eisai [Head
and neck cancer clinical trials (None)]."},{"name":"Daniel E Haggstrom,
MD","credentials":["Co-leader, Senior Oncology Program\n","Levine Cancer
Institute\n","Charlotte, NC"],"disclosure":""},{"name":"David A Haggstrom, MD,
MAS","credentials":["Investigator\n","VA HSR&D Center of Excellence on Implementing
Evidence-Based Practice\n","Associate Professor\n","Indiana University School of
Medicine\n","Division of General Internal Medicine & Geriatrics"],"disclosure":""},
{"name":"John D Hainsworth, MD","credentials":["Chief Scientific Officer\n","Sarah
Cannon Research Institute"],"disclosure":""},{"name":"Omid Hamid,
MD","credentials":["Director, Melanoma Center\n","The Angeles Clinic and Research
Institute"],"disclosure":"Grant/Research Support: Astra Zenica; BMS; Celldex;
Genentech; Immunocore; Incyte; Novartis; Merck; Merck Serano; Medimmune; Pfizer;
Rinat; Roche [Melanoma phase I (Avelumab, atezolizunab, pembrolizumab, novolomab,
durvalumab, iprlimumab, talimogene laheperepoec)]. Speaker's Bureau: Genentech
[Oncology (Trametanib)]; BMS [Melanoma (Dabrafenib)]; Novartis [Immuno
(Remurafenib)]; Amgen [Solid tumors (Cobimetamib)]. Consultant/Advisory Boards:
Amgen, Novartis, Roche, BMS, Merck [Mucosal melanoma]."},{"name":"Gary D Hammer,
MD, PhD","credentials":["Millie Schembechler Professor of Adrenal
Cancer\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial
Support: Eisai Co Ltd [Differentiated thyroid cancer (Lenvatinib E7080)].
Consultant/Advisory Boards: Embera NeuroTherapeutics [Adrenal cancer (Drug
development)]; HRA Pharma [Adrenal cancer]; Ionis Pharmaceuticals; Millendo
[Adrenal cancer (ATR-101)]; Orphagen Pharmaceuticals; [Adrenal cancer (Drug
development)]. Equity Ownership/Stock Options: Embera NeuroTherapeutics;
Millendo."},{"name":"M Elizabeth H Hammond, MD, FCAP","credentials":["Professor of
Pathology\n","University of Utah School of Medicine"],"disclosure":""},
{"name":"George Handzo, BCC, CSSBB","credentials":["Director of Health Services
Research & Quality\n","HealthCare Chaplaincy, New York, NY"],"disclosure":""},
{"name":"Nasser Hanna, MD","credentials":["Indiana
University"],"disclosure":"Grant/Research/Clinical Trial Support: Merck; Bristol
Myers Squibb [Lung cancer (Research grant)]."},{"name":"Wendy Hara,
MD","credentials":["Clinical Associate Professor, Department of Radiation
Oncology\n","Stanford University"],"disclosure":""},{"name":"Daniel J Haraf,
MD","credentials":["Professor\n","University of Chicago"],"disclosure":""},
{"name":"J William Harbour, MD","credentials":["Professor, Vice Chairman & Dr. Mark
J. Daily Endowed Chair, \n","Bascom Palmer Eye Institute;\n","Associate Director
for Basic Research,\n","Sylvester Comprehensive Cancer Center,\n","University of
Miami Miller School of Medicine"],"disclosure":"Consultant/Advisory Boards: Castle
Bioscience [Uveal melanoma (DecisionDx-UM)]; Aura Biosciences [Uveal melanoma (AU-
011)]; Immunocore, Ltd [Uveal melanoma (IMCgp100)]. Other Financial Interest
(royalties): Castle Biosciences [Uveal melanoma (DecisionDx-UM)]."},{"name":"Seth P
Harlow, MD","credentials":["Associate Professor of Surgery\n","University of
Vermont College of Medicine"],"disclosure":""},{"name":"Stephanie M Harman,
MD","credentials":["Clinical Associate Professor\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Griffith R Harsh, IV, MD, MBA","credentials":
["Professor and Vice Chairman\n","Department of Neurosurgery\n","Stanford Medical
School"],"disclosure":""},{"name":"Ken D Hatch, MD","credentials":["Professor of
Obstetrics & Gynecology\n","University of Arizona College of
Medicine"],"disclosure":""},{"name":"Julie Hauer, MD","credentials":["Assistant
Professor\n","Children's Hospital Boston"],"disclosure":""},{"name":"Daniel F
Hayes, MD","credentials":["Section Editor — Breast Cancer\n","Professor of
Medicine\n","University of Michigan School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen R&D, LLC
[Breast cancer (Abiraterone)]; Menarini Silicon Biosystems, LLC [Breast cancer
(CellSearch)]; Puma Biotechnology [Breast cancer (Neratinib)]; Pfizer [Breast
cancer (Palbociclib)]; AstraZeneca [Breast cancer (Circulating tumor cells)]; Eli
Lilly and Company [Breast cancer]. Speaker's Bureau: Lilly Oncology (Breast
cancer). Patent Holder: Immunicon Corporation [Inventor (05725638.0-1223-
US2005008602)]; University of Michigan [Inventor (US 8,790,878 B2)]; University of
Michigan [Inventor (US 8,951,484 B2)]. Equity Ownership/Stock Options: Oncimmune
LLC [Stock]; Inbiomotion [Stock]. Other Financial Interest: Menarini Silicon
Biosystems [Breast cancer (CellSearch)]; University of Michigan [Inventor (US
8,790,878 B2)]."},{"name":"Frances J Hayes, MD","credentials":["Associate Professor
of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Pamela Hebbard,
MD, FRCS","credentials":["Assistant Professor of Surgery\n","University of Manitoba
and CancerCare Manitoba"],"disclosure":""},{"name":"John E Heffner,
MD","credentials":["Professor of Medicine\n","Oregon Health & Science
University\n","Providence Portland Medical Center"],"disclosure":""},{"name":"Josh
H Heinzerling, MD","credentials":["Radiation Oncologist\n","Southeast Radiation
Oncology\n","Charlotte, North Carolina"],"disclosure":"Speaker's Bureau: Vision RT
[Radiation therapy (Surface guided radiation therapy)]."},{"name":"Matthew Hellman,
MD","credentials":["Assistant Attending, Memorial Sloan Kettering Cancer
Center\n","Instructor, Weill Cornell Medical College"],"disclosure":"Grant/Research
Support: BMS [Immunotherapy]. Consultant/Advisory Boards: BMS; Genentech; Merck;
AstraZeneca; Janssen; Novartis [Immunotherapy]."},{"name":"C William Helm,
MD","credentials":["Consultant Gynaecological Oncologist\n","Royal Cornwall
Hospitals Trust\n","Truro, United Kingdom"],"disclosure":""},{"name":"Martee L
Hensley, MD, MSc","credentials":["Attending Physician\n","Gynecologic Medical
Oncology\n","Memorial Sloan-Kettering Cancer Center\n","Professor of
Medicine\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical
Trial Support: Bristol-Myers Squibb [Uterine cancers (Nivolumab)].
Consultant/Advisory Boards: Janssen Pharmaceutica [Soft tissue sarcoma
(Trabectedin)]; Lilly [Soft tissue sarcoma (Olaratumab)]; Tesaro [Ovarian cancer
(Niraparib)]. Employment (spouse): Sanofi [Prostate cancer] - No relevant conflict
on topic."},{"name":"Dwight E Heron, MD, MBA, FACRO, FACR","credentials":["Vice
Chairman & Professor\n","University of Pittsburgh School of Medicine\n","Director
of Radiation Services\n","University of Pittsburgh Cancer
Institute"],"disclosure":""},{"name":"Felix JF Herth, MD, PhD","credentials":
["Professor of Medicine\n","University of
Heidelberg"],"disclosure":"Grant/Research/Clinical Trial Support: BTG; Boston
Scientific; Olympus; Pulmonx [Uptake Interventional Pneumology]. Speaker's Bureau:
BTG; Boston Scientific; Olympus; Pulmonx [Uptake Interventional Pneumology].
Consultant/Advisory Boards: BTG; Boston Scientific; Olympus; Pulmonx [Uptake
Interventional Pneumology]."},{"name":"Martin Hertl, MD","credentials":["Professor
of Surgery\n","Rush University Medical Center"],"disclosure":""},{"name":"Thomas J
Herzog, MD","credentials":["Deputy Director\n","University of Cincinnati Cancer
Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca; J & J; Roche;
Clovis; Tesaro [Ovarian cancer (Olaparib, PLD, bevacizumab, rucaparib, niraparib)];
Genmab [Cervical cancer (Tisotumab)]."},{"name":"Paul J Hesketh, MD","credentials":
["Section Editor — Supportive Care\n","Chair, Lahey Health Cancer
Institute\n","Director, Thoracic Oncology, Lahey Hospital and Medical
Center\n","Professor of Medicine, Tufts University School of
Medicine"],"disclosure":""},{"name":"Patricia L Hibberd, MD, PhD","credentials":
["Chair, Department of Global Health\n","Boston University School of Public
Health"],"disclosure":""},{"name":"John Hicks, MD, DDS, PhD","credentials":
["Professor\n","Department of Pathology\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Andrew Hines, MD","credentials":["Vascular and
Interventional Specialists\n","Charlotte Radiology"],"disclosure":""},
{"name":"Ariel Hirsch, MD","credentials":["Associate Professor of Radiation
Oncology\n","Boston University Medical Center"],"disclosure":""},{"name":"Michelle
S Hirsch, MD, PhD","credentials":["Associate Professor\n","Brigham and Women's
Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Johann Hitzler, MD,
FRCP(C), FAAP","credentials":["Professor, Department of Pediatrics\n","University
of Toronto"],"disclosure":""},{"name":"Ephraim Hochberg, MD","credentials":
["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Fred H Hochberg, MD","credentials":["Professor, Department of
Neurology\n","University of California at San Diego Moores Cancer
Center"],"disclosure":""},{"name":"Lauri Hochberg, MD","credentials":["Assistant
Professor of Obstetrics and Gynecology\n","Director of Imaged Based Gynecology
Service\n","University of South Florida College of Medicine"],"disclosure":""},
{"name":"Sarah E Hoffe, MD","credentials":["Associate Member\n","Moffitt Cancer
Center\n","Department of Radiation Oncology\n","H. Lee Moffitt Cancer Center and
Research Institute"],"disclosure":""},{"name":"Henry T Hoffman, MD, MS,
FACS","credentials":["Professor of Otolaryngology \n","University of
Iowa"],"disclosure":"Consultant/Advisory Boards: Cook Medical (They purchased
licensing rights to a patent I share with the U of Iowa Research foundation
treating the larynx, also work with them on salivary disorders). Patent Holder:
COOK Medical (They purchased licensing rights to a patent I share with the U of
Iowa Research foundation treating the larynx, also work with them on salivary
disorders)."},{"name":"Mitchel S Hoffman, MD","credentials":["Professor\n","USF
Morsani College of Medicine"],"disclosure":""},{"name":"Richard M Hoffman, MD,
MPH","credentials":["Professor of Medicine\n","University of Iowa Carver College of
Medicine"],"disclosure":""},{"name":"Christine H Holschneider, MD","credentials":
["Professor of Obstetrics and Gynecology\n","David Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Angela M Hong, MBBS, MMed, PhD,
FRANZCR","credentials":["Melanoma Institute Australia, \n","The University of
Sydney"],"disclosure":""},{"name":"Richard T Hoppe, MD","credentials":["Professor
of Radiation Oncology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Francis J Hornicek, MD, PhD","credentials":
["Associate Professor of Orthopaedic Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Neil S Horowitz, MD","credentials":["Assistant
Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical
School\n","Director of Clinical Research, Gynecologic Oncology\n","Brigham and
Women’s Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: TRACON
Pharmaceuticals [Gestational trophoblastic neoplasia (TRC105)]."},{"name":"Terzah M
Horton, MD, PhD","credentials":["Assistant Professor,
Hematology/Oncology\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics
[Anti-CD30 antibodies (Brentuximab)]."},{"name":"Mara J Horwitz, MD","credentials":
["Assistant Professor of Medicine\n","University of Pittsburgh"],"disclosure":""},
{"name":"Steven Horwitz, MD","credentials":["Associate Attending\n","Memorial
Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Celgene Corporation [mycosis fungoides (romidepsin)]; Millennium
Pharmaceuticals/Takeda [Hodgkin lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin
[mycosis fungoides (mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma
(brentuximab vedotin)]; Spectrum Pharmaceuticals [mycosis fungoides
(pralatrexate)]; Forty-Seven; Infinity/Verastem; ADCT Therapeutics; Aileron
Therapeutics. Consultant/Advisory Boards: Celgene Corporation; Millennium
Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin; Seattle Genetics; Forty-Seven;
Infinity/Verastem; HUYA; BMA; Mundipharma."},{"name":"Ralph H Hruban,
MD","credentials":["Professor of Pathology and Oncology\n","The Sol Goldman
Pancreatic Cancer Research Center\n","Johns Hopkins Medical
Institutions"],"disclosure":""},{"name":"James Huang, MD","credentials":["Thoracic
Service\n","Department of Surgery\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"Warner K Huh, MD","credentials":["Margaret
Cameron Spain Chair in Obstetrics/Gynecology\n","Professor, Division of Gynecologic
Oncology\n","Senior Scientist, UAB Comprehensive Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Merck [Cervical cytology (HPV
vaccines)]; Intuitive Surgical (Robotic Surgery); LICOR (fluorescence imaging);
InCellDx (cervical cancer screening)."},{"name":"Edwin P Hui, MD","credentials":
["Clinical Associate Professor (Honorary)\n","Department of Clinical
Oncology\n","Prince of Wales Hospital\n","The Chinese University of Hong
Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Nasopharyngeal
cancer (Axitinib)]. Speaker’s Bureau: Merck Sharp & Dohme [Head and neck cancer,
nasopharyngeal cancer (Pembrolizumab)]; Merck Serono [Head and neck cancer,
nasopharyngeal cancer (Cetuximab)]. Consultant/Advisory Boards: Bristol-Myers
Squibb [Head and neck cancer, nasopharyngeal cancer (Nivolumab, ipilimumab)]; Merck
Sharp & Dohme [Head and neck cancer, nasopharyngeal cancer (Pembrolizumab)]."},
{"name":"Linda Humphrey, MD","credentials":["Professor of Medicine and Public
Health and Preventive Medicine\n","Oregon Health and Science
University\n","Portland Veterans Affairs Medical Center"],"disclosure":""},
{"name":"Klaudia U Hunter, MD","credentials":["Lahey Clinic Department of Radiation
Oncology"],"disclosure":""},{"name":"David Huntsman, MD, FRCPC,
FCCMG","credentials":["Professor of Pathology and Laboratory Medicine\n","
University of British Columbia"],"disclosure":""},{"name":"Arti Hurria,
MD","credentials":["Associate Professor of Medicine\n","Director of Cancer and
Aging Research Program\n","Medical Oncology and Therapeutics Research\n","City of
Hope"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline,
Novartis [Breast cancer (Lapatinib)]; Celgene [Breast cancer (Nab-paclitaxel)].
Consultant/Advisory Boards: Boehringer Ingelheim Parmaceuticals [Breast cancer
(Afatinib)];
Carevive [Geriatric oncology (None)]; Sanofi [Breast cancer (Docetaxel)]; Pierian
Biosciences [Geriatric oncology (None)]; MJH Healthcare Holdings, LLC [Breast
cancer (Endopredict)]."},{"name":"Arif Hussain, MD","credentials":["Professor of
Medicine, Pathology, and Biochemistry\n","University of Maryland School of
Medicine"],"disclosure":""},{"name":"Michael Ieong, MD","credentials":["Assistant
Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},
{"name":"Raghava Induru, MD","credentials":["Co-leader, Senior Oncology
Program\n","Levine Cancer Institute\n","Charlotte, NC"],"disclosure":""},
{"name":"Shams I Iqbal, MD","credentials":["Assistant Professor of
Radiology\n","Tufts University Medical School\n","Department of Radiology\n","Lahey
Clinic"],"disclosure":""},{"name":"Richard S Irwin, MD","credentials":["Professor
of Medicine\n","University of Massachusetts Medical School"],"disclosure":""},
{"name":"Claudine Isaacs, MD","credentials":["Professor of Medicine and
Oncology\n","Georgetown University Medical School\n","Jess and Mildred Fisher
Center for Hereditary Cancer and Clinical Genomics
Research"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro
[Breast/ovarian cancer (Niriparib). Consultant/Advisory Boards: Medivation
[Breast/ovarian cancer (Talazoparib)]; AstraZeneca [Breast/ovarian cancer
(Olaparib)]."},{"name":"Leanne Jackson, MD","credentials":["Assistant Professor of
Medicine\n","Michael E. DeBakey Veterans Affairs Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Inc [Breast
cancer (Early intervention palliative care trial)]."},{"name":"Vicki Jackson, MD,
MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Inc [Breast
cancer (Early intervention palliative care trial)]."},{"name":"Eric Jacobsen,
MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene
[Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards: Seattle Genetics [T
cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma (Pralatrexate,
romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},{"name":"Brian C
Jacobson, MD, MPH","credentials":["Associate Professor of Medicine\n","Boston
University School of Medicine"],"disclosure":"Consultant/Advisory Boards: MOTUS GI
[Bowel cleaning for colonoscopy (Device under development to help with bowel
cleaning during colonoscopy)]."},{"name":"Michael T Jaklitsch, MD","credentials":
["Professor in Surgery\n","Harvard Medical School\n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"Maija Jakobsson, MD, PhD","credentials":
["Helsinki University Hospital"],"disclosure":""},{"name":"Katherine A Janeway,
MD","credentials":["Attending Physician of Pediatric Oncology\n","Dana Farber
Cancer Institute\n","Assistant Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":""},{"name":"Aminah Jatoi, MD","credentials":["Professor of
Oncology\n","Mayo Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Enterahealth [Nutrition support (Protein supplement)]."},{"name":"Milind
Javle, MD","credentials":["Professor of Medicine\n","University of Texas MD
Anderson Cancer Center\n","Department of GI Medical Oncology"],"disclosure":""},
{"name":"James R Jett, MD","credentials":["Section Editor — Lung
Cancer\n","Professor of Medicine Emeritus\n","National Jewish
Health"],"disclosure":"Employment: Oncimmune [Biomarkers for early cancer detection
(Early CDT-Lung blood test)]. Equity Ownership/Stock Options: Oncimmune [Biomarkers
for early cancer detection (Early CDT-Lung blood test)]."},{"name":"Kenar D
Jhaveri, MD","credentials":["Professor of Medicine\n","Associate Chief, Division of
Kidney Diseases and Hypertension\n","Zucker School of Medicine at
Hofstra/Northwell"],"disclosure":""},{"name":"Ramon E Jimenez, MD","credentials":
["Associate Professor of Surgery\n","Florida International University\n","Herbert
Wertheim College of Medicine"],"disclosure":""},{"name":"Bonnie N Joe, MD,
PhD","credentials":["Professor of Radiology and Biomedical
Imaging\n","Chief\n","UCSF Breast Imaging"],"disclosure":""},{"name":"Shruti Jolly,
MD","credentials":["Assistant Professor\n","University of Michigan Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [lung cancer
(adaptive radiation therapy)]. Consultant/Advisory Boards: Varian [gynecologic
brachytherapy]."},{"name":"Eric Jonasch, MD","credentials":["Professor\n","The
University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Exelixis; Novartis;
Pfizer [Kidney cancer (Pazopanib, cabozantinib, sunitinib)]. Consultant/Advisory
Boards: BMS; Exelixis; Esai; Novartis; Pfizer [Kidney cancer (Nivolumab,
everolimus, pazopanib, temsirolimus, cabozantinib, sunitinib, lenvatinib)]."},
{"name":"Karin Jordan, MD","credentials":["Associate
Professor\n","Universitätsklinikum Heidelberg"],"disclosure":"Consultant/Advisory
Boards: MSD/Merck & Co [Antiemetics (Aprepitant)]; Helsinn [Antiemetics (NEPA)];
Tesaro, Inc [Antiemetics (Rolapitant)]."},{"name":"Jeffrey Joseph, MD,
PhD","credentials":["Professor of Pathology\n","University of Calgary School of
Medicine"],"disclosure":""},{"name":"Lisa A Kachnic, MD","credentials":["Chair and
Professor\n","Department of Radiation Oncology\n","Vanderbilt University School of
Medicine"],"disclosure":""},{"name":"Larry R Kaiser, MD","credentials":["President
and CEO, Temple University Health System\n","Sr. Executive Vice President for
Health Sciences, Temple University\n","Dean, Temple University School of
Medicine"],"disclosure":""},{"name":"Virginia Kaklamani, MD, DSc","credentials":
["Professor of Medicine\n","Leader, Breast Oncology Program\n","CTRC, University of
Texas Health Science Center San Antonio"],"disclosure":""},{"name":"Gregory P
Kalemkerian, MD","credentials":["Professor of Medicine\n","Co-Director, Thoracic
Oncology\n","University of Michigan Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
Pharmaceuticals [Lung cancer (pevonedistat)]; Novartis [Lung cancer
(Dabrafenib/trametinib)]; Merck [Lung cancer (Pembrolizumab)]; OncoMed
Pharmaceuticals [Lung cancer (OMP-59R5)]; Abbvie [Lung Cancer (SC002)].
Consultant/Advisory Boards (spouse): Takeda Pharmaceuticals, BioMed Valley
Discoveries, Esperion [drug development and safety analysis]."},{"name":"Richard S
Kalman, MD","credentials":["Division of Hepatology, \n","Assistant Professor of
Medicine, \n","Einstein Medical Center/Sidney Kimmel Medical College of Thomas
Jefferson University"],"disclosure":""},{"name":"Kala Kamdar, MD, MS
Epi","credentials":["Associate Professor, Department of Pediatrics, Section of
Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Stephen Kang, MD","credentials":["Head and Neck Oncology Fellow\n","The
Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Philip W
Kantoff, MD","credentials":["Section Editor — Testicular Cancer\n","Chairman of
Medicine\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},
{"name":"Andre A Kaplan, MD","credentials":["Professor of Medicine\n","University
of Connecticut Health Center"],"disclosure":"Grant/Research/Clinical Trial Support:
Nipro Corporation [Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo
[Plasmapheresis (Plasmapheresis machines)]. Consultant/Advisory Boards: Vital
Therapeutics [Extracorporeal liver assist device (ELAD)]."},{"name":"Lawrence D
Kaplan, MD","credentials":["Clinical Professor of Medicine\n","University of
California, San Francisco"],"disclosure":""},{"name":"Amer Karam,
MD","credentials":["Clinical Associate Professor\n","Associate Director and
Director of Outreach\n","Division of Gynecologic Oncology\n","Department of
Obstetrics and Gynecology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Maher Karam-Hage, MD","credentials":["UT MD
Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support:
Pfizer [Smoking cessation (Varenicline)]."},{"name":"Wassim Kassouf, MD, CM,
FRCS","credentials":["Professor of Surgery (Urology)\n","McGill University Health
Center"],"disclosure":""},{"name":"Anne Katz, PhD, RN, FAAN","credentials":
["CancerCare Manitoba\n","Winnipeg MB"],"disclosure":""},{"name":"Laurence
Katznelson, MD","credentials":["Associate Dean of Graduate Medical
Education\n","Professor of Neurosurgery and Medicine (Endocrinology and
Metabolism)\n","Stanford School of Medicine"],"disclosure":"Grant/Research/Clinical
Trial Support: Novartis [Acromegaly (Pasireotide)]; Chiasma [Acromegaly
(Octreotide)]. Consultant/Advisory Board: Chiasma [Acromegaly (Octreotide)]."},
{"name":"Steven M Kawut, MD","credentials":["Associate Professor of Medicine and
Epidemiology, Director, Pulmonary Vascular Disease Program\n","Perelman School of
Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Electron Kebebew,
MD, FACS","credentials":["Senior Investigator\n","Chief, Endocrine Oncology
Branch\n","National Cancer Institute\n","Professor of Surgery\n","George Washington
University School of Medicine & Health Sciences"],"disclosure":""},{"name":"Vicki L
Keedy, MD, MSCI","credentials":["Assistant Professor of Medicine\n","Vanderbilt
University Medical Center"],"disclosure":"Grant/Research Support: Plexxicon [PVNS
(PLX3397)]; Bayer [sarcoma (regorafenib)]; Hoffman-Laroche [cancer
(vemurafenib)]."},{"name":"Yair Y Keilson, MD","credentials":["Adjunct Clinical
Assistant Professor of Medicine\n","Touro College of Osteopathic
Medicine"],"disclosure":""},{"name":"Robert L Keith, MD","credentials":["Professor
of Medicine and Cancer Biology\n","Associate Chief of Staff\n","Research, Division
of Pulmonary Sciences and Critical Care Medicine\n","Denver Veterans Affairs
Medical Center\n","University of Colorado Cancer Center\n","University of Colorado
School of Medicine"],"disclosure":"Patent Holder: US Patent 8,623,917
(Chemoprevention [Prostacyclin, iloprost])."},{"name":"Karen Kelly,
MD","credentials":["Professor of Medicine\n","University of California Davis Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [BMS
Immunotherapy pipeline discussion]; AbbVie [Lung cancer]."},{"name":"Thomas
Archibald Kerr, MD, PhD","credentials":["Assistant Professor of Internal
Medicine\n","Division of Digestive and Liver Diseases\n","University of Texas
Southwestern Medical Center at Dallas"],"disclosure":"Grant/Research/Clinical Trial
Support: Conatus [Fatty liver]. Speaker's Bureau: AbbVie [HCV (Viekira Pak, Viekira
XR)]; Gilead Sciences [HCV (Harvoni, Epclusa)]; Intercept [Primary Biliary
Cholagitis (Ocaliva)]; Alexion [Fatty liver (Kanuma)]. Consultant/Advisory Boards:
AbbVie [HCV (Viekira Pak, Viekira XR)]; Gilead Sciences [HCV (Harvoni, Epclusa)];
Intercept [Primary Billiary Cholangitis (Ocaliva)]; Alexion [Fatty Liver
(Kanuma)]."},{"name":"Joshua P Kesterson, MD","credentials":["Chief, Division of
Gynecologic Oncology\n","Associate professor\n","Penn State Hershey Medical
Center\n","Hershey, Pennsylvania"],"disclosure":""},{"name":"Elizabeth A Kidd,
MD","credentials":["Assistant Professor\n","Department of Radiation
Oncology\n","Stanford University"],"disclosure":""},{"name":"Mark W Kieran, MD,
PhD","credentials":["Boston Children's Hospital\n","Dana-Farber Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [BRAF V600E in
pediatric low-grade gliomas (Dabrafenib)]; Novartis [Sonic hedgehog medulloblastoma
(LDE225)]; Novartis [mTOR inhibition in pediatric low-grade gliomas (Everolimus)];
Boehringer [ErbB inhibition in brain tumors (Afatinib)]; Millenium/Takada [Low-
grade gliomas (MLN2480)]; Bristol-Myers Squibb [pediatric brain tumors
(Nivolumab/ipilumumab)]. Consultant/Advisory Boards: GSK [BRAF V600E in pediatric
low-grade gliomas (Dabrafenib)]; Novartis [Sonic hedgehog medulloblastoma
(LDE225)]; Boehringer [ErbB inhibition in brain tumors (Afatinib)]; Bayer [Phase 1
pediatric cancer]; Celgene [Phase I portfolio (Thalidomide, lenolidomide)]; Merck
[Thrombocytopenia (Eltrombopag)]."},{"name":"Ellen J Kim, MD","credentials":
["Associate Professor of Dermatology\n","Perelman School of Medicine at the
University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support:
Kyowa Hakko Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761,
mogamulizumab])]; Solgenix [CTCL clinical trial investigator (hypericin
photodynamic topical agent)]; Actelion [CTCL clinical trial investigator (nitrogen
mustard gel)]. Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard
gel)]."},{"name":"Youn H Kim, MD","credentials":["Professor of
Dermatology\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL
(E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL
(Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle
Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)],
Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL
(IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL],
Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma
[CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL
(Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven
Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL
(Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Gretchen
Kimmick, MD, MS","credentials":["Associate Professor in Medicine\n","Duke
University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support:
PUMA Biotech; [breast cancer (neratinib)]; GlaxoSmithKline [breast cancer
(lapatinib)]. Other Financial Interest: Genomic Health [breast cancer
(OncotypeDX)]."},{"name":"Hedy Lee Kindler, MD","credentials":["Professor of
Medicine\n","Director, Mesothelioma and Gastrointestinal Oncology
Programs\n","University of Chicago Medicine"],"disclosure":"Grant/Research/Clinical
Trial Support: Aduro [Mesothelioma (CRS-207)]; Bayer [Mesothelioma (Anetumab
ravtanisine)]; GSK, Five Prime Therapeutics [Mesothelioma (GSK3052230)]; Merck
[Mesothelioma (Pembrolizumab)]; Medimmune/AZ [Mesothelioma (Tremelimumab)]; Polaris
[Mesothelioma (ADI-PEG 20)]; Bristol-Myers Squibb [Mesothelioma (Nivolumab,
Ipilimumab)]. Consultant/Advisory Boards: Aduro [Mesothelioma (CRS-207)]; Bayer
[Mesothelioma (Anetumab ravtanisine)]; Medimmune/AZ [Mesothelioma (Tremelimumab)];
Boehringer-Ingleheim [Mesothelioma (Nintedanib)]; Paredox [Mesothelioma]."},
{"name":"Talmadge E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and
Critical Care Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean,
School of Medicine \n","Vice Chancellor, Medical Affairs\n","University of
California San Francisco"],"disclosure":""},{"name":"David G Kirsch, MD,
PhD","credentials":["Professor of Radiation Oncology\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: XRad Therapeutics
[Radiation sensitizers (Not applicable)]; Lumicell Inc. [Intraoperative imaging
(Not applicable)]; Merck [Immunotherapy (Not applicable)]; Eli Lilly and Company
[Radiation sensitizers (Not applicable)]. Consultant/Advisory Boards: Lumicell Inc.
[Intraoperative imaging (Not applicable)]; Sarcoma Alliance for Research through
Collaboration [Sarcoma (Not applicable)]. Patent Holder: Lumicell Inc.
[Intraoperative imaging (Not applicable)]. Equity Ownership/Stock Options: Lumicell
Inc. [Intraoperative imaging (Not applicable)]; XRad Therapeutics [Radiation
Sensitizers (Not applicable)]."},{"name":"Tobias Klatte, MD","credentials":["UCLA
David Geffen School of Medicine"],"disclosure":""},{"name":"Eric A Klein,
MD","credentials":["Chairman, Glickman Urological and Kidney
Institute\n","Professor of Surgery\n","Cleveland
Clinic"],"disclosure":"Consultant/Advisory Boards: Cellanyx [Prostate cancer]."},
{"name":"Heidi D Klepin, MD, MS","credentials":["Associate Professor of Internal
Medicine, Hematology and Oncology\n","Comprehensive Cancer Center of Wake Forest
University"],"disclosure":""},{"name":"David S Klimstra, MD","credentials":
["Attending Pathologist and Chairman\n","Department of Pathology\n","James Ewing
Alumni Chair in Pathology\n","Memorial Sloan Kettering Cancer Center\n","Professor
of Pathology and Laboratory Medicine\n","Weill Medical College of Cornell
University"],"disclosure":""},{"name":"Laurence Klotz, MD","credentials":
["Professor of Surgery\n","University of Toronto\n","Chief\n","Sunnybrook Health
Sciences Centre"],"disclosure":""},{"name":"Michael D Kluger, MD,
MPH","credentials":["Assistant Professor of Surgery\n","College of Physicians and
Surgeons\n","New York-Presbyterian Hospital/CUMC"],"disclosure":""},{"name":"Wayne
M Koch, MD, FACS","credentials":["Professor of
Otolaryngology\n","Director\n","Division of Head & Neck Surgery\n","The Johns
Hopkins Outpatient Center"],"disclosure":""},{"name":"Claus-Henning Köhne,
MD","credentials":["Department of Hematology and Oncology\n","Onkologie Klinikum
Oldenburg"],"disclosure":""},{"name":"E Anders Kolb, MD","credentials":["Director,
Nemours Center for Cancer and Blood Disorders\n","Nemours/Alfred I duPont Hospital
for Children"],"disclosure":""},{"name":"Jonathan E Kolitz, MD","credentials":
["Professor of Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-
351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS
(pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)].
Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},
{"name":"Lavanya Kondapalli, MD","credentials":["Assistant Professor of
Medicine\n","University of Colorado"],"disclosure":""},{"name":"Panagiotis A
Konstantinopoulos, MD, PhD","credentials":["Assistant Professor of
Medicine\n","Harvard Medical School\n","Gynecologic Medical Oncology
Program\n","Dana Farber Cancer Institute"],"disclosure":""},{"name":"Scott E Kopec,
MD","credentials":["Assistant Professor of Medicine\n","University of Massachusetts
Medical Center"],"disclosure":""},{"name":"Tamar Kotz, MS CCC-SLP","credentials":
["Head and Neck Speech Pathologist\n","Otolaryngology-Head and Neck
Surgery\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},
{"name":"Kris V Kowdley, MD, FACP, FACG, FASGE, AGAF","credentials":["Director,
Liver Care Network and Organ Care Research\n","Swedish Medical Center\n","Seattle,
WA"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [PSC (FXR
agonist)]; Intercept [PSC (INT-747, OCA, FXR agonist)]; NGM Biopharma [PSC (NGM-
282)]. Speaker’s Bureau: Gilead [PSC (FXR agonist)]; Intercept [PSC (INT-747, OCA,
FXR agonist)]. Consultant/Advisory Boards: Gilead [PSC (FXR agonist)]; Intercept
[PSC (INT-747, OCA, FXR agonist)]; NGM Biopharma [PSC (NGM-282)]."},{"name":"Shlomo
A Koyfman, MD","credentials":["Assistant Professor of Medicine\n","Departments of
Radiation Oncology and Bioethics\n","Cleveland Clinic"],"disclosure":""},
{"name":"Dennis Kraus, MD","credentials":["Director, Center for Head and Neck
Oncology\n","New York Head & Neck Institute\n","North Shore-LIJ Health
System"],"disclosure":""},{"name":"Mary Lee Krinsky, DO","credentials":["Professor
of Medicine\u2028\n","University of California, San Diego Healthcare
System"],"disclosure":""},{"name":"Smitha S Krishnamurthi, MD","credentials":
["Associate Professor,\n","Case Western Reserve University and University Hospitals
Cleveland Medical Center;\n","Director,\n","Clinical Trials Office,
Case Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Taiho [colorectal cancer (TAS-102)]; Regeneron [solid tumors (REGN2810)];
CytomX Therapeutics [solid tumors (CX-072)]."},{"name":"Susan E Krown,
MD","credentials":["Member Emerita\n","Memorial Sloan-Kettering Cancer
Center\n","Vice-Chair for International Activities \n","The AIDS Malignancy
Consortium"],"disclosure":""},{"name":"Matthew Kulke, MD","credentials":["Chief,
Hematology and Oncology, Boston Medical Center\n","Deputy Director, Cancer Center,
Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards:
Lexicon [Neuroendocrine tumors (Telotristat)]; Novartis [Neuroendocrine tumors
(Octreotide, everolimus)]; Ipsen [Neuroendocrine tumors (Lanreotide)]."},
{"name":"Senthil Kumar, MS, FRCS (Ed), FRCS (Gen Surg)","credentials":["Additional
Professor, Liver Transplantation and Hepatopancreaticobiliary Surgery\n","Institute
of Liver and Biliary Sciences"],"disclosure":""},{"name":"Hiroko Kunitake,
MD","credentials":["Assistant in Surgery, Massachusetts General
Hospital\n","Assistant Professor of Surgery, Harvard Medical
School"],"disclosure":""},{"name":"Calvin J Kuo, MD, PhD","credentials":["Professor
of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: OncoMed [angiogenesis (anti-
DLL4 antibody)]. Equity Ownership/Stock Options (Self and Spouse): OncoMed
[angiogenesis inhibitors (anti-DLL4 antibody)]. Employment (Spouse): OncoMed
[angiogenesis inhibitors (anti-DLL4 antibody)] - No relevant conflict on topic."},
{"name":"Anil Nicholas Kurup, MD","credentials":["Associate Professor of
Radiology\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Galil Medical
[ablation of skeletal metastases (multiple cryoablation systems)]"},{"name":"Bonnie
Ky, MD, MSCE","credentials":["Assistant Professor of Medicine and
Epidemiology\n","University of Pennsylvania School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer
[Investigator initiated award]; Roche [Investigator initiated grant support
(biomarkers)]; Singulex [Research support (biomarkers)]. Consultant/Advisory
Boards: Bristol Myers Squibb [consultant]; Mateon Therapeutics [vascular disrupting
agents (consultant)]; Roche [consultant (biomarkers)]."},{"name":"Robert A Kyle,
MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of
Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards:
Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide,
pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee
[Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee
[Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board
[Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy
of multiple myeloma, made comments concerning a new Pfizer product and received an
honorarium]."},{"name":"Ann S LaCasce, MD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: BMS
(DMB); Seattle Genetics (education materials)."},{"name":"Mario E Lacouture,
MD","credentials":["Associate Professor of Medicine \n","Cornell
University\n","Member\n","Memorial Hospital\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Berg [Rash
(Calcitriol)]; Bristol-Myers Squibb [Rash (Cetuximab)]. Consultant/Advisory Boards:
Quintiles [Rash (Anti-epidermal growth factor receptor monoclonal antibody
mixture)]; Boehringer Ingelheim [Rash (Afatinib)]; AstraZeneca [Rash
(Osimertinib)]; Foamix Pharmaceuticals [Rash (Doxycycline)]; Novartis [Rash
(Alpelisib)]; Novocure [Rash (Device used to treat glioblastoma multiforme)]."},
{"name":"André Lacroix, MD","credentials":["Section Editor — Adrenal
Disease\n","Professor of Medicine\n","University of Montreal, Quebec,
Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Pituitary
tumors, Cushing's syndrome (Pasireotide, octreotide, osilodrostat)]; Cortendo
[Cushing's syndrome (Levoketoconazole)]. Speaker's Bureau: Novartis [Cushing's
syndrome (Pasireotide, octreotide, osilodrostat)]; EMD Serono [Cushing's syndrome
(Lanreotide)]. Consultant/Advisory Boards: Novartis [Pituitary tumors, Cushing's
syndrome (Pasireotide, octreotide, osilodrostat)]; EMD Serono [Pituitary tumors
(Lanreotide)]."},{"name":"Ruth L Lagman, MD, MPH, FACP, FAAHPM","credentials":["The
Harry R. Horvitz Center for Palliative Medicine and Supportive Oncology
\n","Taussig Cancer Institute\n","Cleveland Clinic"],"disclosure":""},
{"name":"Thierry Lamy, MD, PhD","credentials":["Professor in
Hematology\n","University of Rennes, France"],"disclosure":""},{"name":"Paul H
Lange, MD, FACS","credentials":["Professor \n","Department of Urology\n","School of
Medicine\n","University of Washington"],"disclosure":""},{"name":"Christine
Laronga, MD, FACS","credentials":["Professor\n","Moffitt Cancer Center, University
of South Florida"],"disclosure":"Speaker’s Bureau: Genomic Health [Breast cancer
genomic assays (Oncotype DCIS)]."},{"name":"Richard A Larson, MD","credentials":
["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of
Medicine\n","University of Chicago Pritzker School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia
(gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib,
ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia
(enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib,
nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)];
CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety
Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia
(blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},
{"name":"Ilya Laufer, MD","credentials":["Assistant Professor\n","Weill Medical
College of Cornell University"],"disclosure":"Consultant/Advisory Boards: Globus;
DePuy Synthes; Medtronic; Spine Wave; Brainlab [Spine surgery]."},{"name":"Shannon
K Laughlin-Tommaso, MD","credentials":["Consultant and Assistant Professor,
Division of Gynecology, Departments of Obstetrics & Gynecology and Surgery\n","Mayo
Clinic and Mayo Medical School"],"disclosure":"Grant Support: InSightec, Inc
[Fibroid (Focused ultrasound ablation device)]. Consultant/Advisory Boards: Halt
Medical DSMB [Fibroids (Acessa)]; Allergan [Fibroids (Esmya)]."},{"name":"Scott A
Laurie, MD, FRCPC","credentials":["The Ottawa Hospital Cancer Centre\n","University
of Ottawa"],"disclosure":""},{"name":"Christine L Lay, MD, FRCPC","credentials":
["Associate Professor\n","Women's College Hospital"],"disclosure":""},
{"name":"Quynh-Thu Le, MD","credentials":["Professor and Chair\n","Stanford
University"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Head and
neck cancer (Palifermin)]; RedHill [Head and neck cancer (Yeliva)].
Consultant/Advisory Boards: Varian Medical Systems [Head and neck cancer (Proton
therapy)]; BMS [Head and neck cancer (Galectin-1)]."},{"name":"Michelle M Le Beau,
PhD","credentials":["Professor of Medicine\n","University of Chicago Pritzker
School of Medicine"],"disclosure":""},{"name":"Michael S Leapman,
MD","credentials":["Assistant Professor\n","Department of Urology\n","Yale
University School of Medicine"],"disclosure":""},{"name":"Eudocia Quant Lee, MD,
MPH","credentials":["Assistant Professor of Neurology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Genentech/Roche [Radiographic
response criteria for brain Metastases]; Lilly [Brain metastases]."},{"name":"James
Lee, MD","credentials":["Edwin C. and Anne K. Weiskopf Associate Professor of
Surgical Oncology (in Surgery and in the Herbert Irving Comprehensive Cancer
Center)\n","Columbia University Medical Center"],"disclosure":""},{"name":"Nancy Y
Lee, MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"Richard J Lee, MD, PhD","credentials":
["Assistant Professor of Medicine\n","Harvard Medical School\n","Massachusetts
General Hospital"],"disclosure":""},{"name":"Sei Lee, MD","credentials":["Assistant
Adjunct Professor\n","University of California, San Francisco"],"disclosure":""},
{"name":"W Robert Lee, MD, MS, MEd","credentials":["Section Editor — Prostate
Cancer\n","Professor of Radiation Oncology\n","Duke University Medical
Center"],"disclosure":""},{"name":"Michael D Leise, MD","credentials":["Assistant
Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C
(Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},
{"name":"Mario M Leitao, Jr, MD","credentials":["Assistant Member\n","Division of
Gynecology \n","Department of Surgery\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"Anthony J Lembo, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Salix (Rifaximin); Valaent
(Rifaximin); Takeda (Lubiprostone); Ironwood (Linaclotide); Allergan (Linaclotide);
Alkermes; Shire (Prucalopride)."},{"name":"Daniel J Lenihan, MD","credentials":
["Professor of Medicine\n","Director, Cardio-Oncology Center of
Excellence\n","Washington University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
[Cardiotoxicity (Bortezomib)]. Consultant/Advisory Boards: Roche [DSMB
(Trastuzumab)]; Bristol Myers Squibb [Cardiac safety (Dasatinib)]; Amgen [Cardiac
safety [Carfilzomib]); Janssen [Cardiac safety (Rivaroxaban)]."},{"name":"Seth P
Lerner, MD","credentials":["Section Editor — Bladder Cancer\n","Beth and Dave Swalm
Chair in Urologic Oncology\n","Professor
of Urology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical
Trial Support: Endo; FKD; Viventia [Bladder cancer (Valrubicin, Ad/IFN,
Viccinium)]. Consultant/Advisory Boards: Biocancell; UroGen; Vaxxion; Incyte;
Nucleix [Bladder cancer (BC-819, Mitogel, Vesigel)]."},{"name":"Nelson Leung,
MD","credentials":["Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation
[thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis];
Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Deborah
Levine, MD","credentials":["Section Editor — Imaging\n","Professor of
Radiology\n","Director of Ob/Gyn Ultrasound\n","Department of Radiology\n","Beth
Israel Deaconess Medical Center"],"disclosure":""},{"name":"Jan S Lewin,
PhD","credentials":["Professor, Department of Head and Neck Surgery\n","Section
Chief, Speech Pathology and Audiology\n","The University of Texas MD Anderson
Cancer Center"],"disclosure":""},{"name":"Andrew John Li, MD","credentials":["Co-
Director, Women’s Reproductive Cancers Center of Excellence\n","Division of
Gynecologic Oncology, Cedars-Sinai Medical Center\n","Health Sciences Associate
Clinical Professor\n","Department of Obstetrics and Gynecology\n","David Geffen
School of Medicine at UCLA"],"disclosure":""},{"name":"Stuart M Lichtman,
MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"Jennifer Ligibel, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Fitbit [Physical
activity (Fitbit, Aria Scale)]."},{"name":"Rogerio C Lilenbaum, MD,
FACP","credentials":["Section Editor — Lung Cancer\n","Yale Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Non-small
cell lung cancer (Nab-paclitaxel)]. Consultant/Advisory Boards: Genentech [Lung
cancer (Bevacizumab/erlotinib)]; Boehringer Ingelheim [Non-small cell lung cancer
(Afatinib)]; Celgene [Non-small cell lung cancer (Nab-paclitaxel)]; AstraZeneca
[Non-small cell lung cancer (Osimertinib)]."},{"name":"Jean Lee Lim,
MD","credentials":["Department of Dermatology\n","Kaiser Permanente Medical Group,
Santa Rosa, CA"],"disclosure":""},{"name":"Sewanti Limaye, MD","credentials":
["Consultant - Medical Oncology\n","Center for Cancer\n","Kokilaben Dhirubhai
Ambani Hospital and Medical Research Institute"],"disclosure":""},{"name":"Andrew H
Limper, MD","credentials":["Professor of Pulmonary Medicine\n","Mayo Clinic College
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead
[Pulmonary fibrosis (Simtuzumab)]. Consultant/Advisory Boards: NSCI Group
[Pulmonary fibrosis]."},{"name":"Nancy U Lin, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical School\n","Dana Farber Cancer
Institute\n","Adult Oncology"],"disclosure":"Grant/Research/Clinical Trial Support:
Array BioPharma [Breast cancer (ONT-380)]; Cascadian [Breast cancer (ONT-380)];
Genentech [Breast cancer (Trastuzumab, pertuzumab)]."},{"name":"Noralane M Lindor,
MD","credentials":["Professor of Medical Genetics\n","Mayo Clinic School of
Medicine"],"disclosure":""},{"name":"Cornelis J Lips, MD, PhD","credentials":
["Professor of Endocrinology and Metabolism\n","Department of Internal
Medicine\n","University Medical Center Utrecht, The Netherlands"],"disclosure":""},
{"name":"Jennifer K Litton, MD","credentials":["Assistant Professor of
Medicine\n","The University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Medivation,
Novartis, Genentech, AstraZeneca, EMD-Serono, GSK [Breast cancer clinical
trials]."},{"name":"Leslie A Litzky, MD","credentials":["Professor of Pathology and
Laboratory Medicine\n","University of Pennsylvania Medical
Center"],"disclosure":""},{"name":"Catherine Y Liu, MD, PhD","credentials":["The
Gavin Herbert Eye Institute\n","University of California -
Irvine"],"disclosure":""},{"name":"Vincent Liu, MD","credentials":["Clinical
Professor\n","Departments of Dermatology and Pathology\n","University of Iowa
Carver College of Medicine"],"disclosure":""},{"name":"Joseph LoCicero, III, MD,
FCCP","credentials":["Professor of Surgery Emeritus\n","SUNY
Downstate"],"disclosure":""},{"name":"Jay S Loeffler, MD","credentials":["Section
Editor — Neurooncology\n","Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"Daniel S Longnecker, MD","credentials":
["Professor Emeritus\n","Dartmouth Medical School"],"disclosure":"Grant/Research
Support: Shire [ADHD (Guanfacine)]. Consultant/Advisory Boards: AstraZeneca
[Dyslipidemia (Rosuvastatin)]."},{"name":"George F Longstreth, MD","credentials":
["Voluntary Clinical Professor of Medicine\n","University of California San Diego
School of Medicine"],"disclosure":""},{"name":"Billy W Loo Jr., MD,
PhD","credentials":["Associate Professor and Thoracic Radiation Oncology Program
Leader\n","Stanford University"],"disclosure":"Grant/Research/Clinical Trial
Support: Varian Medical Systems [Radiation therapy (Medical linear accelerators)];
RaySearch Laboratories [Radiation therapy (Radiation treatment planning systems)].
Equity Ownership/Stock Options: TibaRay [Radiation therapy (Developing future
radiation therapy technology)]."},{"name":"Charles L Loprinzi, MD","credentials":
["Regis Professor of Breast Cancer Research\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Prevention
and treatment of chemotherapy-induced peripheral neuropathy (pregabalin)]; Pfizer
[Treating blood clots (Apixaban)]; Janssen [Preventing blood clots (Rivaroxaban)].
Consultant/Advisory Boards: Mitsubishi Tanabe Pharma [menopausal hot flashes];
PledPharma; Metys; Lpath; Mundipharma [Prevention and treatment of chemotherapy-
induced peripheral neuropathy]."},{"name":"Yair Lotan, MD","credentials":
["Professor\n","Department of Urology\n","UT Southwestern Medical Center at
Dallas"],"disclosure":"Grant/Research/Clinical Trial Support: Abbott [bladder
cancer (Urovysion FISH assay)]; MDxHealth [bladder cancer]; Cepheid; Pacific Edge
Bladder cancer [bladder cancer (CxBladder)]; Photocure [cystoscopy (Hexvix)];
Genomedx [bladder cancer]. Consultant/Advisory Boards: Cepheid; Pacific Edge
Bladder cancer [bladder cancer (CxBladder)]; Photocure [cystoscopy (Hexvix)];
MDxHealth [bladder cancer]."},{"name":"Thomas P Loughran, Jr, MD","credentials":
["Director, University of Virginia Cancer Center\n","University of
Virginia"],"disclosure":""},{"name":"David N Louis, MD","credentials":
["Pathologist-in-Chief\n","Massachusetts General Hospital\n","Benjamin Castleman
Professor of Pathology\n","Harvard Medical School"],"disclosure":""},
{"name":"Robert C Lowe, MD","credentials":["Assistant Professor of
Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Karen
H Lu, MD","credentials":["Professor\n","Department of Gynecologic Oncology\n","MD
Anderson Cancer Center"],"disclosure":""},{"name":"Aimee L Lucas, MD,
MS","credentials":["Assistant Professor \n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"William M Lydiatt, MD","credentials":["Clinical
Professor\n","United States Naval Hospital \n","Department of Otolaryngology
\n","Portsmouth Virginia\n","Nebraska Methodist Hospital"],"disclosure":""},
{"name":"Gary H Lyman, MD, MPH, FASCO, FACP, FRCP (Edin)","credentials":["Professor
of Medicine, Public Health and Pharmacy\n","University of Washington\n","\n","Co-
Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences
and Clinical Research Divisions\n","Fred Hutchinson Cancer Research
Center"],"disclosure":""},{"name":"Cynthia X Ma, MD, PhD","credentials":["Associate
Professor of Medicine\n","Washington University in St.
Louis"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [breast cancer
treatment (palbociclib)]; Puma Biotechnology [breast cancer treatment (neratinib)];
Eisai [breast cancer treatment (eribulin)]. Consultant/Advisory Boards: Pfizer
[breast cancer treatment (palbociclib)]; Novartis [breast cancer treatment
(ribociclib)]; AstraZeneca [breast cancer treatment (fulvestrant)]; Merck [breast
cancer treatment (pembrolizumab)]."},{"name":"Carole Macaron, MD","credentials":
["Assistant Professor\n","Case Western Reserve University and Louis Stokes VA
Medical Center"],"disclosure":""},{"name":"Mitchell Machtay, MD","credentials":
["Professor and Chair\n","Radiation Oncology Department\n","Ireland Cancer
Center\n","University Hospitals Case Medical Center"],"disclosure":""},
{"name":"Finlay A Macrae, MD","credentials":["Professor, Department of
Medicine\n","University of Melbourne, Victoria, Australia"],"disclosure":""},
{"name":"Cristina Magi-Galluzzi, MD, PhD","credentials":["Professor of
Pathology\n","Director of Genitourinary Pathology\n","Department of Anatomic
Pathology\n","Cleveland Clinic"],"disclosure":""},{"name":"Varocha Mahachai,
MD","credentials":["Professor of Medicine\n","Chulalongkorn University
Hospital\n","Bangkok, Thailand"],"disclosure":""},{"name":"Robert Maki, MD,
PhD","credentials":["Section Editor — Bone and Soft Tissue Tumors\n","Professor of
Medicine \n","Monter Cancer Center\n","Hofstra-Northwell School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Medical
oncology (Regorafenib)]; Gem Pharmaceuticals [Medical oncology (GPX-150)]; Immune
Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology
(Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Sarcoma Alliance for
Research through Collaboration (SARC) [Medical oncology (Regorafenib,
pembrolizumab)], Tracon (TRC105). Speaker’s Bureau: ABIM [Medical oncology];
Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology
(Regorafenib, pembrolizumab)].
Consultant/Advisory Boards: ABIM [Medical oncology]; AADi [Medical oncology (Nab-
rapamycin)]; Arcus (medical oncology); Bayer [Medical oncology (Regorafenib); Gem
Pharmaceuticals [Medical oncology (GPX-150)]; Immune Design [Medical oncology
(LV305+G305)]; Janssen/Pharma Mar [Medical oncology (Trabectedin)]; Karyopharm
[Medical oncology (Selinexor)]; Lilly/Imclone [Medical oncology (Olaratumab)];
Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology
(Regorafenib, pembrolizumab)]."},{"name":"Fabien Maldonado, MD","credentials":
["Associate Professor of Medicine\n","Vanderbilt University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Centurion Medical
[Unexpandable lung, pleural pressure]."},{"name":"Andrew Malone, MB, BCh,
MRCPI","credentials":["Assistant Professor of Medicine, Division of
Nephrology\n","Department of Medicine, Washington University School of
Medicine"],"disclosure":""},{"name":"Harvey Mamon, MD, PhD","credentials":
["Associate Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"William J Mann, Jr, MD","credentials":["Section
Editor — Gynecologic Surgery\n","Clinical Professor\n","Department of Obstetrics
and Gynecology\n","Virginia Commonwealth University School of
Medicine"],"disclosure":""},{"name":"David M Mannino, MD","credentials":["Director,
Pulmonary Epidemiology Research Laboratory\n","University of Kentucky School of
Medicine"],"disclosure":""},{"name":"Paul F Mansfield, MD, FACS","credentials":
["Vice President, Acute Care Services\n","Professor of Surgical Oncology\n","The
University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Ellen F
Manzullo, MD, FACP","credentials":["Professor of Medicine\n","University of
Texas\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Karen J Marcus,
MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical
School\n","Boston Children's Hospital\n","Dana-Farber Cancer
Institute"],"disclosure":""},{"name":"Maurie Markman, MD","credentials":["Clinical
Professor of Medicine\n","Drexel University College of Medicine\n","President,
Medicine & Science\n","Cancer Treatment Centers of America"],"disclosure":""},
{"name":"Lawrence B Marks, MD","credentials":["Department of Radiation
Oncology\n","UNC Hospitals and University of North Carolina at Chapel
Hill"],"disclosure":"Grant/Research/Clinical Trial Support: Vision RT [Radiation
therapy (Breath-holding system to reduce cardiac effects of radiation)]."},
{"name":"John A Martin, MD","credentials":["Associate Professor, Senior Associate
Consultant, and Associate Chair for Endoscopy\n","Mayo Clinic"],"disclosure":""},
{"name":"Renato G Martins, MD, MPH","credentials":["Medical
Director\n","Professor\n","University of Washington\n","Seattle Cancer Care
Alliance"],"disclosure":""},{"name":"Shanthi Marur, MD, MBBS","credentials":
["Medical Officer,\n","Oncology Center of Excellence, Food and Drug Administration
(FDA)\n","Adjunct Assistant Professor,\n","Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center"],"disclosure":""},{"name":"Masao Matsuoka, MD,
PhD","credentials":["Professor\n","Department of Hematology, Kumamoto University
Medical School\n","Institute for Virus Research, Kyoto
University"],"disclosure":""},{"name":"Ursula A Matulonis, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical School \n","Director/Program
Leader\n","Medical Gynecologic Oncology\n","Dana-Farber Cancer
Institute"],"disclosure":""},{"name":"Hani Haytham Mawardi, BDS, DMSc, DABOM, FDS
RCSEd","credentials":["King Abdulaziz University\n","Faculty of
Dentistry\n","Jeddah, Saudi Arabia"],"disclosure":""},{"name":"Jessica N McAlpine,
MD, FACOG, FRCPSC","credentials":["Associate Professor\n","Department of Gynecology
and Obstetrics Division of Gynecologic Oncology\n","University of British
Columbia"],"disclosure":""},{"name":"Kenneth L McClain, MD, PhD","credentials":
["Professor of Pediatrics\n","Texas Children's Cancer Center/Hematology
Service\n","Baylor College of Medicine"],"disclosure":""},{"name":"Elizabeth
McCormick, MD","credentials":["Assistant Professor of Geriatrics and Palliative
Medicine\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"W. Joseph
McCune, MD, MACR","credentials":["Michael H and Marcia S Klein Professor of
Rheumatic Diseases\n","Associate Chief, Division of Rheumatology\n","Director,
Lupus Program\n","University of Michigan"],"disclosure":"Grant/Research/Clinical
Trial Support: AstraZeneca [Lupus (Anifrolumab)]; Eli Lilly [Lupus (Baricitinab)];
GlaxoSmithKline [Lupus (Belimumab)]."},{"name":"Shaunagh McDermott,
MD","credentials":["Assistant Professor\n","Harvard Medical
School"],"disclosure":""},{"name":"Derek R McHaffie, MD","credentials":["Attending
Physician\n","Levine Cancer Institute\n","Carolinas Medical
Center"],"disclosure":""},{"name":"William J McKenna, MD","credentials":["Section
Editor — Myopericardial Disease\n","Professor of Cardiology\n","University College,
London"],"disclosure":""},{"name":"Mary-Ellen Meadows, PhD, ABPP","credentials":
["Clinical Neuropsychologist\n","Brigham and Women's Hospital\n","Assistant
Professor of Psychology\n","Harvard Medical School"],"disclosure":""},
{"name":"Babak Mehrara, MD","credentials":["Associate Professor of
Surgery\n","Cornell Weill Medical Center"],"disclosure":""},{"name":"Bhoomi
Mehrotra, MD","credentials":["Director\n","Cancer Institute at St. Francis
Hospital\n","Roslyn, NY"],"disclosure":""},{"name":"Atul C Mehta, MBBS,
FCCP","credentials":["Professor of Medicine\n","Cleveland Clinic
Foundation"],"disclosure":""},{"name":"Minesh Mehta, MD","credentials":["Chair,
Radiation Oncology\n","Florida International
University"],"disclosure":"Consultant/Advisory Boards: Varian [Radiotherapy (Linear
Accelerators)]; Agenus [Biotech start-up]; Insys [Pharma]; Remedy [Biotech start-
up]; IBA [Proton therapy device company]; Oncoceutics [Biotech start-up];
AstraZeneca [Pharma]; Celgene [Pharma]; Tocagen [Biotech start-up]; AbbVie
[Pharma]. Other Financial Interest: Monteris [DSMB (Laser ablation)]; Oncoceutics
[Biotech start-up (Board of directors)]."},{"name":"Zankhana Mehta,
MD","credentials":["Department of Palliative and Supportive Medicine\n","Geisinger
Medical Center"],"disclosure":""},{"name":"Diane E Meier, MD, FACP","credentials":
["Director, Center to Advance Palliative Care \n","Director, Hertzberg Palliative
Care Institute, Mount Sinai School of Medicine\n","Professor, Geriatrics and
Internal Medicine, Mount Sinai School of Medicine"],"disclosure":""},
{"name":"Shlomo Melmed, MD","credentials":["Senior Vice President and
Dean\n","Cedars Sinai Medical Center\n","Professor of Medicine\n","University of
California at Los Angeles School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Ipsen [Acromegaly
(Lanreotide)]; Pfizer [Acromegaly (Pegvisomant)]. Consultant/Advisory Boards:
Chiasma [Acromegaly (Oral octreotide)]; Ionis Pharmaceuticals [Acromegaly
(Antisense drug)]; Novartis [Acromegaly (Octreotide)]; Stonebridge Pharma
[Acromegaly]."},{"name":"Sanaz Memarzadeh, MD, PhD","credentials":["Associate
Professor \n","Department of Obstetrics and Gynecology\n","Division of Gynecologic
Oncology\n","David Geffen School of Medicine at UCLA\n","Director G.O. Discovery
Laboratory"],"disclosure":""},{"name":"William M Mendenhall, MD","credentials":
["Department of Radiation Oncology\n","University of Florida College of
Medicine"],"disclosure":""},{"name":"Avedis Meneshian, MD","credentials":
["Assistant Professor of Surgery\n","Division of Thoracic Surgery\n","Johns Hopkins
Hospital\n","\n","Thoracic Surgeon\n","Anne Arundel Medical
Center"],"disclosure":""},{"name":"Sofia D Merajver, MD, PhD","credentials":
["Professor of Internal Medicine\n","University of Michigan Medical
School"],"disclosure":""},{"name":"Jaime R Merchan, MD, MMSc","credentials":
["Associate Professor of Medicine\n","University of Miami Miller School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Agensys [Cancer
(ASG-22CE)]; Rexahn Pharmaceuticals [Cancer (RX-3117)]; Lilly [Cancer (LY3039478)];
Tracon [Cancer (TRC105)]; Acceleron [Cancer (Dalantarcept)]; Novartis [Cancer
(Trametinib/ribociclib)]. Consultant/Advisory Boards: Exelixis [Cancer
(cabozantinib)]."},{"name":"Christian Meyer, MD, PhD","credentials":["Instructor in
Oncology\n","Sidney Kimmel Comprehensive Cancer Center\n","Johns Hopkins
Hospital"],"disclosure":""},{"name":"Fremonta L Meyer, MD","credentials":
["Assistant Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},
{"name":"Janelle Meyer, MD","credentials":["Hematology Oncology of
Salem"],"disclosure":""},{"name":"Jeffrey J Meyer, MD","credentials":["Assistant
Professor\n","University of Texas-Southwestern Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Peregrine
Pharmaceuticals, Inc. [Cancer (Bavituximab - an antibody drug)]; DFine, Inc.
[Cancer (Medical device for radiofrequency ablation of spine tumors)]."},
{"name":"Jeffrey A Meyerhardt, MD, MPH","credentials":["Associate Professor of
Medicine\n","Dana-Farber Cancer Institute"],"disclosure":"Consultant/Advisory
Boards: Genentech [Oncology (Oncology drugs, payment <$5000)]; Chugai
Pharmaceutical [Therapeutics for gastrointestinal cancers (Bevacizumab and
capecitabine, payment <$5000)]."},{"name":"M Dror Michaelson, MD,
PhD","credentials":["Associate Professor in Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Dominique Michaud, Sc.D","credentials":
["Professor\n","Department of Public Health & Community Medicine\n","Tufts
University Medical School"],"disclosure":""},{"name":"David E Midthun,
MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine, Mayo
Clinic College of Medicine"],"disclosure":""},{"name":"Martin C Mihm, Jr,
MD","credentials":["Clinical Professor of Pathology\n","Harvard
Medical School\n","Brigham and Women's
Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [Multiple tumor
therapies]; Alnylam [Question of allergic reaction to injected microRNA
conjugates]; MelaSciences [Clinical diagnosis in melanoma]; Caliber I.D. [Confocal
microscope diagnosis of tumors (Pre- and postbiopsy drugs)]; Biocoz [Skin
activation and wound recovery (Cutaneous lotion/moisturizer)]. Other Financial
Interest: John Wiley & Sons [Published book]."},{"name":"Michael T Milano, MD,
PhD","credentials":["Associate Professor\n","Department of Radiation
Oncology\n","University of Rochester"],"disclosure":""},{"name":"Andrea Milbourne,
MD","credentials":["Professor of Gynecologic Oncology\n","The University of
Texas"],"disclosure":""},{"name":"Dianne M Miller, MD, FRCSC","credentials":
["Division Head of Gynecologic Oncology\n","University of British Columbia and the
BC Cancer Agency"],"disclosure":""},{"name":"York E Miller, MD","credentials":
["Thomas L Petty Chair of Lung Research\n","Division of Pulmonary Sciences and
Critical Care Medicine\n","Co-Leader, Lung, Head and Neck Cancer Program
\n","University of Colorado Cancer Center\n","Staff Physician\n","Denver Veterans
Affairs Medical Center\n","University of Colorado School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: SomaLogic
[Proteomic detection of lung cancer (None)]; HealthTell [Autoantibody detection of
lung cancer (None)]; VisionGate [Cancer chemoprevention (3D imaging of sputum cells
for the detection of lung cancer)]. Patent Holder: University of Colorado [Cancer
chemoprevention (prostacyclin analogs such as iloprost)]."},{"name":"Omar A Minai,
MD","credentials":["Pulmonary and Critical Care Associates\n","Southside regional
medical Center"],"disclosure":""},{"name":"Jennifer Minnix, PhD","credentials":["UT
MD Anderson Cancer Center"],"disclosure":""},{"name":"Timur Mitin, MD,
PhD","credentials":["Assistant Professor\n","Department of Radiation
Medicine\n","Oregon Health and Science University"],"disclosure":""},
{"name":"Anirban P Mitra, MD, PhD","credentials":["Resident, Institute of
Urology\n","University of Southern California\n","Keck School of Medicine & Norris
Comprehensive Cancer Center"],"disclosure":""},{"name":"Kathleen M Moore,
MD","credentials":["Associate Professor\n","Division of Gyn Oncology\n","Mai Eager
Anderson Chair of Cancer Clinical Trials \n","Stephenson Cancer
Center\n","Universitiy of Oklahoma HSC"],"disclosure":"Grant/Research/Clinical
Trial Support: Astra Zeneca [Ovarian cancer (Olaparib)]; Genentech/Roche [Ovarian
cancer (Bevacizumab)]."},{"name":"Douglas Morgan, MD, MPH","credentials":["Division
of Gastroenterology, Hepatology, & Nutrition \n","VIGH Director for Latin America
sites \n","Vanderbilt Institute for Global Health (VIGH) \n","Vanderbilt Ingram
Cancer Center (VICC) \n","Vanderbilt
University"],"disclosure":"Grant/Research/Clinical Trial Support: Cancer Prevention
Pharmaceuticals (CPP) [Gastric cancer prevention (Eflornithine - CPP provided
donation of study drug for an NIH-funded study)]; Biomerica [H pylori diagnostic
assay (multicenter trial)."},{"name":"James P Morgan, MD, PhD","credentials":
["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},
{"name":"Jeffrey Morgan, MD","credentials":["Instructor in Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"R Sean Morrison, MD","credentials":
["Section Editor — Selected End Stage Conditions\n","Hermann Merkin Professor of
Palliative Care\n","Mount Sinai School of Medicine"],"disclosure":""},
{"name":"Maria Moschovi, MD","credentials":["Assistant Professor of Pediatric
Hematology-Oncology\n","University of Athens"],"disclosure":""},{"name":"Craig
Moskowitz, MD","credentials":["Attending Physician, Lymphoma and Adult BMT
Services\n","Member, Memorial Sloan Kettering Cancer Center \n","Professor of
Medicine, Weill Medical College of Cornell University"],"disclosure":""},
{"name":"Judd W Moul, MD, FACS","credentials":["James H. Semans, MD Professor of
Surgery\n","Division of Urologic Surgery\n","Duke University Medical
Center\n","Director, Duke Prostate Center\n","Duke Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astelas [Prostate
cancer (Enzalutamide)]; Medication [Prostate cancer (Enzalutamide)]. Speaker's
Bureau: Dendreon [Prostate cancer (Sipuleucel-T)]; Janssen [Prostate cancer
(Abiraterone)]; Ferring [Prostate cancer (Degarelix)]; Sanofi [Prostate cancer
(N/A)]; Genomic Health [Prostate cancer (Oncotype GPS)]. Consultant/Advisory
Boards: Theralogic [Nutrition (Various nutritional supplements)]; Blue Earth
Diagnostics [Prostate cancer (Axumin PET scan)]."},{"name":"Beverly Moy, MD,
MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards (spouse/partner): Motus GI
[gastroenterology (endoscopy technology)]."},{"name":"Timothy J Moynihan,
MD","credentials":["Associate Professor of Medical Oncology\n","Mayo Clinic College
of Medicine"],"disclosure":""},{"name":"John T Mullen, MD, FACS","credentials":
["Associate Professor of Surgery\n","Harvard Medical School\n","Division of
Surgical Oncology\n","Massachusetts General Hospital"],"disclosure":""},
{"name":"Arno J Mundt, MD","credentials":["Section Editor — Radiation
Therapy\n","Chairman of Radiation Oncology\n","University of California, San
Diego"],"disclosure":""},{"name":"Nikhil C Munshi, MD","credentials":["Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Janssen [Castleman disease (siltuximab)]."},{"name":"Septimiu Murgu,
MD","credentials":["Associate Professor\n","University of
Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Pinnacle Biologics
[PDT (Porfimer sodium). Consultant/Advisory Boards: Pinnacle Biologics [PDT
(Porfimer sodium)."},{"name":"Barbara A Murphy, MD","credentials":["Professor of
Medicine\n","Director, Pain and Symptom Management Program\n","Vanderbilt Ingram
Cancer Center"],"disclosure":""},{"name":"Janet E Murphy, MD, MPH","credentials":
["Instructor of Medicine, Harvard Medical School\n","Massachusetts General Hospital
Cancer Center\n","Tucker Gosnell Center for GI Malignancies"],"disclosure":""},
{"name":"Jodi A Muscal, MD","credentials":["Assistant Professor of Pediatric
Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Michael G Muto, MD","credentials":["Associate Professor of Obstetrics,
Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},
{"name":"Lida Nabati, MD","credentials":["Instructor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Maurice Nahabedian, MD","credentials":
["Professor of Plastic Surgery\n","Georgetown University"],"disclosure":"Speaker's
Bureau: LifeCell [Breast and abdominal wall reconstruction (Acellular dermal
matrices)]; Allergan [Breast and abdominal wall reconstruction (Breast implants)].
Consultant/Advisory Boards: LifeCell [Breast and abdominal wall reconstruction
(Acellular dermal matrices)]; Allergan [Breast and abdominal wall reconstruction
(Breast implants)]."},{"name":"Eiad Nasser, MD","credentials":["University at
Buffalo\n","Gastroenterology Division"],"disclosure":""},{"name":"Jim Natale,
PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer
Centers"],"disclosure":"Speaker's Bureau: Merck [Lung Cancer (Keytruda)]."},
{"name":"Joel W Neal, MD, PhD","credentials":["Assistant Professor of Medicine
(Oncology)\n","Stanford University/ Stanford Cancer
Institute"],"disclosure":"Grant/Research Support: Genentech/Roche [lung cancer
(erlotinib)]; Merck [lung cancer]; Novartis [lung cancer (ceritinib)]; Nektar [lung
cancer (brigatinib)]. Consultant/Advisory Boards: Takeda [lung cancer
(brigatinib)]; Lilly [lung cancer]; Astra Zeneca [lung cancer (osimertinib)]."},
{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow
Transplantation\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz
Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular
therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock
Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals
[Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest:
American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},
{"name":"Larissa Nekhlyudov, MD, MPH","credentials":["Section Editor — Cancer
Survivorship\n","Associate Professor\n","Department of Medicine\n","Brigham &
Women’s Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Peter S
Nelson, MD","credentials":["Member, Divisions of Human Biology and Clinical
Research\n","Fred Hutchinson Cancer Research Center\n","Professor, Division of
Medical Oncology, University of Washington"],"disclosure":""},{"name":"Andrea K Ng,
MD, MPH","credentials":["Professor, Radiation Oncology, Harvard Medical
School\n","Brigham and Women's Hospital\n","Dana-Farber Cancer
Institute"],"disclosure":""},{"name":"Lynnette K Nieman, MD","credentials":
["Section Editor — Adrenal Disease\n","Senior Investigator\n","Bethesda,
MD"],"disclosure":"Grant/Research/Clinical Trial Support: HRA Pharma [Cushing's
syndrome (Metapyrone)]."},{"name":"Errol R Norwitz, MD, PhD, MBA","credentials":
["Professor and Chair\n","Department of Obstetrics and Gynecology\n","Tufts Medical
Center and Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Illumina
[Preeclampsia (primary investigator on a prospective cohort study to collect
samples from patients with preeclampsia to facilitate development of a biomarker
test to predict/diagnose this disorder)]. Consultant/Advisory Boards: Hologic
[Preterm birth (Fetal fibronectin test to predict preterm birth)];
Natera [Fetal aneuploidy testing (NIPT as a screening test for fetal aneuploidy)];
Seracare [Fetal aneuploidy testing (Developing controls for NIPT screening test for
fetal aneuploidy)]; Bayer [Prediction test for preeclampsia (Use of urinary
angiogenic factors to predict preeclampsia)]."},{"name":"Jed G Nuchtern, MD, FACS,
FAAP","credentials":["Professor of Surgery, Pediatric Surgery Division\n","Baylor
College of Medicine"],"disclosure":""},{"name":"Michael A O'Donnell, MD,
FACS","credentials":["Professor of Urology\n","University of
Iowa"],"disclosure":"Grant/Research/Clinical Trial Support: Abbot Molecular
[Bladder cancer diagnostic (Urovision FISH test)]; Roche [Bladder cancer clinical
trial investigator (Atezolizumab)]; Photocure [Bladder Cancer Clinical Trial with
Diagnostic Investigator (Cysview and new flexible imaging system)].
Consultant/Advisory Boards: Medical Enterprises [Bladder cancer treatment-
microwave hyperthermia (synergo device)]; Telesta [Bladder cancer treatment
(MCNA)]; Viventia [Bladder cancer treatment (Vicinium)]; Spectrum (Bladder cancer
treatment-apaziquone); Fidia Pharmaceuticals (Bladder cancer treatment). Equity
Ownership/Stock: Therlasae [Bladder cancer-Laser (New therapeutic laser for photo
dynamic therapy)]."},{"name":"Ronan O'Driscoll, BSc, MD, FRCP","credentials":
["Consultant Respiratory Physician\n","Salford Royal University Hospital, United
Kingdom"],"disclosure":""},{"name":"Robert D Odze, MD, FRCPC","credentials":
["Professor of Pathology\n","Harvard Medical School"],"disclosure":""},
{"name":"Kevin Oh, MD","credentials":["Assistant Professor of Radiation
Oncology\n","Harvard Medical School\n","\n","Attending Radiation
Oncologist\n","Massachusetts General
Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Merck
[Immunotherapy in brain metastases (pembrolizumab)]; Elekta [Funding for multi-
institutional brain metastases consortium (Linear accelerator)]."},{"name":"William
K Oh, MD","credentials":["Section Editor — Testicular Cancer\n","Professor of
Medicine\n","Mount Sinai School of Medicine\n","Chief, Division of Hematology
Oncology\n","Tisch Cancer Institute"],"disclosure":""},{"name":"Devin J Okay,
DDS","credentials":["Division of Prosthodontics\n","Mount Sinai Beth
Israel"],"disclosure":""},{"name":"M Fatih Okcu, MD, MPH","credentials":["Professor
of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Tomasz R
Okon, MD","credentials":["Clinical Assistant Professor\n","Department of Internal
Medicine\n","University of Wisconsin - Madison\n","Marshfield Clinic,
Wisconsin"],"disclosure":""},{"name":"Scott Okuno, MD","credentials":["Professor of
Oncology\n","Division of Medical Oncology\n","Mayo Clinic"],"disclosure":"Other
Financial Interest: AXIS Medical Education Faculty [Certified educational
activities]."},{"name":"Alexander B Olawaiye, MD","credentials":["Associate
Professor of Obstetrics, Gynecology and Reproductive Sciences\n","University of
Pittsburgh"],"disclosure":""},{"name":"Kenneth R Olivier, MD","credentials":
["Associate Professor\n","Mayo Clinic, Rochester, MN"],"disclosure":""},
{"name":"Elise A Olsen, MD","credentials":["Professor of Dermatology and
Oncology\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical
Trial Support: Bioniz [CTCL, consultant]; Galderma [CTCL, investigator clinical
trial]; Elorac [CTCL, investigator clinical trial]."},{"name":"Lynn Bunch O'Neill,
MD","credentials":["Associate Professor\n","Emory University School of
Medicine"],"disclosure":""},{"name":"David Ost, MD, MPH","credentials":["Professor,
Department of Pulmonary Medicine\n","The University of Texas MD Anderson Cancer
Center"],"disclosure":""},{"name":"Jamie Ostroff, PhD","credentials":["Behavioral
Sciences Service \n","Department of Psychiatry & Behavioral Sciences \n","Memorial
Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: CVS Health [Smoking cessation (Nicotine replacement products)]; Pfizer
Inc. [Smoking cessation (Varenicline)]. Speaker's Bureau: Bristol-Myers Squibb
[Lung cancer survivorship (Psychosocial adaptation methods)]."},{"name":"Shirley
Otis-Green, MSW, MA, LCSW, ACSW, OSW-C","credentials":
["Consultant\n","Collaborative Caring"],"disclosure":""},{"name":"Michael J
Overman, MD","credentials":["Associate Professor\n","Department of Gastrointestinal
Medical Oncology\n","MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [small bowel
adenocarcinoma (panitumumab)]; Roche [small bowel adenocarcinoma (bevacizumab)];
BMS [colon cancer (cetuximab)]. Consultant/Advisory Boards: Roche [colon cancer
(atezolizumab)]; BMS [colon cancer (nivolumab)]."},{"name":"Cindy Owen,
MD","credentials":["Assistant Professor of Medicine\n","University of
Louisville"],"disclosure":""},{"name":"Eric Padron, MD","credentials":["Assistant
Member, Malignant Hematology\n","H. Lee Moffitt Cancer Center and Research
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte, CTI,
KaloBios [CMML (ruxolitinib, pacritinib)]. Consultant/Advisory Boards: CTI, Incyte
[myelofibrosis (pacritinib)]."},{"name":"Lance C Pagliaro, MD","credentials":
["Professor of Oncology\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Sumanta K Pal, MD","credentials":["Assistant Professor, Department of
Medical Oncology & Experimental Therapeutics\n","City of Hope Comprehensive Cancer
Center"],"disclosure":"Speaker's Bureau: Genentech [Papillary RCC (Atezolizumab)].
Consultant/Advisory Boards: Pfizer [Papillary RCC (Sunitinib, axitinib)]; Genentech
[Papillary RCC (Bevacizumab, atezolizumab)]; Novartis [Papillary RCC (Everolimus)];
Exelixis [Papillary RCC (Cabozantinib)]; BMS [Papillary RCC (Nivolumab,
ipilimumab)]."},{"name":"Joel M Palefsky, MD","credentials":
["Professor\n","University of California San Francisco\n","Immediate Past
President, International Papillomavirus Society\n","Past President, International
Anal Neoplasia Society"],"disclosure":"Grant/Research/Clinical Trial Support: Merck
and Co [HPV vaccine (Gardasil-9)]. Consultant/Advisory Boards: Antiva Therapeutics
[HPV therapeutics]; Agenovir Corporation [HPV therapeutics]. Equity Ownership/Stock
Options: Antiva Therapeutics [HPV therapeutics]; Agenovir Corporation [HPV
therapeutics]; Ubiome [HPV diagnostics]."},{"name":"Manisha Palta,
MD","credentials":["Assistant Professor of Radiation Oncology\n","Duke
University"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Esophago-
gastric cancer (Pembrolizumab; research support for investigator-initiated clinical
trial)]. Speaker's Bureau: Oakstone CME [lower GI cancers (product unrelated to
UpToDate contribution; received honorarium)]."},{"name":"Liron Pantanowitz,
MD","credentials":["Professor of Pathology\n","University of Pittsburgh Medical
Center"],"disclosure":""},{"name":"Allan J Pantuck, MD, MS, FACS","credentials":
["Associate Professor\n","UCLA David Geffen School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Pfizer [Renal cell carcinoma
(Sunitinib)]."},{"name":"John K Park, MD, PhD","credentials":["Santa Barbara
Neuroscience Institute"],"disclosure":""},{"name":"Ann H Partridge, MD,
MPH","credentials":["Director, Adult Survivorship Program\n","Dana-Farber Cancer
Institute\n","Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Harvey I Pass, MD","credentials":["Stephen E.
Banner Professor of Thoracic Oncology\n","NYU Langone Medical
Center"],"disclosure":"Speaker’ s Bureau (Spouse): Genetech [Breast surgery
(none)]."},{"name":"Devanshi Patel, MS, CGC","credentials":["Senior Genetic
Counselor\n","Massachusetts General Hospital Center for Cancer Risk
Assessment"],"disclosure":""},{"name":"Maitray D Patel, MD","credentials":
["Associate Professor of Radiology\n","Department of Radiology\n","Mayo Clinic
Arizona"],"disclosure":""},{"name":"Shreyaskumar R Patel, MD","credentials":
["Center Medical Director, Sarcoma Center\n","Professor of Medicine and Deputy
Chairman\n","Department of Sarcoma Medical Oncology\n","MD Anderson Cancer
Center\n","The University of Texas"],"disclosure":"Grant/Research/Clinical Trial
Support: Johnson & Johnson [Sarcomas (Trabectedin)]; Eisai [Sarcomas (Eribulin)];
Morphotek [Sarcomas (Farletuzumab)]. Consultant/Advisory Boards: Novartis [GIST
(Imatinib mesylate)]; CytRx [Sarcomas (Aldoxorubicin)]; Johnson & Johnson [Sarcomas
(Trabectedin)]; EMD Serono [Sarcomas (Evofosfamide)]; Eli Lilly [Sarcomas
(Olaratumab)]; Bayer [GIST (Regorafenib)]; Immune Design [Liposarcomas (CMB305
vaccine)]; Epizyme [Epithelioid sarcomas/chordomas (Tazemetostat)]."},{"name":"Erik
K Paulson, MD","credentials":["Professor and Chairman\n","Department of
Radiology\n","Duke University School of Medicine"],"disclosure":""},{"name":"Aimee
S Payne, MD, PhD","credentials":["Associate Professor\n","Department of
Dermatology\n","University of Pennsylvania"],"disclosure":""},{"name":"York Pei,
MD, FRCPC, FACP, FASN","credentials":["Professor of Medicine\n","University Health
Network and University of Toronto"],"disclosure":""},{"name":"Tobias Peikert,
MD","credentials":["Consultant, Division of Pulmonary and Critical Care
Medicine\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Jeffrey F
Peipert, MD, PhD","credentials":["Clarence E. Ehrlich Professor and
Chair\n","Department of Obstetrics & Gynecology\n","Indiana University School of
Medicine"],"disclosure":""},{"name":"David F Penson, MD, MPH","credentials":
["Professor of Urologic Surgery\n","Director of Vanderbilt Center for Surgical
Quality and Outcomes Research"],"disclosure":"Consultant/Advisory Boards: Astellas;
Dendreon, Janssen [Prostate cancer (Enzalutamide, abiraterone, apalutamide,
sipuleucel-T)]."},{"name":"Richard T Penson, MD, MRCP","credentials":["Associate
Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical
Trial Support: Array BioPharma, AstraZeneca, Cerulean Pharma, Eisai, Genentech,
Regeneron, Sanofi-Aventis US LLC, Tesaro, Vascular Biogenics Ltd [Ovarian cancer.
Consultant/Advisory Boards: Amgen, Genentech, AstraZeneca, Eisai, Vascular
Biogenics Ltd, Baxalta Oncology, AbbVie, Clovis Oncology, Tesaro [Ovarian cancer].
Other Financial Interest: BMJ; Blackwell Publishing Medicine at a Glance
[Royalties]; Advance Medical HCMS, SA [Consulting]."},{"name":"Mark A Perazella,
MD, FACP","credentials":["Professor of Medicine\n","Yale University School of
Medicine"],"disclosure":""},{"name":"Beth N Peshkin, MS, CGC","credentials":
["Professor of Oncology, Senior Genetic Counselor\n","Georgetown University Medical
School\n","Jess and Mildred Fisher Center for Hereditary Cancer and Clinical
Genomics Research"],"disclosure":"Consultant/Advisory Boards: Clear Genetics
[Genetic counseling and testing (Technology to expand access)]."},{"name":"Amy H
Peterman, PhD","credentials":["Associate Professor\n","University of North Carolina
at Charlotte"],"disclosure":""},{"name":"Curtis A Pettaway, MD","credentials":
["Professor of Urology\n","University of Texas"],"disclosure":""},{"name":"Lori J
Pierce, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of
Radiation Oncology\n","University of Michigan School of
Medicine"],"disclosure":""},{"name":"Phillip M Pierorazio, MD","credentials":
["Associate Professor of Urology and Oncology, \n","Brady Urological Institute and
Department of Urology, \n","Johns Hopkins Medicine"],"disclosure":""},
{"name":"Eugene J Pietzak, MD","credentials":["Assistant Attending Surgeon, Urology
Service\n","Department of Surgery\n","Memorial Sloan Kettering Cancer\n","Assistant
Professor of Urology\n","Weill Medical College of Cornell
University"],"disclosure":""},{"name":"Roberto Pili, MD","credentials":["Robert
Wallace Miller Professor of Medicine, Director of GU Oncology Division of
Hematology/Oncology\n","Department of Medicine Professor of Pharmacology and
Toxicology Indiana University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech, Syndax,
Merck [Renal and urothelial cancer (drug development)]."},{"name":"Louis L Pisters,
MD","credentials":["Professor\n","The University of Texas School of Medicine\n","MD
Anderson Cancer Center"],"disclosure":""},{"name":"Marie Plante, MD","credentials":
["Full Professor of Gynecologic Oncology\n","Department of Obstetrics and
Gynecology\n","Division of Gynecologic Oncology\n","L'Hôtel-Dieu de
Québec\n","Centre Hospitalier Universitaire de Québec\n","Laval
University"],"disclosure":""},{"name":"Steven C Plaxe, MD","credentials":
["Professor, Reproductive Medicine\n","Director, Gynecologic
Oncology\n","University of California, San Diego School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro, Milennium,
Pfizer, Astra-Zeneca, Pharma Mar, Bind, Janssen, Novartis, Incyte, Azaya [Oncology
(various study drugs)]. Equity Ownership/Stock Options (Spouse): Abbvie."},
{"name":"Sharon E Plon, MD, PhD","credentials":["Professor, Departments of
\n","Pediatrics/Hematology-Oncology\n","Molecular and Human Genetics\n","Human
Genome Sequencing Center\n","Baylor College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Baylor Genetics Laboratories
[genetic testing (hereditary cancer genetic testing)]."},{"name":"Scott L Pomeroy,
MD, PhD","credentials":["Bronson Crothers Professor of Neurology\n","Harvard
Medical School"],"disclosure":""},{"name":"Colin S Poon, MD, PhD,
FRCPC","credentials":["Clinical Assistant Professor of Radiology\n","Department of
Diagnostic Radiology\n","Yale University School of Medicine"],"disclosure":""},
{"name":"Thaddeus M Pope, JD, PhD","credentials":["Director, Health Law
Institute\n","Professor, Mitchell Hamline School of Law (Saint Paul,
MN)"],"disclosure":""},{"name":"Sandro V Porceddu, MD","credentials":["Radiation
Oncologist, Princess Alexandra Hospital\n","Associate Professor, University of
Queensland"],"disclosure":"Consultant/Advisory Boards: Merck Serono [Head and neck
(Cetuximab)]; Merck Sharpe Dome [Head and Neck (Pembrolizumab)]."},{"name":"Russell
K Portenoy, MD","credentials":["Chief Medical Officer\n","MJHS Hospice and
Palliative Care\n","Professor of Neurology and Family and Social
Medicine\n","Albert Einstein College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Pain
(Opioid antagonist)]; Tabula Rasa [Decision support]."},{"name":"Didier Portilla,
MD","credentials":["Professor of Medicine\n","University of
Virginia"],"disclosure":""},{"name":"Michael Postow, MD","credentials":["Assistant
Attending Physician\n","Memorial Sloan-Kettering Cancer Center\n","Assistant
Professor of Medicine\n","Weill Medical College of Cornell
University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers
Squibb [Immunotherapy (ipilimumab, nivolumab)]. Consultant/Advisory Boards: Bristol
Myers Squibb [Immunotherapy (ipilimumab, nivolumab)]; Merck [Immunotherapy
(pembrolizumab)]."},{"name":"Matthew A Powell, MD","credentials":["Associate
Professor, Division of Gynecologic Oncology\n","Director, Gynecologic Oncology
Fellowship"],"disclosure":"Speaker's Bureau: Roche/Genetech [Ovary, Cervix
(Bevacizumab)]; AstraZeneca; Clovis Oncology; Tesaro, Inc. [Ovary].
Consultant/Advisory Board: Roche/Genetech [Ovary, cervix (Bevacizumab)];
AstraZeneca [Ovary (Olaparib)]; Clovis Oncology [Ovary (Rucaparib)]; Tesaro, Inc.
[Ovary (Niraparib)]."},{"name":"Olga Pozdnyakova, MD","credentials":["Assistant
Professor of Pathology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Promedior [myeloproliferative
neoplasms]."},{"name":"Josef T Prchal, MD","credentials":["Professor of
Medicine\n","University of Utah"],"disclosure":""},{"name":"Kathleen I Pritchard,
MD, FRCPC","credentials":["Professor Emerita\n","Division of Medical
Oncology\n","Department of Medicine\n","University of Toronto\n","\n","Medical
Oncologist\n","Sunnybrook Odette Cancer Centre\n","Senior Scientist\n","Sunnybrook
Research Institute\n","Toronto, Canada"],"disclosure":"Grant/Research/Clinical
Trial Support: Pfizer, Roche, Amgen, Novartis, Eisai [Breast cancer (Exemestane,
letrozole, trastuzumab, pertuzumab)]. Consultant/Advisory Boards: Pfizer, Roche,
Amgen, Novartis, Eisai [Breast cancer (Exemestane, letrozole, trastuzumab,
pertuzumab])."},{"name":"Christina M Puchalski, MD, MS, FACP,
FAAHPM","credentials":["Director and Professor\n","George Washington Institute for
Spirituality and Health, School of Medicine and Health Sciences\n","The George
Washington University, Washington, DC"],"disclosure":""},{"name":"Ching-Hon Pui,
MD","credentials":["Chair of the Department of Oncology\n","Fahad Al-Rashid Chair
of Leukemia Research\n","St. Jude's Children's Hospital\n","American Cancer Society
Professor \n","Professor of Pediatrics\n","University of Tennessee Health Science
Center"],"disclosure":"Consultant/Advisory Boards: Adaptive Biotechnologies [Deep
sequencing for minimal residual disease detection]."},{"name":"Jose S Pulido, MD,
MS, MPH","credentials":["Professor of Ophthalmology and Molecular Medicine\n","Mayo
Clinic"],"disclosure":"Equity Ownership/Stock Options: Lagen Laboratories
[Chemotherapy (Nonhuman laboratory use of iPSC-RPE cells)]."},{"name":"Bradley J
Quade, MD, PhD","credentials":["Associate Professor of Pathology\n","Harvard
Medical School"],"disclosure":""},{"name":"David I Quinn, MBBS (Hons I), PhD,
FRACP, FACP","credentials":["Associate Professor of Medicine\n","University of
Southern California Norris Cancer Center\n","Keck School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Millenium [Renal
cell cancer (Tak700)]; Genentech [Renal cell carcinoma (Avastin, atezoluzimab)];
Glaxo Smith Kline/Novartis [Urothelial cancer (Everolimus, zometa, pazopanib)].
Consultant/Advisory Boards: Pfizer [Renal cell carcinoma, prostate cancer
(Sunitinib, axitinib, temsirolimus, avelumab, enzalutamide)]; Novartis/GSK [Renal
cell carcinoma, prostate (Everolimus, zometa, pazopanib)]; Genentech [Bladder
cancer, renal cell carcinoma (Atezoluzimab, bevacuzimab)]; Bayer [Renal cell
carcinoma, prostate cancer , urothelial cancer (Radium 223, sorafenib,
rogaratinib)]; Dendeon [Prostate cancer (Sipuleucel-T)]; Astellas [Prostate cancer
(Enzalutamide)]; BMS [Renal cancer, bladder cancer (Nivolumab, ipilumumab)]; Merck
Sharp Dohme [Bladder cancer, renal cancer (Pembroluzimab)]; Exelexis [Renal cell
carcinoma (Caboxantinib); Jannsen [Prostate cancer (Abiraterone, apalutamide)];
Sanofi Genzyme [Prostate cancer (Cabazitaxel)]."},{"name":"Jeanne M Quivey, MD,
FACR","credentials":["Professor\n","Clinical Radiation Oncology\n","University of
California, San Francisco"],"disclosure":""},{"name":"Dmitry J Rabkin, MD,
PhD","credentials":["Assistant Professor\n","Harvard Medical School\n","Division of
Angiography and Interventional Radiology\n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"Derek Raghavan, MD, PhD, FACP,
FASCO","credentials":["Section Editor — Bladder Cancer\n","President, Levine Cancer
Institute\n","Carolinas HealthCare System\n","Charlotte, NC"],"disclosure":"Other
Financial Interest: Caris Life Sciences [Molecular prognostication (Panomic
sequencing - unpaid)]."},{"name":"Kanti R Rai, MD","credentials":["Professor of
Medicine and Molecular Medicine\n","Zucker School of Medicine at
Hofstra/Northwell"],"disclosure":"Advisory Boards: Pharmacyclics [CLL (ibrutinib)],
Gilead [CLL (idelalisib)], Roche/Genentech [CLL (obinutuzumab, rituximab)],
Cellectis [CLL (not named, generic: allogeneic CAR-T cells)]."},{"name":"Isaac
Raijman, MD","credentials":["Clinical Associate Professor of Medicine\n","Baylor
College of Medicine, Houston, TX\n","Digestive Associates of Houston,
PA"],"disclosure":"Speaker's Bureau: Covidien [ERCP, Spyglass, RFA]; Boston
Scientific
[ERCP, Spyglass, RFA]. Consult/Advisory Boards: Boston Scientific [Spyglass,
ERCP]. Patent Holder: ENDO RX [Biliary Balloon]. Equity Ownership/Stock Options:
ENDO RX [Co-owned]."},{"name":"Nino Rainusso, MD","credentials":["Assistant
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College
of Medicine\n","Texas Children's Cancer & Hematology Centers"],"disclosure":""},
{"name":"S Vincent Rajkumar, MD","credentials":["Edward W. and Betty Knight Scripps
Professor of Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Naren
Ramakrishna, MD, PhD","credentials":["Director of Neuro and Pediatric Radiation
Oncology\n","University of Florida Health Cancer Center at Orlando
Health\n","Professor of Radiation Oncology \n","University of Central Florida
College of Medicine"],"disclosure":"Speaker's Bureau: Brainlab Ag [Radiation
treatment of brain tumors (Treatment planning software, Image-guided patient
positioning)]."},{"name":"Suresh S Ramalingam, MD","credentials":
["Professor\n","Director of Medical Oncology\n","Department of Hematology and
Medical Oncology\n","Emory University, Winship Cancer
Institute"],"disclosure":"Consultant/Advisory Boards: AbbVie; AstraZeneca; Bristol-
Myers Squibb; Boehringer Ingelheim; Celgene; Lilly; Merck; Novartis; Genentech
[Lung cancer (Pemetrexed)]."},{"name":"Scott D Ramsey, MD","credentials":
["Professor of Medicine\n","University of Washington\n","Fred Hutchinson Cancer
Research Center"],"disclosure":"Consultant/Advisory Boards: Epigenomics [Colorectal
cancer (blood test to screen for colorectal cancer in average-risk persons)]."},
{"name":"Shyam SD Rao, MD, PhD","credentials":["Assistant Professor of Radiation
Oncology\n","University of California Davis Comprehensive Cancer
Center"],"disclosure":""},{"name":"Chandrajit P Raut, MD, MSc, FACS","credentials":
["Associate Professor of Surgery, Harvard Medical School\n","Division of Surgical
Oncology, Brigham and Women's Hospital \n","Center for Sarcoma and Bone Oncology,
Dana-Farber Cancer Institute"],"disclosure":"Other Financial Interest: Novartis
China [GIST (Clinical trial data discussions on neoadjuvant and adjuvant
imatinib)]."},{"name":"Vinod Ravi, MD","credentials":["Associate
Professor\n","Sarcoma Medical Oncology\n","MD Anderson Cancer Center\n","The
University of Texas"],"disclosure":""},{"name":"Lawrence D Recht,
MD","credentials":["Professor of Neurology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Susan D Reed, MD, MPH","credentials":
["Professor\n","Departments of Obstetrics and Gynecology &
Epidemiology\n","Harborview Medical Center\n","University of
Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer
Pharmaceuticals [Uterine fibroids, endometriosis, uterine perforation
(Levonorgestrel IUS)]."},{"name":"Samuel Refetoff, MD","credentials":["Professor of
Medicine, Pediatrics, and Committee on Genetics\n","University of
Chicago"],"disclosure":""},{"name":"Mara H Rendi, MD, PhD","credentials":
["Department of Anatomic Pathology\n","University of Washington"],"disclosure":""},
{"name":"Jerome P Richie, MD, FACS","credentials":["Section Editor — Cancer of the
Urethra, Penis, and Ureter; Urologic Surgery; Prostate Cancer\n","Elliott Carr
Cutler Professor of Surgery\n","Harvard Medical School"],"disclosure":""},
{"name":"Stephen Riggs, MD, FACS","credentials":["Urologic Oncologist\n","Levine
Cancer Institute\n","Carolinas HealthCare System"],"disclosure":"Speaker’s Bureau:
Prostate Conditions Education Council. Equity Ownership/Stock Options: Exelixis."},
{"name":"Mack Roach, III, MD","credentials":["Professor of Radiation Oncology and
Urology\n","University of California, San Francisco\n","Department of Radiation
Oncology\n","Helen Diller Family Comprehensive Cancer
Center"],"disclosure":"Speaker’ s Bureau: Janssen (Johnson & Johnson) [Prostate
cancer & hormonal therapy (ARN-509)]. Consultant/Advisory Boards: Accuray
[Radiation devices (CyberKnife/Tomotherapy)], Ferring Pharmaceuticals [Drug company
(Degarelix)]; Myriad [Prostate cancer (Polaris diagnostic test)]. Employment: NCI
(National Cancer Advisory Board); IAEA (International Atomic Energy Agency)
[Special Government Employee/Consultant]."},{"name":"William R Robinson,
MD","credentials":["Professor of Gynecologic Oncology\n","Tulane Medical
School"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor
of Nephrology and Clinical Pathology\n","University of Turin Medical
School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher
Disease)]."},{"name":"James W Rocco, MD, PhD, FACS","credentials":["Professor and
John and Mary Alford Chair of Head and Neck Surgery\n","The Ohio State University
Wexner Medical Center"],"disclosure":""},{"name":"Richard J Rodeheffer,
MD","credentials":["Professor of Medicine\n","Mayo Medical
School"],"disclosure":""},{"name":"Linda Rodgers, MGC, CGC","credentials":["Genetic
Counselor\n","Massachusetts General Hospital Center for Cancer Risk
Assessment"],"disclosure":""},{"name":"Miguel A Rodriguez-Bigas, MD","credentials":
["Professor of Surgery\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"G
David Roodman, MD, PhD","credentials":["Indiana
University"],"disclosure":"Consultant/Advisory Boards: Amgen [bone metastasis
(denosumab)]."},{"name":"Alain H Rook, MD","credentials":["Professor of
Dermatology\n","Perelman School of Medicine at the University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix [CTCL
research (hypericin clinical trial)]; Medimmune [CTCL trial]; Galderma [CTCL
trial]."},{"name":"Jonathan E Rosenberg, MD","credentials":["Associate Attending
Physician\n","Associate Professor\n","Section Head, Non-Prostate Genitourinary
Malignancies\n","Memorial Sloan-Kettering Cancer Center\n","Weill-Cornell Medical
College"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech/Roche
[Bladder cancer (Atezolizumab)]; AstraZeneca [Bladder cancer (durvalumab,
olaparib)]; Bayer [Bladder cancer (rogaratinib)]. Consultant/Advisory Boards: Merck
[Bladder cancer (Pembrolizumab)]; Bristol-Myers Squibb [Bladder cancer
(Nivolumab)]; AstraZeneca [bladder cancer (durvalumab, tremelimumab]);
Genentech/Roche (Bladder cancer [atezolizumab]); EMD-Serono [Bladder cancer
(Avelumab)]; Agensys [bladder cancer (ASG-22CE)]; Seattle Genetics [bladder
cancer]; Bayer [Bladder cancer]; Gristone [Bladder Cancer]."},{"name":"Laurie
Rosenblatt, MD","credentials":["Assistant Professor of Psychiatry
(Medicine)\n","Harvard Medical School"],"disclosure":""},{"name":"Myrna R
Rosenfeld, MD, PhD","credentials":["Professor of Neurology\n","Hospital
Clinic/IDIBAPS, University of Barcelona, Spain\n","Adjunct Professor of
Neurology\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical
Trial Support (spouse): CELLEX Foundation [unrestricted research grant focus on
memory alteration in autoimmune encephalitis]; Euroimmun [autoimmune encephalitis
(antibody testing kits)]. Patent Holder/Royalties: Euroimmun Inc [NMDAR
encephalitis (antibody tests)]; Athena [Ma2 encephalitis (antibody tests)]. Patent
Holder/Royalties (spouse): Euroimmun Inc [NMDAR encephalitis, DPPX, GABA-B
encephalitis, GABA-A, IgLON5 (antibody tests)]; Athena [Ma2 encephalitis (antibody
tests)]."},{"name":"Kenneth Rosenzweig, MD","credentials":["Professor and
Chairman\n","Department of Radiation Oncology\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"Ashley Ross, MD, PhD","credentials":["Associate
Professor of Urology and Oncology\n","Johns Hopkins Brady Urological
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Metamark Genetics
[Prostate cancer biomarker (Unrestricted research grant)]. Consultant/Advisory
Boards: GenomeDX [Prostate cancer biomarker (Genomic classifier test)];
Healthtronics [Cryotherapy]. Equity Ownership/Stock Options: GenomeDX [Prostate
cancer biomarker (Genomic classifier test)]."},{"name":"Douglas S Ross,
MD","credentials":["Section Editor — Thyroid Disease\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board:
Medullary Thyroid Cancer Registry Consortium [Thyroid cancer]; Shire
[Hypoparathyroidism (Parathyroid hormone for injection)]; Spectrix Therapeutics,
LLC [Hypothyroidism (Thyroid hormone)]. Other Financial Interests: Abbott India
(honorarium) [Hyperthyroidism (carbimazole, levothyroxine)]; Quest Diagnostics
(honorarium) [Hyperthyroidism]."},{"name":"Michael E Ross, MD","credentials":
["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology"],"disclosure":""},
{"name":"Nan Rothrock, PhD","credentials":["Research Associate
Professor\n","Medical Social Sciences\n","Feinberg School of
Medicine\n","Northwestern University"],"disclosure":""},{"name":"Peter P Roy-Byrne,
MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive
Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of
Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society
(journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock
Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"James L
Rubenstein, MD, PhD","credentials":["Professor of Medicine, Division of
Hematology/Oncology\n","University of California, San
Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma
(Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Kathryn J Ruddy, MD,
MPH","credentials":["Director of Cancer Survivorship\n","Associate Professor of
Oncology\n","Mayo Clinic"],"disclosure":""},{"name":"Michelle A Rudek, PharmD,
PhD","credentials":["Associate Professor of Oncology\n","Director of the Analytical
Pharmacology Core Lab\n","Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Drug
analysis (5-azacitidine,
romidepsin)]; Taiho Pharmaceutical [Organ dysfunction (TAS-102)]; RenovoRx [Drug
analysis]. Other Financial Interest: Otsuka [Honorarium]. Equity Ownership/Stock
Options (spouse/partner): Novavax; Amplimmune. Employment (spouse/partner): Novavax
[Vaccines to treat infectious diseases] - No relevant conflict on topic."},
{"name":"Charles M Rudin, MD, PhD","credentials":["Chief, Thoracic Oncology
Service\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Hope
S Rugo, MD","credentials":["Professor of Medicine\n","UCSF Helen Diller Family
Comprehensive Cancer Center"],"disclosure":""},{"name":"Carolyn D Runowicz,
MD","credentials":["Executive Associate Dean for Academic Affairs\n","Professor of
Obstetrics and Gynecology\n","Florida International University\n","Herbert Wertheim
College of Medicine"],"disclosure":""},{"name":"Bruce A Runyon, MD","credentials":
["Section Editor — Cirrhosis and Its Complications\n","Special Hepatology
Consultant to the Indian Health Service \n","Northern Navajo Medical Center,
Shiprock, New Mexico"],"disclosure":""},{"name":"Erich W Russi, MD","credentials":
["Professor of Medicine\n","University Hospital, Switzerland"],"disclosure":""},
{"name":"Andrea L Russo, MD","credentials":["Assistant Professor\n","Harvard
Medical School\n","Department of Radiation Oncology\n","Massachusetts General
Hospital"],"disclosure":""},{"name":"Jose Russo, MD","credentials":["Senior
Member\n","Director Breast Cancer Research\n","Fox Chase Cancer
Center"],"disclosure":""},{"name":"Charles J Ryan, MD","credentials":["Professor of
Clinical Medicine and Urology\n","UCSF/Helen Diller Family Comprehensive
Cancer"],"disclosure":"Grant/Research/Clinical Trial Support: Karyopharm [Prostate
cancer (Selinexor)]; Clovis Oncology [Prostate cancer (Rucaparib)]. Speaker's
Bureau: Janssen [Prostate cancer (Abiraterone)]; Astellas [Prostate cancer
(Enzalutamide)]. Consultant/Advisory Boards: Astra Zeneca [Prostate cancer
(Olaparib)]; Asana [Prostate cancer]; Bayer [Prostate cancer (Rad223)]; Sanofi
[Prostate cancer]; Churchill Pharmaceuticals [Prostate cancer (Abiraterone
Solumatrix)]."},{"name":"Christopher W Ryan, MD","credentials":
["Professor\n","Oregon Health & Science University\n","Knight Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Eisai [Sarcoma
(Eribulin)]; Janssen [Sarcoma (Trabectedin)]; Bayer [Sarcoma (Sorafenib)];
Threshold [Sarcoma (Investigational agent)]; Tracon [Renal carcinoma
(Investigational agent)]; GSK/Novartis [Sarcoma (Pazopanib)]; Argos Therapeutics
[Renal carcinoma (Investigational agent)]; Bristol Myers Squib [Renal carcinoma
(Nivolumab, ipilumumab)]; CytRx [Sarcoma (Investigational agent)]; Exelexis [Renal
carcinoma (Cabozantinib)]; MabVax [Sarcoma (Investigational agent)]; Morphotek
[Sarcoma (Investigational agent)]; OSI [Renal carcinoma (Erlotinib)]; Ziopharm
[Sarcoma (Investigational agent)]; Daiichi [Sarcoma (Investigational agent)];
Pfizer [Renal carcinoma (sunitinib)]. Consultant/Advisory Boards: Eisai [Sarcoma
and renal carcinoma (Eribulin)]; Karyopharm [Sarcoma (No commercial drug)]; EMD-
Serono [Sarcoma (No commercial drug)]; Pfizer [Renal carcinoma (N/A)]; Janssen
[Sarcoma (Trabectedin)]; Onyx [Renal carcinoma (N/A)]; Exelixis [Renal carcinoma
(N/A)]; Novartis[Renal carcinoma (pazopanib)]."},{"name":"David P Ryan,
MD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: MPM Capital [Drug
development (Clinical trials)]."},{"name":"Nabil F Saba, MD, FACP","credentials":
["Professor, Department of Hematology and Medical Oncology\n","Director of Head and
Neck Oncology \n","Winship Cancer Institute of Emory
University"],"disclosure":"Consultant/Advisory Boards: BMS; Pfizer [Development of
head and neck cancer (Nivolumab)]; Merck [development of head and neck cancer
(pembrolizumab)]; Lilly [development of head and neck cancer (cetuximab)]; Pfizer
[development of head and neck cancer (avelumab)]."},{"name":"Paul Sabbatini,
MD","credentials":["Attending Physician\n","Gynecologic Medical Oncology
Service\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol M Squibb
[ovarian cancer (nivolumab)(immunologic trial )]."},{"name":"Michael S Sabel,
MD","credentials":["Associate Professor of Surgery\n","University of Michigan
Medical School"],"disclosure":""},{"name":"A Mazin Safar, MD","credentials":
["Associate Professor of Medicine\n","University of Arkansas for Medical
Sciences"],"disclosure":""},{"name":"Sunil K Sahai, MD, FAAP, FACP","credentials":
["Associate Professor of Medicine\n","Department of General Internal
Medicine\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Wasif M Saif,
MD","credentials":["Professor of Medicine\n","Tufts University School of
Medicine\n","Director, Gastrointestinal Oncology Program\n","Leader, Experimental
Therapeutics Program\n","Tufts Medical Center Cancer
Center"],"disclosure":"Grant/Research/Trial Support: Taiho [Colorectal cancer
(trifluridine and tipiracil hydrochloride)]; Genetech [Colorectal cancer
(FOLFOXIRI-bevacizumab versus FOLFOX-BEV for the first-line treatment)]; Celgene
[Pancreatic cancer (Metronomic fluorouracil in Combination With nab-paclitaxel,
bevacizumab, leucovorin, and oxaliplatin)]; Pharmcyclic [Blood cancers and immune-
mediated disorders (Ibrutinib)]; NanoCarrier [Various types of cancer (Cisplatin)];
Ipsen [Neuroendocrine tumors (Somatuline depot)]. Speaker's Bureau: Genentech
[Colorectal cancer (Bevacizumab)]; Amgen [Colorectal cancer (Panitumumab)];
Novartis [Pancreatic cancer (Everolimus)]; Ipsen [Pancreatic cancer (Lanreotide)];
Celgene [Pancreas (Paclitaxel)]; Lexicon [Neuroendocrine tumors (Xermalo)].
Consultant/Advisory Boards: EMD Sereno [Pancreatic cancer]."},{"name":"Joseph K
Salama, MD","credentials":["Associate Professor\n","Department of Radiation
Oncology\n","Duke University Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Non-small
cell lung cancer (Veliparib)]. Grant/Research/Clinical Trial Support (Spouse):
Bristol-Myers Squibb [Melanoma (Ipilimumab)]; Merck [Melanoma (PD-1 inhibition)];
Genentech [Melanoma]; Celldex [Melanoma]; Immunocore [Melanoma]; Reata
Pharmaceuticals [Melanoma]. Consultant/Advisory Boards: Bristol-Myers Squibb."},
{"name":"Benjamin E Saltman, MD","credentials":["Assistant Professor of
Otolaryngology\n","Division of Head and Neck Surgery\n","Hofstra North Shore LIJ
School of Medicine"],"disclosure":""},{"name":"John R Saltzman, MD, FACP, FACG,
FASGE, AGAF","credentials":["Section Editor — Therapeutic and Diagnostic
Endoscopy\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Wolfram E Samlowski, MD","credentials":["Comprehensive Cancer Centers of
Nevada (Las Vegas)\n","Clinical Professor\n","University of Nevada
(Reno)"],"disclosure":"Speaker’ s Bureau: BMS; Merck; Pfizer; Novartis [renal cell
carcinoma (trametinib, pembrolizumab, ipilimumab, nivolumab, dabrafenib)].
Consultant/Advisory Board: Pfizer [renal cell carcinoma (sunitunib, axitinib)];
Castle Biosciences [molecular testing for melanoma]."},{"name":"Hanna K Sanoff, MD,
MPH","credentials":["Associate Professor\n","University of North Carolina at Chapel
Hill"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Colorectal
cancer (Regorafenib, Sorafenib)]; Merck [Colorectal cancer (Pembrolizumab)];
Precision Biologics [Colorectal cancer (No approved agents)]."},{"name":"A Oliver
Sartor, MD","credentials":["Laborde Professor for Cancer Research\n","Medical
Director, Tulane Cancer Center\n","Depts. of Medicine and Urology\n","Tulane
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer
[Prostate cancer (Radium-223)]; Endocyte [Prostate cancer (EC1169)]; Innocrin
[Prostate cancer (VT464)]; Johnson & Johnson [Prostate cancer (Abiraterone)];
Sanofi-Aventis [Prostate cancer (Cabazitaxel)]; Merk [Prostate cancer].
Consultant/Advisory Boards: AstraZeneca [Prostate cancer]; Bayer [Prostate cancer
(Radium-223)]; Bellicum [Prostate cancer (vaccine development)]; Bristol-Myers
Squibb [Prostate cancer (Nivolumab)]; Celgene [Prostate cancer (Lenalidomide)];
Dendreon [Prostate cancer (Sipuleucel-T)]; EMD Serono [Prostate cancer]; Johnson &
Johnson [Prostate cancer (ARN-509, abiraterone)]; OncogeneX [Prostate cancer
(Custirsen)]; Pfizer [Prostate cancer]; Sanofi-Aventis [Prostate cancer
(Cabazitaxel)]; Tokai [Prostate cancer (Galeterone)]; NRG Oncology [Genitourinary
cancer (Co-chairman of Genitourinary cancer committee)]; Constellation [Prostate
cancer]; Endocyte [Prostate cancer]; Advanced Accelerator Applications [Prostate
cancer]; Bavarian-Nordic [Prostate cancer]."},{"name":"Diane MF Savarese,
MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology
and Palliative Care\n","Clinical Instructor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Philip Saylor, MD","credentials":["Assistant
Professor of Medicine \n","Harvard Medical School\n","Assistant
Physician\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Mark T
Scarborough, MD","credentials":["Department of Orthopaedics and
Rehabilitation\n","University of Florida College of Medicine"],"disclosure":""},
{"name":"Steven J Scheinman, MD","credentials":["President and Dean, Professor of
Medicine\n","Geisinger Commonwealth School of Medicine"],"disclosure":""},
{"name":"Bradley Schiff, MD","credentials":["Associate Professor\n","Albert
Einstein College of Medicine"],"disclosure":""},{"name":"David Schiff,
MD","credentials":["Professor of Neurology, Neurological Surgery, and
Medicine\n","University of Virginia School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Cavion [GBM
(Mibefradil)]; Tocagen [GBM, AA (Toca 511)]; Bayer [IDHmt gliomas (BAY 1436032)];
BeiGene [GBM (BGB-290)].
Consultant/Advisory Boards: Orbus [AA (Eflornithine)]; Monteris [GBM (LITT
probe)]."},{"name":"Rachel Schiff, PhD","credentials":["Associate
Professor\n","Breast Center\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astra Zeneca
[Kinase inhibitors, PARP inhibitors, oral anti-estrogen SERD (AZD 5363, AZD 2014,
AZD 6244, Olaparib)]; Gilead [Endocrine therapy BET inhibitor (GS-649629, GS-
626510). Consultant/Advisory Boards: E. Lilly [CDK4/6 inhibitor (Abemaciclib (a one
time))]."},{"name":"Charles A Schiffer, MD","credentials":["Professor of Medicine
and Oncology\n","Barbara Ann Karmanos Cancer Institute\n","Wayne State University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis,
BMS, Ariad [CML (imatinib, nilotinib, dasatinib, ponatinib)]. Consultant/Advisory
Boards: Celgene [AML, thrombotic complications (5-azacytidine, lenalidomide)];
Pfizer [CML (bosutinib)]; Takeda; Ambit; Pharmacyclics; Juno; Astellas [DSMB
thrombotic complications]."},{"name":"Steven E Schild, MD","credentials":["Section
Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Kathleen M Schmeler,
MD","credentials":["Associate Professor\n","Department of Gynecologic
Oncology\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Arthur B
Schneider, MD, PhD","credentials":["Professor Emeritus of Medicine\n","University
of Illinois at Chicago College of Medicine"],"disclosure":""},{"name":"John O
Schorge, MD","credentials":["Gynecologic Oncologist\n","Obstetrics and
Gynecology\n","Gynecologic Oncology\n","Tufts Medical Center"],"disclosure":""},
{"name":"Anne F Schott, MD","credentials":["Professor of Medicine\n","University of
Michigan"],"disclosure":""},{"name":"Kasmintan A Schrader, MBBS, FRCPC,
PhD","credentials":["Medical Genetics\n","University of British
Columbia"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":["Editor-
in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood
Cell Disorders\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Iris Schrijver, MD","credentials":["Adjunct
Professor of Pathology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Jonathan M Schwartz, MD","credentials":
["Professor of Clinical Medicine\n","Montefiore Medical Center/Albert Einstein
College of Medicine"],"disclosure":""},{"name":"Peter E Schwartz,
MD","credentials":["Professor of Obstetrics, Gynecology and the Reproductive
Sciences\n","Yale University School of Medicine"],"disclosure":""},{"name":"Angeles
Alvarez Secord, MD","credentials":["Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Ovarian
cancer (veliparib)]; Amgen [Ovarian cancer (trebananib)]; Astellas Pharma [Ovarian
cancer (linsitinib)]; Astex Pharmaceuticals [Ovarian cancer (guadecitabine)];
AstraZeneca [Ovarian cancer (oliparib)]; Boerhinger Ingelheim [ovarian cancer
(nintedanib)]; Bristol Myers Squibb [Ovarian cancer (ipilimumab)]; Eisai [Ovaryian
(lenvatinib)]; Endocyte [Ovarian cancer (farletuzumab)]; Exelixis [Ovarian cancer
(cabozantinib)]; Incyte [Ovarian cancer (acadostat); Merck [Ovarian cancer
(pembrolizumab)]; PharmaMar [Ovarian cancer (lurbinectedin)]; Prima Biomed [Ovarian
cancer (CVac)]; Roche/Genentech [Endometrial cancer (bevacizumab)]; TESARO [Ovarian
cancer (niraparib)]. Consultant/Advisory Boards: Alexion [Endometrial cancer];
Astex [Ovarian cancer (guadecitabine)]; AstraZeneca [Ovarian cancer (olaparib)];
Clovis [Ovarian cancer (rucaparib)]; Janssen/Johnson & Johnson [Uterine
sarcoma/ovarian cancer (trabectadin)]; Roche/Genentech [Endometrial cancer
(atezolizumab/bevacizumab)]; TESARO [Ovarian cancer (niraparib)]."},{"name":"Pearl
H Seo, MD, MPH","credentials":["Assistant Professor\n","Sylvester Cancer
Center\n","University of Miami School of Medicine"],"disclosure":""},{"name":"Lecia
V Sequist, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard
Medical School"],"disclosure":"Grant/Research/Clinical Trail Support: AstraZeneca;
Boehringer Ingelheim; Genentech; Merrimack; Novartis; Pfizer; Incyte Corporation
[Lung cancer (Multiple anti-cancer therapies)]. Consultant/Advisory Boards:
AstraZeneca; Boehringer Ingelheim; Genentech; Merrimack; Novartis; Pfizer [Lung
cancer (Multiple anti-cancer therapies)]."},{"name":"F John Service, MD,
PhD","credentials":["Emeritus Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Sanjeev Sethi, MD, PhD","credentials":
["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Joshua Shadd, MD, CCFP","credentials":
["Assistant Professor, Division of Palliative Care, Department of Family
Medicine\n","McMaster University Faculty of Health Sciences"],"disclosure":""},
{"name":"Mark Edwin Shaffrey, MD","credentials":["Professor and Chairman \n","UVA
Health System\n","Department of Neurological Surgery"],"disclosure":""},
{"name":"Mehnaz A Shafi, MD","credentials":["Professor of Medicine\n","Department
of Gastroenterology, Hepatology and Nutrition\n","MD Anderson Cancer
Center"],"disclosure":""},{"name":"Elizabeth Shane, MD","credentials":["Professor
of Medicine\n","Columbia University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis
(denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},
{"name":"Melissa L Shannon, MD","credentials":["Staff Physician\n","Catholic Health
Initiatives\n","St Vincent Health System"],"disclosure":""},{"name":"Charles L
Shapiro, MD","credentials":["Professor of Medicine\n","Director of Translational
Breast Cancer Research\n","Director of Cancer Survivorship, Tisch Cancer
Institute"],"disclosure":""},{"name":"Shahrokh F Shariat, MD, PhD","credentials":
["Professor and Chairman \n","Department of Urology\n","Medical University of
Vienna\n","Adjunct Professor of Urology and Medical Oncology\n","Weill Medical
College of Cornell University\n","Adjunct Professor of Urology\n","University of
Texas Southwestern Medical Center"],"disclosure":"Consultant/Advisory Boards:
Astellas [Prostate cancer (Enzalutamide)]; AstraZeneca [Bladder cancer
(Durvalumab)]; Bristol-Myers Squibb [Bladder cancer (Nivolumab)]; Cepheid [Bladder
cancer (Urine test)]; Ipsen [Bladder cancer (Optical imaging agent)]; Ipsen
[Prostate cancer (Triptorelin)]; Janssen [Prostate cancer (Abiraterone)]; Janssen
[Bladder cancer (FGFR antibody)]; Merck & Co., Inc. [Bladder cancer
(Pembrolizumab)]; Olympus [Bladder cancer (Endoscopes)]; Pfizer [Kidney cancer
(Sunitinib)]; Pierre Fabre [Bladder cancer (Vinflunine)]; Richard Wolf [Endoscopy
(Endoscopes)]; Roche [Bladder cancer (Atezolizumab)]; Sanochemia [Bladder cancer
(Hypericin)]; Sanofi [Prostate cancer (Cabazitaxel)]."},{"name":"Alice T Shaw, MD,
PhD","credentials":["Massachusetts General Hospital Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Pfizer [ALK inhibitor
(Crizotinib, Lorlatinib)]; Novartis [ALK inhibitor (Ceritinib)]; Ariad [ALK
inhibitor (Brigatinib)]; Genentech [ALK inhibitor (Alectinib)]; Ignyta [ALK
inhibitor (Entrectinib)]; Roche [ALK inhibitor (Alectinib)]; Chugai [ALK inhibitor
(Alectinib)]."},{"name":"David J Sher, MD, MPH","credentials":["Associate Professor
of Radiation Oncology\n","UT Southwestern Medical Center"],"disclosure":""},
{"name":"Amandeep Shergill, MD, MS","credentials":["Associate Clinical Professor of
Medicine\n","University of CA, San Francisco/ San Francisco VA
Medical"],"disclosure":"Grant/Research/Clinical Trial Support: Pentax [Ergonomics
(Endoscopic ergonomics)]."},{"name":"Eric J Sherman, MD","credentials":["Assistant
Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Clinical Trial
Support: Eisai [Thyroid cancer (Lenvatinib)]; Roche [HNSCC
((obimetinib/atezolizumab)]. Consultant/Advisory Boards: Eisai [Thyroid cancer
(Lenvatinib)]; Bristol-Myers Squibb [Head and neck cancer (Nivolumab)]; Novartis
[Thyroid cancer (dabrafenib/trametinib)]."},{"name":"Steven I Sherman,
MD","credentials":["Associate Vice Provost, Clinical Research\n","Chair and Naguib
Samaan Distinguished Professor in Endocrinology\n","University of Texas MD Anderson
Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme
[Thyroid cancer (Thyrotropin alfa)]. Consultant/Advisory Boards: Eisai [Thyroid
cancer (Lenvatinib)]; Exelixis [Thyroid cancer (Cabozantinib)]; Novo Nordisk
[Diabetes (Liraglutide)]; Veracyte [Thyroid cancer (Thyroid FNA analysis)];
Bristol-Myers Squibb [Thyroid cancer (Nivolumab)]; Loxo Oncology [Thyroid cancer
(LOXO105)]; Genzyme [Thyroid cancer (Thyrotropin alfa; vandetanib)]."},
{"name":"David Shibata, MD","credentials":["Professor and Chair\n","Department of
Surgery\n","University of Tennessee Health Science Center"],"disclosure":""},
{"name":"Helen A Shih, MD","credentials":["Associate Professor of Radiation
Oncology\n","Harvard Medical School\n","Attending Radiation
Oncologist\n","Massachusetts General Hospital"],"disclosure":"Consultant/Advisory
Boards: Genentech [Lung cancer]. Other Financial Interest: International Journal of
Radiation Oncology Biology Physics [CNS (senior editor, CNS section)]."},
{"name":"Karin K Shih, MD","credentials":["Hofstra University School of
Medicine"],"disclosure":""},{"name":"Dong Moon Shin, MD, FACP","credentials":
["Emory University School of Medicine\n","Frances Kelly Blomeyer Distinguished
Chair in Cancer Research\n","Professor and Executive Vice Chair, Department of
Hematology and Medical Oncology\n","Associate Director, Academic
Development\n","Adjunct Professor of Biomedical Engineering, The Wallace H. Coulter
Departm"],"disclosure":"Grant/Research/Clinical Trial Support: Tarceva
[Chemoprevention of the head and neck (Astellas)]; Bristol-Myers
Squibb [Recurrent metastatic head and neck cancer (Nivolumab, ipilimumab)]."},
{"name":"Jason M Shohet, MD, PhD","credentials":["Division Chair, Pediatric
Hematology/Oncology\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Alexander N Shoushtari, MD","credentials":
["Assistant Attending Physician\n","Memorial Sloan Kettering Cancer
Center\n","Instructor\n","Weill Medical College of Cornell
University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers
Squibb [Immunotherapy (Ipilimumab, nivolumab)]. Consultant/Advisory Boards:
Vaccinex [Immunotherapy (N/A)]; Castle Biosciences [Immunotherapy (N/A)];
Immunocore [Immunotherapy (IMCgp100)]; Bristol-Myers Squibb [Immunotherapy
(Ipilimumab, nivolumab)]."},{"name":"Brian Shuch, MD","credentials":["Assistant
Professor\n","Department of Urology\n","Yale School of Medicine"],"disclosure":""},
{"name":"William M Sikov, MD, FACP","credentials":["Associate Professor of
Medicine\n","Obstetrics and Gynecology\n","Warren Alpert Medical School of Brown
University"],"disclosure":"Speakers Bureau: Eisai [Metastatic Breast cancer
(eribulin). Consultant Advisory Board: Celgene [neaodjuvant therapy (nab-
paclitaxel)]; Abbvie [neaodjuvant therapy (veliparib)]."},{"name":"Shonni J
Silverberg, MD","credentials":["Professor of Medicine\n","Columbia University
College of Physicians and Surgeons"],"disclosure":""},{"name":"Amit G Singal,
MD","credentials":["Associate Professor of Medicine\n","UT Southwestern Medical
Center, Dallas TX"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie
[Hepatitis C]; Speaker's Bureau: Gilead [Hepatitis C (Velpatasvir, sofosbuvir,
ledipasvir)]; Bayer [HCC (Sorafenib)]; BMS [HCC (Nivolumab)]. Consultant/Advisory
Boards: Bayer [HCC (Sorafenib)]; Eisai [HCC (Lenvatinib)]; Roche [HCC biomarkers];
Wako Diagnostics [HCC biomarkers]."},{"name":"Ted A Skolarus, MD, MPH,
FACS","credentials":["Associate Professor of Urology\n","University of
Michigan\n","Research Investigator\n","VA HSR&D Center for Clinical Management
Research\n","VA Ann Arbor Healthcare System"],"disclosure":""},{"name":"Priscilla J
Slanetz, MD, MPH, FACR","credentials":["Associate Professor of
Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Alexander Smith,
MD","credentials":["Associate Professor of Medicine\n","University of California,
San Francisco"],"disclosure":""},{"name":"Joseph A Smith, MD","credentials":
["Professor and Chairman of Urologic Surgery\n","Vanderbilt University School of
Medicine"],"disclosure":""},{"name":"Matthew R Smith, MD, PhD","credentials":
["Professor of Medicine\n","Harvard Medical School\n","Massachusetts General
Hospital Cancer Center"],"disclosure":""},{"name":"Richard Smith,
MD","credentials":["Professor and Vice-Chair, Otorhinolaryngology-Head and Neck
Surgery\n","Albert Einstein College of Medicine, Montefiore Medical
Center"],"disclosure":"Speaker's Bureau: Medical Education Speakers Network
(thyroid nodules). Other Financial Interest: [Education Coordinator, American
Academy of Otolaryngology-Head and Neck Surgery]."},{"name":"Claire Snyder,
PhD","credentials":["Professor of Medicine\n","Division of General Internal
Medicine\n","Johns Hopkins School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech
[Survivorship care planning (JourneyForward survivorship care plan tools)].
Consultant/Advisory Boards: Caret MD [Cancer disease management (Electronic disease
management technology)]; Tower Health [Care delivery system].
Equity/Ownership/Stock Options: Immunomedics [Cancer (Cancer treatments)]."},
{"name":"Peter J Snyder, MD","credentials":["Editor-in-Chief —
Endocrinology\n","Section Editor — Pituitary Disease; Male Reproductive
Endocrinology\n","Professor of Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie
[Hypogonadism (Testosterone gel)]; Novo Nordisk [Growth hormone (Somatropin)];
Novartis [Cushing's (LCI699)]; Cortendo [Cushing's]. Consultant/Advisory Boards:
AbbVie [Hypogonadism (Testosterone gel)]; Novartis [Cushing's (LCI699)]; Pfizer
[Acromegaly (Pegvisomant)]; Watson [Testosterone (Testosterone gel)]."},
{"name":"Carl Snyderman, MD, MBA","credentials":["Professor, Departments of
Otolaryngology and Neurological Surgery\n","University of Pittsburgh School of
Medicine"],"disclosure":"Consultant/Advisory Boards: SPIWay, LLC [Endoscopic
endonasal surgery of the skull Base (SPIWay Endonasal Access Guide)]. Equity
Ownership/Stock Options: SPIWay, LLC [Endoscopic Endoscopic endonasal surgery of
the skull Base (SPIWay Endonasal Access Guide)]."},{"name":"Jonas M Sokolof,
DO","credentials":["Assistant Professor\n","Department of Rehabilitation
Medicine\n","Weill College of Medicine of Cornell University\n","Assistant
Attending Physician \n","Department of Neurology/Rehabilitation
Services\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},
{"name":"Benjamin Solomon, MBBS, PhD","credentials":["Medical Oncologist\n","Peter
MacCallum Cancer Centre"],"disclosure":"Consultant/Advisory Boards: Pfizer [Lung
cancer, ALK inhibitors (Crizotinib, lorlatinib)]; Novartis [Lung cancer, ALK
inhibitors (Ceritinib)]; Roche [Lung cancer, ALK inhibitors (Alectinib)]."},
{"name":"Shiyu Song, MD, PhD","credentials":["Associate Professor of Radiation
Oncology\n","Virginia Commonwealth University Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: Seattle Genetics
[Cancer (Brentuxiam and total skin electron beam radiation)]."},{"name":"Guru
Sonpavde, MD","credentials":["Associate Professor of Medicine\n","Director,
Urologic Medical Oncology\n","UAB Comprehensive Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Onyx-Amgen [prostate
cancer (carfilzomib)]; Bayer [bladder cancer (regorafenib)]; Boehringer- Ingelheim
[penile cancer (afatinib)]; Celgene [bladder cancer (abraxane)]; Merck [penile
cancer (pembrolizumab)]; Pfizer [renal cancer (avelumab, sunitinib)]. Speaker's
Bureau: Clinical Care Options [prostate cancer (enzalutamide)]. Consultant/Advisory
Boards: Merck; Bayer; Genentech; Sanofi; GSK; Agensys; Novartis; Argos; Pfizer;
AstraZeneca; Exelixis; Eisai; BMS; Amgen [Bladder cancer, prostate cancer, kidney
cancer (Pembrolizumab, atezolizumab, sunitinib, pazopanib, cabazitaxel, radium-223,
everolimus, cabozantinib, lenvatinib, durvalumab, nivolumab, ABP215)]."},
{"name":"Halfdan Sorbye, MD","credentials":["Professor of Medicine\n","Haukeland
University Hospital, Bergen, Norway"],"disclosure":"Grant/Research/Clinical Trial
Support: Novartis [neuroendocrine carcinoma (everolimus)]. Consultant/Advisory
Boards: Novartis [neuroendocrine carcinoma (everolimus)]."},{"name":"Jeffrey A
Sosman, MD","credentials":["Professor of Medicine\n","Robert H. Lurie Comprehensive
Cancer Center of Northwestern"],"disclosure":"Grant/Research/Clinical Trial
Support: Miomedical Valley [Cancer (BVD-523)]. Consultant/Advisory Boards: Gentech;
Meck; Array; Novartis [Cancer (no specific drugs, BRAFi, Vem, MEKi, Ribociclib,
Binimetinib, Pembrolizumab)]."},{"name":"Stuart J Spechler, MD","credentials":
["Chief, Division of Gastroenterology \n","Co-Director, Center for Esophageal
Diseases\n","Baylor University Medical Center at
Dallas\n","Investigator/Professor\n","Co-Director, Center for Esophageal
Research\n","Baylor Scott and White Research
Institute"],"disclosure":"Consultant/Advisory Board: Ironwood Pharmaceuticals [GERD
(Linaclotide)]; Takeda Pharmaceuticals [GERD (Lansoprazole, dexlansoprazole)]."},
{"name":"Ulrich Specks, MD","credentials":["Professor of Medicine, Mayo Clinic
College of Medicine\n","Division of Pulmonary and Critical Care Medicine, Mayo
Clinic Rochester"],"disclosure":""},{"name":"Steven M Sperry, MD","credentials":
["Assistant Professor\n","Head & Neck Oncology and Reconstructive Surgery\n","Dept
of Otolaryngology—Head & Neck Surgery\n","University of Iowa Hospitals and
Clinics"],"disclosure":""},{"name":"Philippe E Spiess, MD, MS,
FRCSC","credentials":["Professor\n","Assistant chief of surgery\n","Moffitt Cancer
Center\n","The University of South Florida"],"disclosure":""},{"name":"Peter P
Stanich, MD","credentials":["Assistant Professor\n","Division of Gastroenterology,
Hepatology and Nutrition\n","Director, Section of Intestinal Neoplasia and
Hereditary Polyposis\n","The Ohio State University Wexner Medical
Center"],"disclosure":""},{"name":"Paul Stark, MD","credentials":["Professor of
Radiology\n","University of California San Diego"],"disclosure":""},{"name":"Graeme
S Steele, MBBCh, FCS","credentials":["Assistant Professor of Surgery\n","Harvard
Medical School"],"disclosure":""},{"name":"David P Steensma, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Celgene [MDS (Lenalidomide,
azacitidine)]; Janssen [AML (Experimental agent)]; Takada/Millennium [MDS (None)];
Tesaro [MDS (None)]; Otsuka [MDS (Decitabine)]; Acceleron [MDS (Experimental
agent)]; H3 Biosciences [MDS (Experimental agent)]."},{"name":"Jennifer A Stein,
MD, PhD","credentials":["Associate Professor of Dermatology\n","NYU School of
Medicine"],"disclosure":""},{"name":"Margaret M Steinhoff, MD","credentials":
["Professor of Pathology and Laboratory Medicine\n","The Warren Alpert Medical
School of Brown University"],"disclosure":""},{"name":"Kerstin M Stenson, MD,
FACS","credentials":["Professor of Otolaryngology\n","Chief, Head and Neck Cancer
Program, Rush University Medical Center\n","Department of Otolaryngology/Head and
Neck Surgery"],"disclosure":""},{"name":"Andrew J Stephenson, MD","credentials":
["Associate Professor\n","Cleveland Clinic Lerner College of Medicine\n","Chief,
Section of Urologic Oncology\n","Glickman Urological and Kidney
Institute"],"disclosure":""},{"name":"Daniel H Sterman, MD","credentials":
["Director, Division of Pulmonary,
Critical Care, and Sleep Medicine \n","NYU School of Medicine \n","NYU Langone
Medical Center"],"disclosure":""},{"name":"Cora N Sternberg, MD,
FACP","credentials":["Chief\n","Department of Medical Oncology\n","San Camillo and
Forlanini Hospitals\n","Rome, Italy"],"disclosure":"Grant/Research/Clinical Trial
Support: Lilly [Bladder cancer (Cyramza)]; Janssen [Bladder cancer
(JNJ42756493/Erdafitinib)]. Consultant/Advisory Boards: Bristol-Myers Squibb
[Bladder cancer (Nivolumab)]; Merck [Bladder cancer (Avelumab)]; Pfizer [Bladder
cancer (Avelumab)]; Clovis [Bladder cancer (Rucaparib)]."},{"name":"C Philip
Steuber, MD","credentials":["Professor of Pediatric Hematology and
Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Elizabeth A
Stewart, MD","credentials":["Consultant and Professor of Obstetrics and
Gynecology\n","Division of Reproductive Endocrinology, Department of Obstetrics and
Gynecology\n","Mayo Clinic and Mayo Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: NIH Grants [Uterine
fibroids (R01HD060503, P50 HS023418, R01HD074711, K12HD065987)].
Consultant/Advisory Boards: AbbVie [Uterine fibroids (Leuprolide acetate)];
Allergan [Uterine fibroids (None)]; Astellas Pharma [Uterine fibroids (None)];
Bayer Health Care [Uterine fibroids (Levonorgestrel IUS)]; Glaxo Smith Kline
[Adenomyosis (None)]; Gynesonics [Uterine fibroids (VizAblate (investigational in
US))]; Welltwigs [Infertility (None)]. Patent Holder: Methods and compounds for
treatment of abnormal uterine bleeding [Nowak RA, Stewart EA, US 6440445 (No
commercial activity)]."},{"name":"Stephan Stilgenbauer, MD","credentials":
["Professor of Medicine\n","Ulm University"],"disclosure":"Grant/Research/Clinical
Trial Support: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]);
Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL,
NHL [venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]);
Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]);
Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL,
NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab]).
Consultant/Advisory Boards: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL
[blinatumumab]); Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL
[lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab, obinutuzumab]);
Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL);
Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL [bendamustine]); Novartis
(CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche (CLL, NHL [venetoclax,
rituximab, obinutuzumab])."},{"name":"Thomas E Stinchcombe, MD","credentials":
["Associate Professor\n","University of North Carolina, Chapel
Hill"],"disclosure":""},{"name":"Wendy Stock, MD","credentials":["Professor of
Medicine\n","Pritzker School of Medicine of the University of
Chicago"],"disclosure":"Consultant/Advisory Boards: Pfizer [ALL (Inotuzumab)]; Jazz
[ALL (Erwinia asparaginase)]; Astellas [AML (Gilteritinib)]."},{"name":"Elena
Stoffel, MD, MPH","credentials":["Assistant Professor Internal Medicine, Division
of Gastroenterology\n","Director, Cancer Genetic Clinic\n","University of
Michigan"],"disclosure":""},{"name":"Michael Stone, MD","credentials":["Chairman of
Surgery\n","Stamford Hospital"],"disclosure":"Grant/Research/Clinical Trial
Support: Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease
(Rituximab)]; Xencor [IgG4-related disease (Xmab5871)]. Consultant/Advisory Boards:
Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)];
Xencor [IgG4-related disease (Xmab5871)]."},{"name":"Richard M Stone,
MD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis.
Consultant/Advisory Boards: Abbvie, Agios, Amgen, Celator, Celgene, Novartis,
Pfizer, Jazz, FujiFilm, Ono, Orsenix."},{"name":"Alison T Stopeck,
MD","credentials":["Professor of Medicine\n","Associate Director For Clinical and
Translational Research\n","Stony Brook Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Breast cancer
(Denosumab)]. Consultant/Advisory Boards: Amgen [Breast Cancer (Denosumab and
biosimilar therapeutics)], Novartis [Breast cancer (ribociclib)] , Sandoz [Breast
cancer (biosimilars)], Pfizer [Breast cancer (palbociclib and biosimilar
trastuzumab)]."},{"name":"E Alessandra Strada, PhD, MSCP, FT","credentials":
["Director of Integrative Medicine and Bereavement Services\n","MJHS Institute for
Innovation in Palliative Care, MJHS Hospice and Palliative Care, New York
City\n","Adjunct Associate Professor of East-West Psychology\n","California
Institute of Integral Studies, San Francisco\n","Adjunct Faculty, Postdoctoral
Ps"],"disclosure":""},{"name":"J Michael Straughn, Jr, MD","credentials":
["Professor\n","Division of Gynecologic Oncology\n","University of Alabama at
Birmingham"],"disclosure":""},{"name":"Carrie Tompkins Stricker, PhD,
RN","credentials":["Nurse Practitioner Division of
Hematology/Oncology\n","University of Pennsylvania Health System\n","Chief Clinical
Officer, Carevive Systems, Inc."],"disclosure":"Equity/Ownership/Stock Options:
Carevive Systems, Inc [Clinical decision support and care planning (Electronically
generated survivorship care plans)]. Employment: Carevive Systems, Inc [Clinical
decision support and care planning (Electronically generated survivorship care
plans)]."},{"name":"Jonathan R Strosberg, MD","credentials":["Associate
Professor\n","Department of Gastrointestinal Oncology\n","H. Lee Moffitt Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [NETs
(Octreotide, 177Lu-Dotatate)]. Speaker's Bureau: Ipsen [NETs (Lanreotide)]; LEXICON
[NETs (Telotristat)]. Consultant/Advisory Boards: Novartis [NETs (Octreotide,
177Lu-Dotatate)]."},{"name":"Keith E Stuart, MD","credentials":["Chairman,
Department of Hematology and Oncology\n","Lahey Hospital and Medical
Center\n","Professor of Medicine,\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"Michael D Stubblefield, MD","credentials":
["National Medical Director for Cancer Rehabilitation\n","Select Medical
Corporation\n","Medical Director for Cancer Rehabilitation\n","Kessler Institute
for Rehabilitation"],"disclosure":""},{"name":"Jack M Su, MD, MS","credentials":
["Associate Professor\n","Texas Children's Cancer Center\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Ryan J Sullivan, MD","credentials":
["Massachusetts General Hospital \n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Lilly [Melanoma
(LY3214996)]; Genentech [Melanoma (atezolizumab)]; Merck [Melanoma
(pembrolizumab)]; Viralytics [Melanoma (CVA-021)]; Novartis [Melanoma (dabrafenib,
trametinib)]; BMS [Melanoma (nivolumab)]; BioMed Valley Discoveries [Melanoma
(ulixertinib)]; Aelgea [Melanoma (AEB1102)]; Adaptimmune [Melanoma (MAGE-A10 TCR
product)]; Moderna [Melanoma (MRNA-2416)]; Immunocore [Melanoma (IMC-gp100-202)];
Sanofi [Melanoma (SAR439459, REGN2810)]. Consultant/Advisory Boards: Amgen
[Melanoma immunotherapy (TVEC and IO pipeline)]; Novartis [Melanoma immunotherapy
(Dabrafenib, trametinib)]; Roche-Genentech [Melanoma (Targeted therapy and
immunotherapy)]; Takeda [Melanoma (Immunotherapy toxicity)]; Merck [Melanoma
immunotherapy]."},{"name":"Christina Sun-Edelstein, MD, FRACP","credentials":
["Department of Clinical Neurosciences\n","St. Vincent's
Hospital"],"disclosure":""},{"name":"Arief Suriawinata, MD","credentials":
["Professor of Pathology and Laboratory Medicine\n","Geisel School of Medicine at
Dartmouth"],"disclosure":""},{"name":"Ritsuro Suzuki, MD, PhD","credentials":
["Associate Professor, Department of Oncology and Hematology\n","Shimane University
Hospital Cancer Center"],"disclosure":"Speaker's Bureau: Kyowa-Kirin [lymphoma (L-
asparaginase)]."},{"name":"Richard Swanson, MD","credentials":["Chief of
Surgery\n","Cambridge Health Alliance"],"disclosure":""},{"name":"Scott Swanson,
MD","credentials":["Professor of Surgery\n","Harvard Medical School\n","Director of
Minimally Invasive Thoracic Surgery\n","Brigham and Women's Hospital\n","Chief
Surgical Officer, Dana Farber Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Ethicon [lung
cancer (PATHWAY trial)]; Covidien [Minimally invasive surgery (support seminars and
training)]."},{"name":"Susan Swetter, MD","credentials":["Professor of
Dermatology\n","Director, Pigmented Lesion & Melanoma Program\n","Physician Leader,
Cancer Care Program in Cutaneous Oncology\n","Stanford University Medical Center
and Cancer Institute/\n","VA Palo Alto Health Care System"],"disclosure":""},
{"name":"Karen L Syrjala, PhD","credentials":["Fred Hutchinson Cancer Research
Center"],"disclosure":""},{"name":"Alphonse Taghian, MD, PhD","credentials":
["Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},
{"name":"Patricia Tai, MB, BS, DABR, FRCR, FRCPC","credentials":["Clinical
Oncologist\n","Clinical Professor\n","University of Saskatchewan\n","Canada
Department of Radiation Oncology\n","Allan Blair Cancer Center"],"disclosure":""},
{"name":"Martin S Tallman, MD","credentials":["Chief, Leukemia Service, Memorial
Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical
College"],"disclosure":""},{"name":"Kenneth K Tanabe, MD","credentials":["Section
Editor — Gastrointestinal Malignancies\n","Professor of Surgery\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Nimbus Therapeutics
[Hepatocellular carcinoma (ND654, Acetyl Co-A Carboxylase allosteric inhibitor)].
Consultant/Advisory Boards: Best Doctors [GI cancers; melanoma (Medical care)];
CRICO [Medical malpractice (Case review)]. Patent Holder: EGF SNP to determine
risk for HCC [Cirrhosis, hepatocellular carcinoma]; Use of EGFR inhibitors to
prevent HCC [Cirrhosis, hepatocellular carcinoma]. Equity Ownership/Stock Options:
Helix12 [Breast cancer (Company owns IP on selective estrogen receptor modulators
for breast cancer)]."},{"name":"Mary-Ellen Taplin, MD","credentials":["Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Janssen; Medivation/Pzier; Bayer; Clovis [Systemic therapy for rising PSA
(Zytiga, Xtandi, Xofigo, PARP inhibitors)]. Consultant/Advisory Boards: Janssen;
Clovis [Systemic therapy for rising PSA (Zytiga, Apalutamide, Niraparib)]."},
{"name":"Katherine Tarlock, MD","credentials":["Research Associate\n","Fred
Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Jerome B Taxy,
MD","credentials":["Clinical Professor of Pathology\n","University of Chicago
Pritzker School of Medicine"],"disclosure":""},{"name":"Nicholas P Taylor,
MD","credentials":["Section Chief of Gynecologic Oncology\n","St. Lukes
Hospital\n","Temple University"],"disclosure":""},{"name":"Henry D Tazelaar,
MD","credentials":["Consultant\n","Mayo Clinic Arizona\n","Professor of
Pathology\n","Mayo Clinic College of Medicine\n","Chair of the Department of
Laboratory Medicine and Pathology\n","Mayo Clinic Arizona"],"disclosure":""},
{"name":"Ayalew Tefferi, MD","credentials":["Professor of Medicine and
Hematology\n","Mayo Medical School"],"disclosure":""},{"name":"Theodoros N Teknos,
MD","credentials":["Professor and Chair\n","The Ohio State University Wexner
Medical Center"],"disclosure":""},{"name":"Clare M C Tempany, MD","credentials":
["Professor of Radiology\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [Liver
imaging]. Consultant/Advisory Boards: Profound Medical[Prostate gland cancer
ablation Device development]. Consultant/Advisory Board Member (Spouse): Echosens;
Ligand; Shionogi Gilead; Merck; [Liver disease]. Employment (Spouse): Chief
Medical Officer, Spring Bank Pharmaceuticals; Director, TRIO Healthcare. Equity
Ownership/Stock Options: Springbank; TRIO."},{"name":"Marita S Teng, MD,
FACS","credentials":["Associate Professor and Residency Program
Director\n","Department of Otolaryngology\n","Head & Neck Surgery Icahn School of
Medicine at Mount Sinai New York, NY"],"disclosure":""},{"name":"Amanda M
Termuhlen, MD","credentials":["Professor of Clinical Pediatrics\n","Keck School of
Medicine, University of Southern California"],"disclosure":""},{"name":"William P
Tew, MD","credentials":["Associate Member\n","Memorial Sloan Kettering Cancer
Center\n","Associate Professor of Medicine\n","Weill Medical College of Cornell
University\n","New York Presbyterian Hospital"],"disclosure":""},{"name":"Michael J
Thirman, MD","credentials":["Associate Professor of Medicine\n","Pritzker School of
Medicine of the University of Chicago"],"disclosure":""},{"name":"David M Thomas,
FRACP, PhD","credentials":["Medical Oncologist\n","Director, Kinghorn Cancer
Centre\n","Garvan Institute of Medical Research\n","National Health and Medical
Research Council Principal Research Fellow"],"disclosure":"Grant/Research/Clinical
Trial Support: Amgen [IL23 antibody]."},{"name":"Karl W Thomas, MD","credentials":
["Professor of Medicine - Pulmonary, Critical Care, Allergy and Immunology\n","Wake
Forest School of Medicine"],"disclosure":""},{"name":"Charles F Thomas, Jr,
MD","credentials":["Associate Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Robert D Timmerman, MD","credentials":
["Professor of Radiation Oncology and Neurosurgery\n","University of Texas
Southwestern"],"disclosure":"Grant/Research/Clinical Trial Support: Varian Medical
Systems [Clinical trials (TruBeam linear accelerator); Elekta Oncology [Clinical
trials (Agility, Versa linear accelerators)]; Accuray Incorporated [Clinical
trials(Cyberknife)]."},{"name":"Joseph A Toljanic, DDS","credentials":
["Professor\n","Midwestern University School of Dental Medicine"],"disclosure":""},
{"name":"Vicente E Torres, MD","credentials":["Professor of Medicine\n","Mayo
Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support
[Otsuka (ADPKD)]."},{"name":"William D Travis, MD","credentials":["Adjunct
Professor of Pathology\n","Weill Medical College - Cornell
University"],"disclosure":""},{"name":"Nathaniel S Treister, DMD,
DMSc","credentials":["Assistant Professor of Oral Medicine\n","Department of Oral
Medicine, Infection and Immunity\n","Harvard School of Dental Medicine\n","Division
of Oral Medicine & Dentistry\n","Brigham and Women's Hospital"],"disclosure":""},
{"name":"Anne S Tsao, MD","credentials":["Associate Professor\n","The University of
Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: MedImmune [Mesothelioma, non-small cell lung cancer]; Merck [Thymoma, non-
small cell lung cancer]; Bristol-Myers Squibb [Mesothelioma]; ARIAD [Non-small cell
lung cancer]; Seattle Genetics [Mesothelioma], Genentech [Non-small cell lung
cancer, mesothelioma]; Polaris Partners [Mesothelioma]; Boehringer Ingelheim
[Mesothelioma]. Consultant/Advisory Boards: Astellas Pharma [Mesothelioma, non-
small cell lung cancer]; Boehringer Ingelheim [Mesothelioma, non-small cell lung
cancer]; Eli Lilly and Company [Mesothelioma, non-small cell lung cancer];
Genentech [Mesothelioma, non-small cell lung cancer]; MedImmune [Mesothelioma, non-
small cell lung cancer]; Roche [Mesothelioma, non-small cell lung cancer],
AstraZeneca [Non-small cell lung cancer]."},{"name":"Hensin Tsao, MD,
PhD","credentials":["Section Editor — Melanocytic Lesions and Disorders of
Pigmentation\n","Professor of Dermatology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Epiphany Dermatology [Med
advisory board]."},{"name":"George Tsoulfas, MD","credentials":["Assistant
Professor of Surgery\n","Strong Memorial Hospital\n","University of Rochester
Medical Center"],"disclosure":""},{"name":"R Michael Tuttle, MD","credentials":
["Professor of Medicine\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":"Grant/Research Support: AstraZeneca [Thyroid cancer
(Selumetinib)]. Consultant/Advisory Boards: Bayer/Onyx [Thyroid cancer
(Sorafenib)]; Eisai [Thyroid cancer (Lenvatinib)]; Genzyme/Sanofi [Thyroid cancer
(Recombinant human TSH)]; Novo Nordisk [Thyroid cancer (Liraglutide)]; Roche
[Thyroid cancer (Thyroglobulin assay)]; Veracyte [Thyroid cancer (Gene
testing)]."},{"name":"Douglas Tyler, MD","credentials":["Chair\n","Department of
Surgery\n","University of Texas Medical Branch at
Galveston"],"disclosure":"Consultant/Advisory Boards: Castle Biosciences [Melanoma
(Gene signature risk predictor)]."},{"name":"Frederick Rand Ueland,
MD","credentials":["Professor of Gynecologic Oncology\n","Vice Chair, Department of
Obstetrics and Gynecology\n","Markey Cancer Center\n","University of
Kentucky"],"disclosure":""},{"name":"Renata R Urban, MD","credentials":["Assistant
Professor\n","Gynecologic Oncology\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"Eric Vallières, MD, FRCSC","credentials":
["Section Editor — Lung Cancer\n","Surgical Director of the Lung Cancer
Program\n","Swedish Cancer Institute"],"disclosure":""},{"name":"Martin van den
Bent, MD, PhD","credentials":["Daniel den Hoed Oncology Center\n","Neuro-Oncology
Unit"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Glioma
(ABT414)]. Consultant/Advisory Boards: AbbVie [Glioma (ABT414)]; Roche [Glioma
(Bevacizumab)]; Novartis [Glioma (IDH305)]; BMS [Glioma (Nivolumab)]; Celldex
(rindopepimut)."},{"name":"Richard A Van Etten, MD, PhD","credentials":["Professor
of Medicine\n","University of California, Irvine"],"disclosure":""},
{"name":"Catherine Van Poznak, MD","credentials":["Associate Professor Department
of Internal Medicine\n","University of
Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Bone
metastases (Ra223)]."},{"name":"Nicholas Vander Els, MD","credentials":["Assistant
Professor of Medicine\n","Cornell University Medical College"],"disclosure":""},
{"name":"Donald Vander Griend, PhD","credentials":["Assistant Professor of
Surgery\n","University of Chicago"],"disclosure":""},{"name":"Thomas J Vander Salm,
MD","credentials":["Clinical Professor\n","Harvard Medical
School"],"disclosure":""},{"name":"David J Vaughn, MD","credentials":["Professor of
Medicine\n","Abramson Cancer Center of the University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Bladder
cancer (Pembrolizumab)]; Genentech [Bladder cancer (Atezoliumab)]."},
{"name":"Adrian Vella, MD","credentials":["Professor of Medicine\n","Mayo
Clinic"],"disclosure":"Grant/Research Support: vTv Therapeutics [Diabetes]; XOMA
[Hypoglycemia]; Novo Nordisk [Diabetes (Liraglutide)]. Consultant/Advisory board:
vTv Therapeutics [Diabetes]."},{"name":"Shambhavi Venkataraman, MD","credentials":
["Instructor\n","Harvard Medical School\n","Staff Radiologist\n","Beth Israel
Deaconess Medical Center"],"disclosure":""},{"name":"Alan P Venook,
MD","credentials":["Professor of Clinical Medicine\n","University of California at
San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech
[colon cancer (Bbvacizumab)]; BMS [colon cancer (cetuximab). Consultant/Advisory
Boards: Genentech/Roche [colon cancer (bevacizumab)]; BMS [colon cancer
(cetuzimab)]."},{"name":"David M Vernick, MD","credentials":["Assistant Professor
of Otolaryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Nicholas
Vogelzang, MD","credentials":["Section Editor — Prostate Cancer\n","Professor of
Medicine\n","University of Nevada School of Medicine\n","US Oncology
Research"],"disclosure":"Speaker's Bureau: Pfizer [Kidney cancer (Sunitinib,
axitinib)]; Bayer [Prostate cancer (Radium 223)]; Novartis [Kidney cancer, PNET
(Pazopanib,
everolimus); Sanofi [Prostate cancer (Cabazitaxel)], BMS [Kidney cancer (BMS-
nivolumab)]; Genentech/Roche [Bladder cancer (Atezolizumab); Astra Zeneca {Bladder
cancer (durvalumab)]. Consultant/Advisory Boards: Amgen [Prostate cancer
(Denosumab)]; Bayer [Prostate cancer (Radium 223)]; Pfizer [Kidney cancer
(Sunitinib, axitinib)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus)];
Sanofi [Prostate cancer (cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)];
Genentech/Roche (Bladder cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer
(durvalumab)] Exelexis [Kidney cancer (Cabozantinib)]; Clinical Care Options,
Cerulean [Kidney cancer (Liposomal irinotecan)]; Dava Oncology/PER; Dendreon;
Medivation/Astellas [Prostate (Enzalutamide)], Janssen [Prostate cancer
(Abiraterone,apalutamide)]; Heron [Nausea control (Liposomal granisetron)]; Eisai
[Kidney cancer (Levantinib)]; Agensys [Kidney cancer (New targeted agent)];
Boehringer Ingelheim [Mesothelioma (Nerantinib)]. Employment: US Oncology [GU
research (none)]. Equity Ownership/Stock Options: Caris [Genetic testing for
cancer (none)]."},{"name":"Everett E Vokes, MD","credentials":["John E. Ultmann
Professor\n","Chairman, Department of Medicine\n","Physician-in-Chief, University
of Chicago Medicine and Biologic Sciences"],"disclosure":"Consultant/Advisory
Boards: Amgen [Head and neck and Lung (Epo)]; Ariad [Lung cancer]; AstraZeneca
[Head and neck and Lung (Immune Modulation)]; Bayer [Lung cancer]; Boehringer-
Ingelheim [Head and neck and Lung (Nintedanib, Afatinib)]; Celgene [Head and neck
and Lung (Abraxane)]; Eli Lilly [Head and neck and Lung (EGFR inhibition)];
Genentech [Head and neck and Lung (Immune modulation)]; Merck [Head and neck and
Lung (Immune modulation)]; VentiRx [Head and neck and Lung (Immune modulation)] ;
Abbvie [Lung]; Bristol Meyers Squibb [Lung, Head and Neck]; Leidos [Lung]; Novartis
[Lung]; Regeneron [Lung]; Serono [all tumor types]; Takeda [Lung]."},
{"name":"Sadhna R Vora, MD","credentials":["Deputy Editor — Oncology\n","Instructor
in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Heather Wakelee,
MD","credentials":["Associate Professor of Medicine\n","Stanford Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Clovis, Exelixis,
AstraZeneca, MedImmune, Genentech/Roche, Bristol-Myers Squibb, Gilead, Novartis,
Xcovery, Pfizer, Celgene, Pharmacyclics, Lilly Oncology, ACEA Oncology [Thoracic
Oncology]. Consultant/Advisory Boards: Novartis, Genentech, AstraZeneca
(uncompensated) [Thoracic Oncology]."},{"name":"Janet R Walczak, MSN, RN,
CRNP","disclosure":""},{"name":"Lisa L Wang, MD","credentials":["Associate
Professor\n","Pediatric Hematology and Oncology\n","Baylor College of
Medicine"],"disclosure":""},{"name":"John F Ward, MD, FACS","credentials":
["Associate Professor of Surgery\n","University of Texas MD Anderson Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Healthtronics [Prostate cancer,
kidney cancer (Cryoablation)]."},{"name":"Donald L Weaver, MD","credentials":
["Professor of Pathology\n","University of Vermont College of
Medicine"],"disclosure":""},{"name":"Randal S Weber, MD","credentials":["Professor
and Chairman\n","Department of Head and Neck Surgery \n","The University of Texas
MD Anderson Cancer Center"],"disclosure":""},{"name":"Harrison G Weed, MS, MD,
FACP","credentials":["Professor of Internal Medicine\n","The Ohio State University
College of Medicine"],"disclosure":""},{"name":"Steven E Weinberger,
MD","credentials":["Adjunct Professor of Medicine\n","University of Pennsylvania
School of Medicine\n","Executive Vice President and CEO Emeritus\n","American
College of Physicians"],"disclosure":""},{"name":"Gerald L Weinhouse,
MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Elisabeth Weiss, MD","credentials":["Associate
Professor\n","Department of Radiation Oncology\n","Virginia Commonwealth
University"],"disclosure":""},{"name":"Roy E Weiss, MD, PhD","credentials":
["Professor and Chairman\n","The University of Miami Miller School of
Medicine"],"disclosure":""},{"name":"William C Welch, MD, FACS,
FICS","credentials":["Professor of Neurosurgery\n","University of Pennsylvania
School of Medicine\n","Chief of Neurological Surgery\n","The Pennsylvania
Hospital"],"disclosure":"Equity Ownership/Stock Options: Transcendental Spine, LLC
(Spine products)."},{"name":"Corrine K Welt, MD","credentials":["Professor of
Medicine\n","University of Utah School of
Medicine"],"disclosure":"Consultant/Advisory Board: Novartis [Polycystic ovary
syndrome (Letrozole)]."},{"name":"Patrick Y Wen, MD","credentials":["Section Editor
— Neurooncology\n","Professor of Neurology\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta [Brain tumor
(ACP196); Agios [Brain tumor (AG120, AG881); Angiochem [Brain tumor (ANG1005);
AstraZeneca [Brain tumor (Vandetanib)]; Kadmon [Brain tumor 9tesevatinib);
Karyopharm [Brain tumor (Selinexor)]; Merck [Brain tumor (Pembrolizumab)]; Novartis
[Brain tumor (Trametanib, dabrafenib, BGJ398, INC208)]; Oncoceutics [Brain tumor
(ONC201)]; Vascular Biogenics [Brain tumor (VB111)]; Roche [Brain tumor
(Bevacizumab)]; Sanofi-Aventis [Brain tumor (Plerixafor)]. Speaker's Bureau: Merck
[Brain tumor]. Consultant/Advisory Boards: Agios [Brain tumor (AG120)]; Astra
Zeneca [Brain tumor]; Cavion [Brain tumor (Mibefradil)]; Cortice Biosciences [Brain
tumor (TP12887)]; Foundation Medicine [Brain tumor (none)]; Genentech/Roche [Brain
tumor (Bevacizumab)]; Monteris [Brain tumor (Neuroblate)]; Novartis [Brain tumor
(LDK298)]; Novogen [Brain tumor (GDC0084); Regeneron [Brain tumor (PD1
antibodies)]; Vascular Biogenics [Brain tumor (VB111)]; VBI Vaccines [Brain
tumors]."},{"name":"Barry L Wenig, MD, MPH","credentials":["Francis L. Lederer
Professor of Otolaryngology\n","Director of Head and Neck and Robotic
Surgery\n","University of Illinois College of Medicine at
Chicago"],"disclosure":""},{"name":"Howard J West, MD","credentials":["Section
Editor — Lung Cancer\n","Medical Director\n","Thoracic Oncology Program\n","Swedish
Cancer Institute (Seattle)"],"disclosure":"Speaker’s Bureau: BristolMyersSquibb
[Non-small cell lung cancer (Nivolumab)]; Genentech/Roche [Non-small cell lung
cancer (Atezolizumab)]. Consultant/Advisory Boards: AstraZeneca [Non-small cell
lung cancer (Gefitinib)]; Boehringer-Ingelheim [Non-small cell lung cancer
(Afatinib)]; BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)]; Celgene
[Non-small cell lung cancer (nab-paclitaxel)]; Genentech/Roche [Non-small cell lung
cancer (Alectinib, Atezolizumab, Erlotinib)]; Merck [Non-small cell lung cancer
(Pembrolizumab)]; Novartis [Non-small cell lung cancer (Ceritinib)]; Pfizer [Non-
small cell lung cancer (Crizotinib)]; Takeda [Non-small cell lung cancer (nab-
Paclitaxel, dabrafenib, trametinib, durvlumab)]."},{"name":"Julia White,
MD","credentials":["Professor and Vice Chair\n","Department of Radiation
Oncology\n","Klotz Sister Chair of Cancer Research\n","The James CCC, Ohio State
University"],"disclosure":""},{"name":"Louise Wilkins-Haug, MD, PhD","credentials":
["Section Editor — Prenatal Diagnosis and Genetics\n","Professor of Obstetrics,
Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},
{"name":"Rein Willemze, MD","credentials":["Professor and Chairman, Department of
Dermatology\n","Leiden University Medical Center"],"disclosure":""},
{"name":"Christopher G Willett, MD","credentials":["Section Editor — Radiation
Therapy\n","Professor\n","Duke University Medical
School"],"disclosure":"Consultant/Advisory Boards: Entrinsic Health [Esophageal,
stomach, pancreatic, and colorectal cancer and GIST (Amino acid medical foods, a
liquid solution that may improve mucosal reactions to chemotherapy and radiation
therapy)]."},{"name":"Aung Ko Win, MBBS, MPH, PhD","credentials":["Senior Research
Fellow\n","The University of Melbourne"],"disclosure":""},{"name":"John R Wingard,
MD","credentials":["Professor of Medicine\n","University of Florida College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal
drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs,
vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene
[CAR T-cell product]."},{"name":"Scott M Wirth, PharmD, BCOP","credentials":
["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker's
Bureau: Celgene Corporation [NSCLC, pancreatic cancer, breast cancer (Nab-
paclitaxel)]; Tesaro, Inc. [Gynecologic malignancies (Niraparib)]."},{"name":"Jedd
Wolchok, MD, PhD","credentials":["Chief \n","Melanoma and Therapeutics
Service\n","Memorial Sloan Kettering Cancer Center\n","\n","Professor of
Medicine\n","Weill Medical College of Cornell
University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers
Squibb; Merck; Medimmune; Genentech [Cancer immunotherapy (Ipilimumab, nivolumab,
pembrolizumab)]. Consultant/Advisory Boards: Bristol-Myers Squibb; Merck;
Medimmune; Genetech [Cancer immunotherapy (Ipilimumab, nivolumab,
pembrolizumab)]."},{"name":"Benjamin Wong, DSc, MD, PhD","credentials":["Honorary
Clinical Professor\n","Department of Medicine\n","University of Hong
Kong"],"disclosure":""},{"name":"Eric T Wong, MD","credentials":["Associate
Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Julia
S Wong, MD","credentials":["Assistant Professor of Radiation Oncology\n","Harvard
Medical School"],"disclosure":""},{"name":"Francis P Worden, MD","credentials":
["Professor\n","Department of Internal Medicine\n","Division of Hematology and
Oncology\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial
Support: Pfizer [Oncology (Axitinib)]; BMS [Oncology, metastatic head and neck
cancer (Nivolumab)]; Merck [Oncology,
head and neck cancer (Pembrolizumab and cisplatin and radiation)].
Consultant/Advisory Boards: Merck [Oncology, head and neck cancers
(Pembrolizumab)]."},{"name":"Cameron D Wright, MD","credentials":["Division of
Thoracic Surgery\n","Massachusetts General Hospital"],"disclosure":""},
{"name":"Jason D Wright, MD","credentials":["Sol Goldman Associate Professor of
Obstetrics and Gynecology \n","Chief, Division of Gynecologic Oncology
\n","Columbia University College of Physicians and
Surgeons"],"disclosure":"Consultant/Advisory Boards: Tesaro [Gynecologic cancer
(Drug development)]; Clovis Oncology [Gynecologic cancer (Drug development)]."},
{"name":"Jonathan L Wright, MD, MS","credentials":
["AssociateProfessor\n","Department of Urology\n","University of Washington School
of Medicine\n","Affiliate Investigator\n","Fred Hutchinson Cancer Research
Center"],"disclosure":""},{"name":"Matthew Wszolek, MD","credentials":["Instructor
of Urology\n","Harvard Medical School\n","Assistant in Urology\n","Massachusetts
General Hospital"],"disclosure":""},{"name":"Julian K Wu, MD","credentials":
["Professor of Neurosurgery\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"Peggy A Wu, MD","credentials":["Assistant
Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},
{"name":"Joachim Yahalom, MD","credentials":["Member and Professor of Radiation
Oncology\n","Memorial Sloan-Kettering Cancer Center \n","Cornell University Weill
College of Medicine"],"disclosure":""},{"name":"Motoko Yamaguchi, MD,
PhD","credentials":["Assistant Professor, Department of Hematology and
Oncology\n","Mie University Graduate School of Medicine"],"disclosure":""},
{"name":"Hideko Yamauchi, MD","credentials":["Adjunct Instructor\n","Department of
Breast and Endocrine Surgery,\n","Juntendo University School of
Medicine\n","Director of Breast Surgical Oncology\n","Breast Center\n","St. Luke's
International Hospital\n","Tokyo, Japan"],"disclosure":"Speaker's Bureau: Elsevier
Japan, Shionogi, Novartis, Pfizer, Galderma; Eisai; Taiho; AstraZeneca; Chugai
Pharmaceutical Co; Allergan Japan [Breast cancer]."},{"name":"Ximing J Yang, MD,
PhD","credentials":["Professor\n","Northwestern University Feinberg School of
Medicine\n","Chief of Urologic Pathology"],"disclosure":""},{"name":"Zhaohai Yang,
MD, PhD","credentials":["Associate Professor of Pathology\n","Penn State Health
Milton S. Hershey Medical Center\n","Penn State College of
Medicine"],"disclosure":""},{"name":"Catheryn Yashar, MD","credentials":["Associate
Professor of Radiation Medicine and Applied Sciences\n","University of California
San Diego"],"disclosure":""},{"name":"Sriram Yennurajalingam, MD","credentials":
["Associate Professor, Department of Palliative Care and Rehabilitation
Medicine\n","University of Texas, MD Anderson Cancer Center at
Houston"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [patient
experience]; Bayer [fatigue (fish oil and exercise)]; Helsinn [fatigue
(Anamorelin)]."},{"name":"Jean Chiyon Yi, PhD","credentials":["Fred Hutchinson
Cancer Research Center"],"disclosure":""},{"name":"Linwah Yip, MD","credentials":
["Associate Professor of Surgery\n","University of Pittsburgh School of
Medicine"],"disclosure":""},{"name":"Kaleb Yohay, MD","credentials":["Co-Director,
Comprehensive Neurofibromatosis Center\n","Department of Neurology\n","Division of
Child Neurology\n","NYU School of Medicine"],"disclosure":""},{"name":"Sue S Yom,
MD, PhD, MAS","credentials":["Associate Professor \n","Departments of
Radiation\n","Oncology and Otolaryngology\n","Head and Neck Surgery\n","University
of California, San Francisco School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Skin
cancer (Vismodegib)]; Bristol-Myers Squibb [Head and neck cancer (Nivolumab)];
Merck [Lung cancer (Pembrolizumab)]."},{"name":"David S Yoo, MD,
PhD","credentials":["Medical Instructor\n","Department of Radiation
Oncology\n","Duke University Medical Center"],"disclosure":""},{"name":"Harry H
Yoon, MD, MHS","credentials":["Associate Professor of Oncology,\n","Co-Chair,
Esophageal/Gastric Cancer Disease Group, \n","Mayo
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Eli Lilly
[Esophagogastric cancer (Ramucirumab)]; Merrimack [Esophagogastric cancer (MM-
111)]; Genetech/Roche [Esophagogastric cancer (Trastuzumab)]; Boston Biomedical
[Esophagogastric cancer (BBI608)]; Merck [Esophagogastric cancer (Pembrolizumab)].
Consultant/Advisory Boards: FivePrime Therapeutics [Esophagogastric cancer
(FPA144)]. Other Financial Interest: Eli Lilly [Esophagogastric cancer (CME
activity)]."},{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of
Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory
Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal
imaging)]."},{"name":"H Michael Yu, MD, ScM","credentials":["Associate Member,
Department of Radiation Oncology\n","H. Lee Moffitt Cancer Center and Research
Institute"],"disclosure":"Consultant/Advisory Boards: Novocure [Glioblastoma (tumor
treatment field)]; Abbvie [Glioblastoma (ABT-414 - not yet commercialized or on the
market)]."},{"name":"James L Zehnder, MD","credentials":["Professor of Pathology
and Medicine (Hematology)\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Novo Nordisk [Hemostasis
testing methods]; Novartis [Thrombopoietin agonists (Eltrombopag)]; Instrumentation
Laboratory [laboratory instrumentation (hemostasis testing methods)]."},
{"name":"Joseph Zenga, MD","credentials":["Fellow, Head and Neck Oncology and
Microvascular Reconstruction\n","Massachusetts Eye and Ear Infirmary\n","Harvard
Medical School"],"disclosure":""},{"name":"Michael R Zenn, MD, FACS","credentials":
["Adjunct Professor – Clinical Professor of Plastic Surgery\n","Duke University
Medical Center"],"disclosure":"Consultant/Advisory Boards: Stryker [ICG angiography
(Imaging system)]."},{"name":"Yanming Zhang, MD","credentials":
["Attending\n","Director of Cytogenetics Laboratory\n","Memorial Sloan Kettering
Cancer Center"],"disclosure":""},{"name":"Ming Zhou, MD, PhD","credentials":["Dr.
Charles T. Ashworth\n","Professor of Pathology\n","University of Texas
Southwestern"],"disclosure":""},{"name":"Oliver Zivanovic, MD","credentials":
["Attending Surgeon\n","Memorial Sloan Kettering Cancer Center\n","Assistant
Professor\n","Cornell Weill Medical College"],"disclosure":""},{"name":"Jeffrey
Zonder, MD","credentials":["Professor of Medicine and Oncology\n","Barbara Ann
Karmanos Cancer Institute\n","Wayne State University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene
[amyloidosis (lenalidomide, thalidomide, pomalidomide [IMiDs])].
Consultant/Advisory Boards: Celgene [myeloma, amyloidosis (IMiDs)]; Janssen
[myeloma, amyloidosis (daratumumab)]; BMS [myeloma, amyloidosis (elotuzumab)];
Seattle Genetics [myeloma, amyloidosis (investigational mAb)]; Takeda [myeloma,
amyloidosis (bortezomib, Ixazomib)]; Prothena [myeloma, amyloidosis (NEOD001)];
Amgen [myeloma, amyloidosis (carfilzomib)]. Other Financial Interest (contributor
and spouse): \tMMRF travel grant supported by Takeda and CURE magazine [Moving
Mountains for Multiple Myeloma Fundraising team for the MMRF]."}]},{"name":"Peer
Reviewers","contributors":[{"name":"Sanjiv S Agarwala, MD","credentials":
["Professor of Medicine\n","Temple University School of Medicine\n","Chief of
Oncology & Hematology\n","St Luke’s Cancer Center"],"disclosure":""},{"name":"Jose
Banchs, MD, FACC, FASE","credentials":["Director of Echocardiography\n","Associate
Professor of Medicine\n","Cardiology Department\n","University of Texas \n","MD
Anderson Cancer Center"],"disclosure":""},{"name":"Sally Y Barbour, PharmD, BCOP,
CPP","credentials":["Clinical Oncology Pharmacist\n","Duke Comprehensive Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Genentech, Taiho, Teva, Astra
Zeneca [EGFR drugs in lung cancer (trifuridine/tipiracil)]."},{"name":"Aditya
Bardia, MD, MPH","credentials":["Attending Physician\n","Massachusetts General
Hospital Cancer Center\n","Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Novartis [Breast cancer
(Letrozole)]; Pfizer [Breast cancer (Exemestane)]."},{"name":"Emily Bergsland,
MD","credentials":["Professor of Medicine \n","University of California San
Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Lexicon [Carcinoid
(telotristat)]; Merck [Carcinoid/panNET (Pembrolizumab)]; Novartis
[Carcinoid/pNET]. Consultant/Advisory Board: Lexicon [Carcinoid (telotristat)];
Ipsen [ Neuroendocrine tumors (lanreotide)]; Exelixis [Carcinoid/panNET
(cabozantinib)]."},{"name":"Lawrence Blaszkowsky, MD","credentials":["MGH Cancer
Center"],"disclosure":""},{"name":"Linda D Bosserman, MD, FACP","credentials":
["President and Medical Oncologist\n","Wilshire Oncology Medical Group,
Inc"],"disclosure":"Speaker's Bureau: Genentech [oncology value panel]; Association
of Managed Care Pharmacy [value in specialty pharmacy]; PER [case studies and value
talks]; Association of Nurse Navigators [Value-based cancer care (talk)]; Pfizer
[Value-based cancer and breast care (None)]. Consultant/Advisory Boards: Pfizer
[Biosimilars for Her2 and breast cancer]; Anthem Blue Cross Wellpoint [Breast
cancer standards (None)]; American Society of Breast Surgeons [Breast cancer value-
based care (None)]; GSK [Cancer care (None)]; Genentech/Roche [Breast cancer
(None)]; ACCC [Value-based cancer care (None)]; Novartis [ Breast cancer value-
based care (None)]; Sandox-Novartis [Value-based breast cancer care (None)].
Employment: City of Hope Medical Foundation [value based care initiatives]; Front
Line Medical Communications Inc [editor]."},{"name":"John Buatti,
MD","credentials":["Professor of Radiation
Oncology\n","University of Iowa"],"disclosure":""},{"name":"Mark Buyyounouski, MD,
MS","credentials":["Associate Professor\n","Stanford University\n","Department of
Radiation Oncology\n","Director, Genitourinary Cancers"],"disclosure":""},
{"name":"George P Canellos, MD","credentials":["Editor-in-Chief —
Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Shamus Carr, MD,
FACS","credentials":["Assistant Professor of Surgery\n","University of Maryland
School of Medicine"],"disclosure":""},{"name":"Robert L Coleman, MD","credentials":
["Professor & Vice Chair\n","Clinical Research\n","Ann Rife Cox Chair in
Gynecology\n","Department of Gynecologic Oncology\n","University of Texas MD
Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support:
Merck, Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie [ovarian,
uterine, cervix (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib,
veliparib, bevacizumab, emactuzumab, durvalumab, tremelumumab, nivolumab,
selumetinib, everolimus, ribociclib, AZD-1775)]. Consultant/Advisory Boards: Merck,
Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie, Bayer, immunogen
[ovarian, uterine (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib,
veliparib, bevacizumab, emactuzumab, AZD-1775, IMGN-853)]."},{"name":"A Dimitrios
Colevas, MD","credentials":["Associate Professor of Medicine\n","Stanford
University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support:
BMS [head and neck (nivolumab)]; Astra Zeneca [head and neck (durvalumab,
tremelimumab); Regeneron [squamous cell cancer skin (REGN2810)]; Fourty Seven
[generic ph 1 (Hu5F9-G4)]; Novartis [ameloblastoma (dabrafenib, trametinib)]; IRX
[head and neck (IRX-2 Regimen)]; Merck [basal cell cancer (pembrolizumab)]; Celldex
[head and neck (varlilumab)]."},{"name":"Siamak Daneshmand, MD","credentials":
["Associate Professor of Urology\n","Director, Center for Urologic
Oncology\n","University of Southern California"],"disclosure":""},{"name":"Laura A
Dawson, MD","credentials":["Professor\n","Department Radiation Oncology, University
of Toronto\n","Radiation Medicine Program, Princess Margaret Cancer
Centre"],"disclosure":"Consultant/Advisory Boards: Merck [Hepatocellular
carcinoma]. Patent Holder/Lisensure: Raysearch [Image registration (Radiation
planning systems may include image registration tools)]."},{"name":"Jennifer F De
Los Santos, MD","credentials":["Associate Professor\n","Department of Radiation
Oncology\n","University of Alabama at Birmingham"],"disclosure":"Speaker's Bureau:
Varian Medical Systems [Breast cancer (Course in breast cancer treatment)]."},
{"name":"Shrina Duggal, PharmD, BCOP","credentials":["Clinical Pharmacy
Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker’s Bureau: Incyte
[Gastrointestinal cancer (Ruxolitinib)]; Boehringer Ingelheim [Gastrointestinal
cancer (Afatinib)]; Pfizer/Astellas [Gastrointestinal cancer (Enzalutamide)]."},
{"name":"Anthony Elliott, PharmD","credentials":["Duke University
Hospital"],"disclosure":""},{"name":"Katherine Evans, PharmD","credentials":
["Director, Pharmacy Technology\n","Cape Fear Community College"],"disclosure":""},
{"name":"Shelly A Fallo, BS, RPh","credentials":["Clinical Pharmacy Specialist of
Oncology\n","Department of Pharmacy Services\n","Tufts Medical
Center"],"disclosure":""},{"name":"Karen M Fancher, PharmD, BCOP","credentials":
["Clinical Pharmacist\n","Blood & Marrow Transplantation\n","H Lee Moffitt Cancer
Center and Research Institute"],"disclosure":""},{"name":"Heidi D Finnes, PharmD,
BCOP","credentials":["Assistant Professor of Pharmacy\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Harold Frucht, MD","credentials":["Associate
Professor of Clinical Medicine\n","College of Physicians and Surgeons, Columbia
University"],"disclosure":""},{"name":"Thomas Galloway, MD","credentials":
["Assistant Professor\n","Department of Radiation Oncology\n","Fox Chase Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Varian Medical Systems [Head and
neck cancer (Training course)]."},{"name":"Jennifer Suzanne Gass, MD,
FACS","credentials":["Chief of Surgery\n","Breast Fellowship Director\n","Program
in Women’s Oncology\n","Women and Infants’ Hospital\n","Associate Professor of
Surgery \n","Associate Professor of Obstetrics and Gynecology"],"disclosure":""},
{"name":"Geoffrey T Gibney, MD","credentials":["Lombardi Comprehensive Cancer
Center\n","Medstar Georgetown University
Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [oncology
(dabrafenib/trametinib)]; Genentech [oncology (vemurafenib/cobimetinib)]; Newlink
Genetics [oncology (indoximod)]; Incyte [oncology (epacadostat)]; Boston Biomedical
[oncology]. Speaker's Bureau: Merek [melanoma (pembrolizumab)]; Genentech [oncology
(vemurafenib/cobimetinib)]."},{"name":"Timothy D Gilligan, MD","credentials":
["Associate Professor of Medicine\n","Cleveland Clinic Lerner College of
Medicine\n","Vice-Chair for Education\n","Cleveland Clinic Taussig Cancer
Institute\n","Director of Coaching, Center for Excellence in Healthcare
Communication\n","Cleveland Clinic"],"disclosure":""},{"name":"Stephen L Graziano,
MD","credentials":["Professor of Medicine\n","SUNY Upstate Medical
University"],"disclosure":""},{"name":"Robert I Haddad, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: BMS; Merck; Astra
Zeneca; Celgene [Head and neck cancer clinical trials support to institution
(None)]. Consultant/Advisory Boards: BMS; Astra Zeneca; Merck; Pfizer; Eisai [Head
and neck cancer clinical trials (None)]."},{"name":"R Donald Harvey, PharmD, FCCP,
BCPS, BCOP","credentials":["Assistant Professor of Hematology/Medical
Oncology\n","Director of Phase I Program\n","Emory University/Winship Cancer
Institute"],"disclosure":""},{"name":"Thomas J Herzog, MD","credentials":["Deputy
Director\n","University of Cincinnati Cancer
Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca; J & J; Roche;
Clovis; Tesaro [Ovarian cancer (Olaparib, PLD, bevacizumab, rucaparib, niraparib)];
Genmab [Cervical cancer (Tisotumab)]."},{"name":"Warner K Huh, MD","credentials":
["Margaret Cameron Spain Chair in Obstetrics/Gynecology\n","Professor, Division of
Gynecologic Oncology\n","Senior Scientist, UAB Comprehensive Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Merck [Cervical cytology (HPV
vaccines)]; Intuitive Surgical (Robotic Surgery); LICOR (fluorescence imaging);
InCellDx (cervical cancer screening)."},{"name":"Gregory P Kalemkerian,
MD","credentials":["Professor of Medicine\n","Co-Director, Thoracic
Oncology\n","University of Michigan Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
Pharmaceuticals [Lung cancer (pevonedistat)]; Novartis [Lung cancer
(Dabrafenib/trametinib)]; Merck [Lung cancer (Pembrolizumab)]; OncoMed
Pharmaceuticals [Lung cancer (OMP-59R5)]; Abbvie [Lung Cancer (SC002)].
Consultant/Advisory Boards (spouse): Takeda Pharmaceuticals, BioMed Valley
Discoveries, Esperion [drug development and safety analysis]."},{"name":"Sara S
Kim, BS, PharmD, BCOP","credentials":["Clinical Oncology Pharmacy
Specialist\n","The Mount Sinai Medical Center"],"disclosure":""},{"name":"Jeffrey
Kirshner, MD","credentials":["Principal Investigator, HOACNY CCOP\n","Director of
Research and Partner \n","Hematology Oncology Associates of Central NY\n","Clinical
Associate Professor\n","Department of Medicine\n","Upstate Medical University,
Syracuse, NY"],"disclosure":""},{"name":"Laura A Lambert, MD","credentials":
["Assistant Professor of Surgery\n","Director of Peritoneal Surface Malignancy
Program\n","UMass Memorial Medical Center"],"disclosure":""},{"name":"Robert D
Legare, MD","credentials":["Director, Breast Health Center\n","Director, Cancer
Risk Assessment and Prevention Program\n","Associate Professor Obstetrics,
Gynecology and Medicine\n","Warren Alpert Medical School\n","Brown
University"],"disclosure":""},{"name":"Ellis Levine, MD","credentials":["Associate
Professor of Medicine\n","State University of New York at Buffalo/Roswell Park
Cancer Institute"],"disclosure":""},{"name":"Emily Mackler, PharmD,
BCOP","credentials":["Clinical Pharmacist in Hematology/Oncology\n","University of
Michigan Hospitals and Health Centers"],"disclosure":"Consultant/Advisory Board:
NCCN (neutropenic fever, chemotherapy templates)."},{"name":"Martin A Martino,
MD","credentials":["Associate Professor\n","Department of Ob/Gyn\n","Division of
Gynecologic Oncology\n","University of South
Florida"],"disclosure":"Consultant/Advisory Boards: Medtronic [Gynecologic
cancers]; Verb Surgical, Intuitive Surgical, Inc., Tesaro, Inc. [Gynecologic
cancers (Educational and patient safety consultant)]."},{"name":"Jacqueline P
Masker, PharmD","credentials":["Duke University Hospital"],"disclosure":""},
{"name":"Mary S McCabe, RN, MA","credentials":["Clinical Director, Survivorship
Center\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},
{"name":"Carolyn McCourt, MD","credentials":["Assistant Professor\n","Division of
Gynecologic Oncology\n","Department of Obstetrics & Gynecology\n","Washington
University School of Medicine"],"disclosure":"Speaker's Bureau: Genentech [Ovarian
cancer (Bevacizumab)]."},{"name":"Matthew L Meyerson, MD, PhD","credentials":
["Professor of Pathology \n","Dana-Farber Cancer Institute and Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Origimed [Cancer diagnosis].
Equity Ownership/Stock Options: Origimed [Cancer diagnosis]."},{"name":"David
Mutch, MD","credentials":["Professor and Division Chief, Obstetrics & Gynecology,
Gynecologic Oncology\n","Washington University School of
Medicine"],"disclosure":"Speaker's Bureau: Clovis Oncology [Ovarian
cancer (Rucaparib)]; AstraZeneca [Ovarian cancer (Olaparib)]."},{"name":"Jim
Natale, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer
Centers"],"disclosure":"Speaker's Bureau: Merck [Lung Cancer (Keytruda)]."},
{"name":"Larissa Nekhlyudov, MD, MPH","credentials":["Section Editor — Cancer
Survivorship\n","Associate Professor\n","Department of Medicine\n","Brigham &
Women’s Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Scott
Okuno, MD","credentials":["Professor of Oncology\n","Division of Medical
Oncology\n","Mayo Clinic"],"disclosure":"Other Financial Interest: AXIS Medical
Education Faculty [Certified educational activities]."},{"name":"Bert H O'Neil,
MD","credentials":["The Jackie and Joseph Cusick Professor of Oncology\n","Indiana
University Simon Cancer Center"],"disclosure":"Consultant/Advisory Boards: Bayer
[GI (regorafenib)]; Genentech [GI (bevacizumab, cobimetinib)]; Amgen [GI tumors
(talimogene laherpravec); CRC (panitumumab)]; Merrimack [pancreatic cancer (Nal-
IRI)]."},{"name":"David F Penson, MD, MPH","credentials":["Professor of Urologic
Surgery\n","Director of Vanderbilt Center for Surgical Quality and Outcomes
Research"],"disclosure":"Consultant/Advisory Boards: Astellas; Dendreon, Janssen
[Prostate cancer (Enzalutamide, abiraterone, apalutamide, sipuleucel-T)]."},
{"name":"Sandro V Porceddu, MD","credentials":["Radiation Oncologist, Princess
Alexandra Hospital\n","Associate Professor, University of
Queensland"],"disclosure":"Consultant/Advisory Boards: Merck Serono [Head and neck
(Cetuximab)]; Merck Sharpe Dome [Head and Neck (Pembrolizumab)]."},{"name":"Daniel
Przybysz, MD","credentials":["Radiation Oncology\n","Siteman Cancer
Center\n","Washington University in St. Louis"],"disclosure":""},{"name":"David I
Quinn, MBBS (Hons I), PhD, FRACP, FACP","credentials":["Associate Professor of
Medicine\n","University of Southern California Norris Cancer Center\n","Keck School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Millenium [Renal
cell cancer (Tak700)]; Genentech [Renal cell carcinoma (Avastin, atezoluzimab)];
Glaxo Smith Kline/Novartis [Urothelial cancer (Everolimus, zometa, pazopanib)].
Consultant/Advisory Boards: Pfizer [Renal cell carcinoma, prostate cancer
(Sunitinib, axitinib, temsirolimus, avelumab, enzalutamide)]; Novartis/GSK [Renal
cell carcinoma, prostate (Everolimus, zometa, pazopanib)]; Genentech [Bladder
cancer, renal cell carcinoma (Atezoluzimab, bevacuzimab)]; Bayer [Renal cell
carcinoma, prostate cancer , urothelial cancer (Radium 223, sorafenib,
rogaratinib)]; Dendeon [Prostate cancer (Sipuleucel-T)]; Astellas [Prostate cancer
(Enzalutamide)]; BMS [Renal cancer, bladder cancer (Nivolumab, ipilumumab)]; Merck
Sharp Dohme [Bladder cancer, renal cancer (Pembroluzimab)]; Exelexis [Renal cell
carcinoma (Caboxantinib); Jannsen [Prostate cancer (Abiraterone, apalutamide)];
Sanofi Genzyme [Prostate cancer (Cabazitaxel)]."},{"name":"Valerie Relias, PharmD,
BCOP","credentials":["Clinical Pharmacy Specialist\n","Assistant Professor of
Medicine\n","Division of Hematology/Oncology\n","Tufts Medical
Center"],"disclosure":"Speaker's Bureau: Genentech [CLL/indolent lymphoma
(Obinutuzumab)."},{"name":"Jerome P Richie, MD, FACS","credentials":["Section
Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery; Prostate
Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Tina Rizack, MD, MPH","credentials":["Alpert
Medical School of Brown University"],"disclosure":""},{"name":"David I Rosenthal,
MD","credentials":["Director\n","Head and Neck Translational
Research\n","Professor\n","The University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trail Support: Merck Serono KGA
[Head and neck cancer (Cetuximab)]. Consultant/Advisory Boards: Merck Serono KGA
[Head and neck cancer (Cetuximab)]."},{"name":"Howard Safran, MD","credentials":
["Associate Professor of Medicine\n","Brown University Oncology
Group"],"disclosure":""},{"name":"Walter M Stadler, MD, FACP","credentials":
["Professor\n","University of Chicago"],"disclosure":"Grant/Research/Clinical Trial
Support: Astra-Zeneca [Renal cancer (savolitinib)]; BMS [Renal cancer (Nivolumab)];
Boehringer-Ingelheim [Bladder (Afatanib)]; Dendreon [Prostate cancer (Sipuleucel-T,
investigational bladder cancer drug)]; Exilixis [Renal cancer (Cabozantinib)];
Novartis [Renal cancer (Pazopanib; everolimus)]; Genentech [Bladder cancer
(Atezolizumab)]; Jansen [Prostate cancer (Abiraterone)]; Johnson & Johnson [Bladder
cancer (Investigational FGFR inhib)]; Merck [Bladder cancer (Pembrolizumab)];
Millenium [Prostate cancer (Enzalutamide)]; Pfizer [Renal cancer (Sunitinib;
axitinib)]. Speaker's Bureau: CME innovations; CME Network; Dava Oncology,
Research-to-Practice; Medical Communications Media [Bladder, kidney, prostate
cancer CME (Standard of care drugs)]. Consultant/Advisory Boards: Astra-Zeneca
[Bladder cancer (DSMB)]; Caremark/CVS [formulary advice]; Bristol-Myers-Squibb
[Renal Cancer (Immunotherapy development)]; Bayer [Prostate Cancer (DSMB)];
Genentech [Bladder cancer (atezolizumab development)]; Sotio [Prostate cancer (DSMB
chair for novel immunotherapy)]; Pfizer [Renal cancer (Utilization of sunitinib and
axitinib)]."},{"name":"Ashley Stuckey, MD","credentials":["Program in Women’s
Oncology\n","Gynecologic Oncology and Breast Surgery\n","Women & Infants’ Hospital
of Rhode Island\n","Assistant Professor of Obstetrics & Gynecology \n","The Warren
Alpert Medical School of Brown University"],"disclosure":""},{"name":"Stephanie D
Sutphin, PharmD, BCOP","credentials":["Hematology/Oncology Pharmacy
Specialist\n","University of Kentucky HealthCare\n","Adjunct Assistant
Professor\n","College of Pharmacy"],"disclosure":"Consultant/Advisory Board:
Seattle Genetics [Hodgkins (Brentuximab)], Amgen [Biosimilars (Neupogen,
Neulasta)]."},{"name":"William D Tap, MD","credentials":["Section Chief, Sarcoma
Oncology\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Blueprint Medicines [Sarcoma
(BLU-285)]; Daiichi Sankyo [Sarcoma (Pexidartinib)]; Eisai [Sarcoma (Eribulin)];
Eli Lilly [Sarcoma (Olaratumab, Abemaciclib, Ly1309478)]; EMD Serono [Sarcoma
(Exofosfamide)]; Plexxikon [Sarcoma (PLX9486)]; Novartis [Sarcoma (Votrient)];
Janssen [Sarcoma (Trabectadin)], Immune Design (CMB305)]."},{"name":"Premal H
Thaker, MD","credentials":["Assistant Professor in Gynecologic
Oncology\n","Washington University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Uterine
Cancer (Pembrolizumab)]. Speaker’s Bureau: Zoll[Sudden cardiac death (Life
vest);Aralez Pharmaceuticals (yosprala)]. Consultant/Advisory Boards: Celsion
[Ovarian Cancer (GEN-1 immunotherapy)]."},{"name":"Evan Tong,
PharmD","credentials":["Duke University Hospital"],"disclosure":""},
{"name":"Tiffany Traina, MD","credentials":["Assistant Attending
Physician\n","Breast Cancer Medicine Service\n","Assistant Professor in Medicine
\n","Weill Cornell Medical College of Cornell
University"],"disclosure":"Grant/Research/Clinical Trial Support: Medivation
[Breast cancer (Enzalutamide)]; Eisai [Breast cancer (Eribulin)]; Pfizer [Breast
cancer (Palbociclib, enzalutamide)]; Myriad Genetics [Breast cancer (HRD assays)];
Innocrin Pharma [Breast cancer (Seviteronel)]; AstraZeneca [Breast cancer
(Bicalutamide, olaparib)]; Astellas Pharma [Breast cancer (Enzalutamide)]; Lilly
[Breast cancer (Notch inhibitor)]. Speaker's Bureau: Genentech/Roche [Breast cancer
(Pertuzumab, TDM1)]; Eisai [Breast cancer (Eribulin)]; Medivation [Breast cancer
(Enzalutamide)]; Pfizer [Breast cancer (Palbociclib, enzalutamide)]; AstraZeneca
[Breast cancer (Olaparib, bicalutamide)]; Bayer [Breast cancer (IMMU132)];
Immunomedics [Breast cancer (IMMU132)]; Merck [Breast cancer (Pembrolizumab)];
Astellas Pharma [Breast cancer (Enzalutamide)]; Puma Biotechnology [Breast cancer
(Neratinib)]; Advaxis [Breast cancer]; Celgene [Breast cancer (nab-paclitaxel)];
Innocrin Pharma [Breast cancer (Seviteronel)]; Genomic Health [Breast cancer
(OncotypeDx)]."},{"name":"Nicholas Vogelzang, MD","credentials":["Section Editor —
Prostate Cancer\n","Professor of Medicine\n","University of Nevada School of
Medicine\n","US Oncology Research"],"disclosure":"Speaker's Bureau: Pfizer [Kidney
cancer (Sunitinib, axitinib)]; Bayer [Prostate cancer (Radium 223)]; Novartis
[Kidney cancer, PNET (Pazopanib, everolimus); Sanofi [Prostate cancer
(Cabazitaxel)], BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche [Bladder
cancer (Atezolizumab); Astra Zeneca {Bladder cancer (durvalumab)].
Consultant/Advisory Boards: Amgen [Prostate cancer (Denosumab)]; Bayer [Prostate
cancer (Radium 223)]; Pfizer [Kidney cancer (Sunitinib, axitinib)]; Novartis
[Kidney cancer, PNET (Pazopanib, everolimus)]; Sanofi [Prostate cancer
(cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche (Bladder
cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer (durvalumab)] Exelexis
[Kidney cancer (Cabozantinib)]; Clinical Care Options, Cerulean [Kidney cancer
(Liposomal irinotecan)]; Dava Oncology/PER; Dendreon; Medivation/Astellas [Prostate
(Enzalutamide)], Janssen [Prostate cancer (Abiraterone,apalutamide)]; Heron [Nausea
control (Liposomal granisetron)]; Eisai [Kidney cancer (Levantinib)]; Agensys
[Kidney cancer (New targeted agent)]; Boehringer Ingelheim [Mesothelioma
(Nerantinib)]. Employment: US Oncology [GU research (none)]. Equity
Ownership/Stock Options: Caris [Genetic testing for cancer (none)]."},
{"name":"Ageliki G Vouyouka, MD, FACS","credentials":["Associate Professor in
Surgery \n","Associate Professor in Radiology\n","Mt Sinai Medical Center/ Icahn
School of Medicine"],"disclosure":""},{"name":"Antonio C Wolff, MD,
FACP","credentials":["Professor of Oncology\n","The Sidney Kimmel Comprehensive
 Cancer Center at Johns Hopkins"],"disclosure":"Grant/Research/Clinical Trial
Support: Myriad [Breast cancer (HRD assay)]. Patent Holder: cMethDNA [Breast cancer
(Breast cancer methylation)]."},{"name":"Jason D Wright, MD","credentials":["Sol
Goldman Associate Professor of Obstetrics and Gynecology \n","Chief, Division of
Gynecologic Oncology \n","Columbia University College of Physicians and
Surgeons"],"disclosure":"Consultant/Advisory Boards: Tesaro [Gynecologic cancer
(Drug development)]; Clovis Oncology [Gynecologic cancer (Drug development)]."}]}]}